Subject ID,Subject,Subject type,Interaction type,Object ID,Object,Object type,Disease,Insulin,complex/PPI,decreases_phosphorylation of,2932,GSK3B,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_activity of,207,AKT1,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_phosphorylation of,207,AKT1,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_activity of,5997,AKT1-PDPK1 complex,complex/PPI,Alzheimer disease8660,IRS2-mut,gene/protein mutant,increases_activity of,MP:0000913,abnormal brain development,phenotype,Alzheimer disease4137,MAPT-phos,protein modification,is localized in,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,MP:0008415,abnormal neurite morphology,phenotype,Alzheimer disease351,Amyloid beta peptide (25-35),gene/protein,increases_quantity of,351,APP,gene/protein,Alzheimer disease,Insulin,complex/PPI,affects_activity of,GO:0007611,learning or memory,process,Alzheimer diseaseC00031,Glucose,drug/chemical compound,affects_activity of,GO:0007611,learning or memory,process,Alzheimer disease104300,Alzheimer disease,disease,decreases_activity of,GO:0007611,learning or memory,process,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,decreased insulin sensitivity,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,MP:0000807,abnormal hippocampus morphology,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,MP:0000774,decreased brain size,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,MP:0001033,abnormal parasympathetic system morphology,phenotype,Alzheimer diseaseD05932,Streptozocin,drug/chemical compound,decreases_activity of,,Insulin receptor,complex/PPI,Alzheimer diseaseD05932,Streptozocin,drug/chemical compound,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD05932,Streptozocin,drug/chemical compound,decreases_activity of,GO:0045333,cellular respiration,process,Alzheimer disease,Insulin receptor,complex/PPI,affects_activity of,GO:0045333,cellular respiration,process,Alzheimer disease,Insulin receptor,complex/PPI,affects_activity of,GO:0030534,adult behavior,process,Alzheimer diseaseD05932,Streptozocin,drug/chemical compound,affects_activity of,GO:0030534,adult behavior,process,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0030534,adult behavior,process,Alzheimer disease,EGb761 (antidementive drug),drug/chemical compound,increases_activity of,GO:0007611,learning or memory,process,Alzheimer disease5663,PSEN1,gene/protein,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease5664,PSEN2,gene/protein,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,affects_processing of,23385,NCSTN,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,affects_glucosylation of,23385,NCSTN,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,interacts (colocalizes) with,23385,NCSTN,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,affects_expression of,3309,HSPA5,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,affects_expression of,1649,DDIT3,gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,increases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,increases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease23385,NCSTN,gene/protein,increases_activity of,51107,APH1A,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_activity of,5524,PPP2R4,gene/protein,Alzheimer diseaseGO:0050667,homocysteine metabolic process,process,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseGO:0050667,homocysteine metabolic process,process,affects_quantity of,4137,MAPT-phos,protein modification,Alzheimer disease,CAPN,gene/protein,affects_quantity of,2932,GSK3B (truncated),protein modification,Alzheimer diseaseC12269,N-Methyl-D-aspartic acid,drug/chemical compound,affects_quantity of,2932,GSK3B (truncated),protein modification,Alzheimer diseaseC00076,Ca2+,drug/chemical compound,affects_quantity of,2932,GSK3B (truncated),protein modification,Alzheimer diseaseD08174,Memantine,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD08174,Memantine,drug/chemical compound,affects_activity of,2932,GSK3B,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,4744,NEFH-mod,protein modification,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,4744,NEFH,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,5300,PIN1,gene/protein,Alzheimer diseaseGO:0008286,insulin receptor signaling pathway,process,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,,Insulin receptor,complex/PPI,Alzheimer disease104300,Alzheimer disease,disease,decreases_activity of,,protein tyrosine kinase,gene/protein,Alzheimer disease,Insulin,complex/PPI,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC00031,Glucose,drug/chemical compound,affects_quantity of,351,APP,gene/protein,Alzheimer disease,Insulin,complex/PPI,affects_quantity of,351,APP,gene/protein,Alzheimer diseaseC00031,Glucose,drug/chemical compound,increases_quantity of,,Insulin,complex/PPI,Alzheimer disease348,APOE,gene/protein,affects_quantity of,351,APP,gene/protein,Alzheimer disease351,APP (KPI-domain-containing),gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_processing of,351,APP,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease682,BSG,gene/protein,interacts (colocalizes) with,466,Gamma-secretase complex,complex/PPI,Alzheimer disease2932,GSK3B,gene/protein,affects_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease5337,PLD1,gene/protein,affects_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease10972,TMED10,gene/protein,affects_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease2932,GSK3B,gene/protein,increases_phosphorylation of,4137,MAPT,gene/protein,Alzheimer disease4137,MAPT-phos,protein modification,increases_quantity of,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer diseaseMP:0003214,neurofibrillary tangles,phenotype,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease2932,GSK3B,gene/protein,interacts (colocalizes) with,5663,PSEN1,gene/protein,Alzheimer disease4137,MAPT,gene/protein,interacts (colocalizes) with,5663,PSEN1,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,affects_activity of,5663,PSEN1,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,affects_activity of,GO:0060070,canonical Wnt signaling pathway,process,Alzheimer disease2931,GSK3A,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC15473,Lithium,drug/chemical compound,decreases_activity of,2931,GSK3A,gene/protein,Alzheimer diseaseC15473,Lithium,drug/chemical compound,decreases_expression of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC15473,Lithium,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC15473,Lithium,drug/chemical compound,decreases_activity of,2932,GSK3B,gene/protein,Alzheimer diseaseC15473,Lithium,drug/chemical compound,affects_processing of,351,APP,gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,interacts (colocalizes) with,1499,CTNNB1,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,affects_quantity of,1499,CTNNB1,gene/protein,Alzheimer disease1499,CTNNB1,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease2931,GSK3A,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer disease2931,GSK3A,gene/protein,increases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer diseaseC17743,Bisdemethoxycurcumin,drug/chemical compound,increases_activity of,GO:0006909,phagocytosis,process,Alzheimer diseaseC17743,Bisdemethoxycurcumin,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC17743,Bisdemethoxycurcumin,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC17743,Bisdemethoxycurcumin,drug/chemical compound,increases_expression of,4248,MGAT3,gene/protein,Alzheimer disease,,,none selected,,,,Alzheimer disease1499,CTNNB1,gene/protein,interacts (colocalizes) with,2932,GSK3B,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,decreases_quantity of,1499,CTNNB1,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,decreases_activity of,GO:0060070,canonical Wnt signaling pathway,process,Alzheimer disease5663,PSEN1,gene/protein,affects_phosphorylation of,1499,CTNNB1,gene/protein,Alzheimer disease,presenilin deficiency,phenotype,affects_quantity of,1499,CTNNB1-phosSer45,protein modification,Alzheimer diseaseGO:0060070,canonical Wnt signaling pathway,process,decreases_quantity of,1499,CTNNB1-phosSer33Ser37Thr41,protein modification,Alzheimer diseaseGO:0060070,canonical Wnt signaling pathway,process,decreases_quantity of,1499,CTNNB1-phosSer45,protein modification,Alzheimer disease2932,GSK3B,gene/protein,increases_phosphorylation of,1499,CTNNB1,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,increases_quantity of,1499,CTNNB1-phosSer33Ser37Thr41,protein modification,Alzheimer disease,Uncharged thioflavin-T derivative,drug/chemical compound,interacts (colocalizes) with,351,Amyloid beta peptide,gene/protein,Alzheimer disease1020,CDK5,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease1020,CDK5,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC15473,Lithium,drug/chemical compound,affects_activity of,2932,GSK3B,gene/protein,Alzheimer disease103029079,Roscovitine,drug/chemical compound,decreases_activity of,1020,CDK5,gene/protein,Alzheimer disease103029079,Roscovitine,drug/chemical compound,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease1020,CDK5,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,PS1/PS2-KO mouse,organism model,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease,PS1/PS2-KO mouse,organism model,decreases_activity of,GO:0007611,learning or memory,process,Alzheimer disease,PS1/PS2-KO mouse,organism model,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,PS1/PS2-KO mouse,organism model,increases_activity of,MP:0002152,abnormal brain morphology,phenotype,Alzheimer disease,PS1/PS2-KO mouse,organism model,increases_activity of,MP:0002183,gliosis,phenotype,Alzheimer disease,PS1/PS2-KO mouse,organism model,increases_quantity of,MP:0004250,tau protein deposits,phenotype,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease5664,PSEN2-mut,gene/protein mutant,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,affects_activity of,GO:0007611,learning or memory,process,Alzheimer disease5664,PSEN2-mut,gene/protein mutant,affects_activity of,GO:0007611,learning or memory,process,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,increases_activity of,MP:0002152,abnormal brain morphology,phenotype,Alzheimer disease5664,PSEN2-mut,gene/protein mutant,increases_activity of,MP:0002152,abnormal brain morphology,phenotype,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,increases_activity of,MP:0002183,gliosis,phenotype,Alzheimer disease5664,PSEN2-mut,gene/protein mutant,increases_activity of,MP:0002183,gliosis,phenotype,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,affects_quantity of,MP:0004250,tau protein deposits,phenotype,Alzheimer disease5664,PSEN2-mut,gene/protein mutant,affects_quantity of,MP:0004250,tau protein deposits,phenotype,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,affects_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,MP:0004250,tau protein deposits,phenotype,Alzheimer diseaseMP:0004250,tau protein deposits,phenotype,is localized in,GO:0005622,intracellular,cellular component,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,is localized in,GO:0005576,extracellular region,cellular component,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer diseaseMP:0003214,neurofibrillary tangles,phenotype,is localized in,GO:0030425,dendrite,cellular component,Alzheimer disease4137,MAPT-phos,protein modification,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease5664,PSEN2-mut,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease351,APP-mut,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseGO:0007568,aging,process,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseGO:0007568,aging,process,affects_activity of,GO:0005739,mitochondrion,cellular component,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,affects_activity of,GO:0005739,mitochondrion,cellular component,Alzheimer disease2534,FYN,gene/protein,interacts (colocalizes) with,4137,MAPT,gene/protein,Alzheimer disease351,Amyloid beta peptide,gene/protein,decreases_activity of,,Mitochondrial respiratory chain complex IV,complex/PPI,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseMP:0004231,abnormal calcium ion homeostasis,phenotype,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,affects_activity of,,Calcium-release channel,complex/PPI,Alzheimer disease351,Amyloid beta peptide,gene/protein,interacts (colocalizes) with,10105,PPIF,gene/protein,Alzheimer disease351,APP,gene/protein,interacts (colocalizes) with,,"TOM complex, mitochondrial",complex/PPI,Alzheimer disease351,APP,gene/protein,interacts (colocalizes) with,,"TIM complex, mitochondrial",complex/PPI,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,GO:0030061,mitochondrial crista,cellular component,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0042407,cristae formation,process,Alzheimer disease5663,PSEN1-p.L286V,gene/protein mutant,affects_activity of,GO:0055074,calcium ion homeostasis,process,Alzheimer disease5663,PSEN1-p.L286V,gene/protein mutant,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,is localized in,GO:0005783,endoplasmic reticulum,cellular component,Alzheimer disease6263,RYR3,gene/protein,interacts (colocalizes) with,5664,PSEN2,gene/protein,Alzheimer disease5664,PSEN2-p.N141I,gene/protein mutant,increases_activity of,836,CASP3,gene/protein,Alzheimer disease5664,PSEN2-p.N141I,gene/protein mutant,increases_activity of,6263,RYR3,gene/protein,Alzheimer disease5664,PSEN2-p.N141I,gene/protein mutant,increases_activity of,,Calcium-release channel,complex/PPI,Alzheimer diseaseC06939,Dantrolene,drug/chemical compound,decreases_activity of,6263,RYR3,gene/protein,Alzheimer diseaseC06939,Dantrolene,drug/chemical compound,decreases_activity of,,Calcium-release channel,complex/PPI,Alzheimer diseaseC06939,Dantrolene,drug/chemical compound,decreases_activity of,5664,PSEN2-p.N141I,gene/protein mutant,Alzheimer diseaseC06939,Dantrolene,drug/chemical compound,decreases_activity of,GO:0070997,neuron death,process,Alzheimer diseaseC06939,Dantrolene,drug/chemical compound,decreases_activity of,836,CASP3,gene/protein,Alzheimer disease6263,RYR3,gene/protein,affects_activity of,836,CASP3,gene/protein,Alzheimer diseaseC06939,Dantrolene,drug/chemical compound,decreases_activity of,GO:0006915,apoptotic process,process,Alzheimer disease5664,PSEN2-p.N141I,gene/protein mutant,increases_quantity of,C00076,Ca2+,drug/chemical compound,Alzheimer disease6263,RYR3,gene/protein,interacts (colocalizes) with,GO:0005783,endoplasmic reticulum,cellular component,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,interacts (colocalizes) with,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,GO:0042803,protein homodimerization activity,process,Alzheimer disease,"Amyloid beta peptide (42, homodimer)",complex/PPI,decreases_activity of,,Mitochondrial respiratory chain complex IV,complex/PPI,Alzheimer diseaseC00070,Cu2+,drug/chemical compound,affects_activity of,,"Amyloid beta peptide (42, homodimer)",complex/PPI,Alzheimer disease351,Amyloid beta peptide,gene/protein,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease351,Amyloid beta peptide,gene/protein,is localized in,GO:0005739,mitochondrion,cellular component,Alzheimer diseaseC07185,Valproic acid,drug/chemical compound,affects_processing of,351,APP,gene/protein,Alzheimer diseaseC15473,Lithium,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer diseaseC07185,Valproic acid,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer diseaseC15473,Lithium,drug/chemical compound,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,LiCl,drug/chemical compound,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,LiCl,drug/chemical compound,decreases_activity of,2932,GSK3B,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,10371,SEMA3A,gene/protein,Alzheimer disease10371,SEMA3A,gene/protein,is localized in,BTO:0003087,subiculum,tissue/cell line,Alzheimer disease10371,SEMA3A,gene/protein,is localized in,BTO:0000601,hippocampus,tissue/cell line,Alzheimer disease104300,Alzheimer disease,disease,affects transport of,10371,SEMA3A,gene/protein,Alzheimer disease1020,CDK5,gene/protein,affects_phosphorylation of,1808,DPYSL2,gene/protein,Alzheimer disease1808,DPYSL2,gene/protein,affects_phosphorylation of,1808,DPYSL2,gene/protein,Alzheimer disease51107,APH1A,gene/protein,affects_quantity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease51107,APH1A,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,affects_phosphorylation of,1808,DPYSL2,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,affects_phosphorylation of,1809,DPYSL3,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,affects_activity of,1808,DPYSL2,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,affects_activity of,1809,DPYSL3,gene/protein,Alzheimer disease1808,DPYSL2-p,protein modification,affects_activity of,GO:0007409,axonogenesis,process,Alzheimer disease2932,GSK3B,gene/protein,increases_phosphorylation of,1808,DPYSL2,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,increases_phosphorylation of,1808,DPYSL2-Ser522,protein modification,Alzheimer disease1808,DPYSL2-mut,gene/protein mutant,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease,HSP70,gene/protein,affects_activity of,4137,MAPT,gene/protein,Alzheimer diseaseGO:0006950,response to stress,process,increases_expression of,,HSP70,gene/protein,Alzheimer disease,HSP70,gene/protein,interacts (colocalizes) with,4137,MAPT,gene/protein,Alzheimer disease,HSP70,gene/protein,affects_quantity of,4137,MAPT,gene/protein,Alzheimer diseaseC10107,Myricetin,drug/chemical compound,decreases_activity of,,HSP70,gene/protein,Alzheimer diseaseC00220,Methylene blue,drug/chemical compound,decreases_activity of,,HSP70,gene/protein,Alzheimer disease5664,PSEN2-mut,gene/protein mutant,affects_activity of,,Calcium-release channel,complex/PPI,Alzheimer disease348,APOE-mut,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease348,APOE-mut,gene/protein mutant,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease351,APP-mut,gene/protein mutant,increases_processing of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,increases_processing of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease351,Amyloid beta peptide,gene/protein,affects_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease351,Amyloid beta peptide,gene/protein,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,increases_activity of,MP:0002183,gliosis,phenotype,Alzheimer disease10273,STUB1,gene/protein,interacts (colocalizes) with,,HSP70,gene/protein,Alzheimer disease10273,STUB1,gene/protein,interacts (colocalizes) with,,HSP90,gene/protein,Alzheimer disease,HSP90,gene/protein,decreases_activity of,3297,HSF1,gene/protein,Alzheimer disease3297,HSF1-phos,protein modification,affects_expression of,,HSP70,gene/protein,Alzheimer disease3297,HSF1-phos,protein modification,affects_expression of,3315,HSPB1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,3315,HSPB1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,,HSP70,gene/protein,Alzheimer disease3309,HSPA5,gene/protein,interacts (colocalizes) with,351,APP,gene/protein,Alzheimer disease3309,HSPA5,gene/protein,is localized in,GO:0005783,endoplasmic reticulum,cellular component,Alzheimer disease10273,STUB1,gene/protein,interacts (colocalizes) with,351,APP,gene/protein,Alzheimer disease26353,HSPB8,gene/protein,interacts (colocalizes) with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease26353,HSPB8,gene/protein,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease3315,HSPB1,gene/protein,interacts (colocalizes) with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease3315,HSPB1,gene/protein,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease3297,HSF1,gene/protein,increases_expression of,351,APP,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,increases_activity of,GO:0070842,aggresome assembly,process,Alzheimer disease3315,HSPB1,gene/protein,decreases_quantity of,4137,MAPT-hyperphos,protein modification,Alzheimer disease3315,HSPB1,gene/protein,interacts (colocalizes) with,4137,MAPT-hyperphos,protein modification,Alzheimer disease3315,HSPB1,gene/protein,interacts (colocalizes) with,4137,MAPT,gene/protein,Alzheimer disease3315,HSPB1,gene/protein,interacts (colocalizes) with,MP:0004250,tau protein deposits,phenotype,Alzheimer disease3315,HSPB1,gene/protein,increases_phosphorylation of,4137,MAPT,gene/protein,Alzheimer disease1410,CRYAB,gene/protein,decreases_quantity of,4137,MAPT-phos,protein modification,Alzheimer disease1410,CRYAB,gene/protein,decreases_quantity of,2932,GSK3B-phos,protein modification,Alzheimer disease4137,MAPT,gene/protein,interacts (colocalizes) with,,HSP70,gene/protein,Alzheimer disease,HSP90,gene/protein,affects_quantity of,4137,MAPT-phosSer202Thr205,protein modification,Alzheimer disease,HSP90,gene/protein,affects_quantity of,4137,MAPT-phosSer396Ser404,protein modification,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,207,AKT1,gene/protein,Alzheimer disease207,AKT1,gene/protein,affects_expression of,10273,STUB1,gene/protein,Alzheimer disease207,AKT1,gene/protein,increases_activity of,2011,MARK2,gene/protein,Alzheimer disease207,AKT1,gene/protein,affects_phosphorylation of,4137,MAPT,gene/protein,Alzheimer disease,HSP90,gene/protein,affects_quantity of,4137,MAPT,gene/protein,Alzheimer disease,HSP70,gene/protein,interacts (colocalizes) with,GO:0005874,microtubule,cellular component,Alzheimer disease10273,STUB1,gene/protein,affects_ubiquitination/sumoylation of,4137,MAPT,gene/protein,Alzheimer disease10273,STUB1,gene/protein,affects_quantity of,4137,MAPT,gene/protein,Alzheimer disease,HSP70,gene/protein,affects_ubiquitination/sumoylation of,4137,MAPT,gene/protein,Alzheimer disease10273,STUB1,gene/protein,increases_quantity of,MP:0004250,tau protein deposits,phenotype,Alzheimer diseaseC11222,Geldanamycin,drug/chemical compound,affects_quantity of,,HSP70,gene/protein,Alzheimer disease,HSP70,gene/protein,decreases_quantity of,4137,MAPT (insoluble),gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,1410,CRYAB,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,3315,HSPB1,gene/protein,Alzheimer disease1410,CRYAB,gene/protein,decreases_phosphorylation of,4137,MAPT,gene/protein,Alzheimer disease1410,CRYAB,gene/protein,decreases_phosphorylation of,GO:0005883,neurofilament,cellular component,Alzheimer disease1410,CRYAB,gene/protein,decreases_expression of,2932,GSK3B,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0000320,re-entry into mitotic cell cycle,process,Alzheimer disease4171,pMCM2,protein modification,affects_activity of,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer disease4171,pMCM2,protein modification,affects_activity of,MP:0008415,abnormal neurite morphology,phenotype,Alzheimer disease4171,pMCM2,protein modification,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease29950,SERTAD1,gene/protein,increases_activity of,1019,CDK4,gene/protein,Alzheimer disease351,Amyloid beta peptide,gene/protein,increases_expression of,29950,SERTAD1,gene/protein,Alzheimer diseaseGO:0032902,nerve growth factor production,process,affects_expression of,29950,SERTAD1,gene/protein,Alzheimer disease29950,SERTAD1,gene/protein,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer disease29950,SERTAD1,gene/protein,affects_activity of,GO:0070997,neuron death,process,Alzheimer disease207,AKT1,gene/protein,increases_phosphorylation of,2932,GSK3B,gene/protein,Alzheimer disease,increased AKT1 level,phenotype,cooccurs with,,increased MAPT level,phenotype,Alzheimer disease,increased AKT1 level,phenotype,cooccurs with,,increased MAPT-phos level,phenotype,Alzheimer disease,increased AKT-phosThr308 level,phenotype,cooccurs with,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer disease207,AKT1,gene/protein,affects_phosphorylation of,,GSK3,gene/protein,Alzheimer disease207,AKT1,gene/protein,increases_quantity of,4137,MAPT-hyperphos,protein modification,Alzheimer disease,A4 (novobiocin analogue),drug/chemical compound,decreases_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease3315,HSPB1,gene/protein,interacts (colocalizes) with,4137,MAPT-mod,protein modification,Alzheimer disease2932,GSK3B,gene/protein,affects_phosphorylation of,4137,MAPT,gene/protein,Alzheimer disease10273,STUB1,gene/protein,affects_ubiquitination/sumoylation of,4137,MAPT-phos,protein modification,Alzheimer disease4137,MAPT-phos,protein modification,affects_activity of,GO:0008219,cell death,process,Alzheimer disease10273,STUB1,gene/protein,decreases_activity of,GO:0008219,cell death,process,Alzheimer disease1020,CDK5,gene/protein,affects_phosphorylation of,4137,MAPT,gene/protein,Alzheimer disease6037,CHIP-HSC70 complex,complex/PPI,increases_ubiquitination/sumoylation of,4137,MAPT-phos,protein modification,Alzheimer diseaseGO:0005874,microtubule,process,affects_dissociation of,4137,MAPT-phos,protein modification,Alzheimer disease4137,MAPT-phos,protein modification,interacts (colocalizes) with,3312,HSPA8,gene/protein,Alzheimer disease7322,UBE2D2,gene/protein,affects_ubiquitination/sumoylation of,4137,MAPT,gene/protein,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,is localized in,GO:0031012,extracellular matrix,cellular component,Alzheimer diseaseMP:0003214,neurofibrillary tangles,phenotype,is localized in,GO:0005622,intracellular,cellular component,Alzheimer disease834,CASP1,gene/protein,increases_processing of,4137,MAPT,gene/protein,Alzheimer disease836,CASP3,gene/protein,increases_processing of,4137,MAPT,gene/protein,Alzheimer disease839,CASP6,gene/protein,increases_processing of,4137,MAPT,gene/protein,Alzheimer disease840,CASP7,gene/protein,increases_processing of,4137,MAPT,gene/protein,Alzheimer disease841,CASP8,gene/protein,increases_processing of,4137,MAPT,gene/protein,Alzheimer disease836,CASP3,gene/protein,affects_processing of,4137,MAPT-p.D421E,gene/protein mutant,Alzheimer disease840,CASP7,gene/protein,affects_processing of,4137,MAPT-p.D421E,gene/protein mutant,Alzheimer disease841,CASP8,gene/protein,affects_processing of,4137,MAPT-p.D421E,gene/protein mutant,Alzheimer disease4137,MAPT-proc (1-421),protein modification,increases_activity of,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer disease,Vaccinium (blueberry plant) supplementation,environment,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,Vaccinium (blueberry plant) supplementation,environment,affects_activity of,GO:0023041,neuronal signal transduction,process,Alzheimer disease,Vaccinium (blueberry plant) supplementation,environment,affects_activity of,GO:0007568,aging,process,Alzheimer diseaseC09731,Epigallocatechin 3-gallate,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC09731,Epigallocatechin 3-gallate,drug/chemical compound,decreases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer diseaseC09731,Epigallocatechin 3-gallate,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC09731,Epigallocatechin 3-gallate,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC09731,Epigallocatechin 3-gallate,drug/chemical compound,increases_processing of,351,APP,gene/protein,Alzheimer diseaseC09731,Epigallocatechin 3-gallate,drug/chemical compound,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease102,ADAM10,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer diseaseC09731,Epigallocatechin 3-gallate,drug/chemical compound,increases_quantity of,351,sAPP-alpha,gene/protein,Alzheimer diseaseC09731,Epigallocatechin 3-gallate,drug/chemical compound,affects_activity of,,Alpha-secretase,gene/protein,Alzheimer diseaseC09731,Epigallocatechin 3-gallate,drug/chemical compound,increases_quantity of,102,ADAM10 (active),protein modification,Alzheimer disease,ADAM10 (active),protein modification,increases_quantity of,351,sAPP-alpha,gene/protein,Alzheimer disease8754,ADAM9,gene/protein,affects_activity of,,Alpha-secretase,gene/protein,Alzheimer disease6868,ADAM17,gene/protein,affects_activity of,,Alpha-secretase,gene/protein,Alzheimer disease102,ADAM10,gene/protein,decreases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer diseaseC08944,Ginsenoside Re,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer diseaseC08946,Ginsenoside Rg1,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease,Ginsenoside Rg3,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer diseaseC08946,Ginsenoside Rg1,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseC08944,Ginsenoside Re,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,Ginsenoside F11,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,Ginsenoside Rg3,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease53787698,Ginsenoside Rb1,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease12013896,Ginsenoside Rb2,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease91145241,American ginseng,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,Chinese ginseng,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,Ginsenoside F11,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease53787698,Ginsenoside Rb1,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease12013896,Ginsenoside Rb2,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease,Allium sativum (garlic) supplementation,environment,increases_quantity of,351,sAPP-alpha,gene/protein,Alzheimer disease,Allium sativum (garlic) supplementation,environment,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease,Insulin,complex/PPI,affects_activity of,23621,BACE1,gene/protein,Alzheimer disease3952,LEP,gene/protein,affects_activity of,23621,BACE1,gene/protein,Alzheimer disease,Insulin,complex/PPI,affects_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease3952,LEP,gene/protein,affects_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease,Insulin,complex/PPI,affects_processing of,351,APP,gene/protein,Alzheimer disease3952,LEP,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer disease,Insulin,complex/PPI,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease3952,LEP,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,Insulin,complex/PPI,affects_activity of,3416,IDE,gene/protein,Alzheimer disease3952,LEP,gene/protein,affects_activity of,3416,IDE,gene/protein,Alzheimer diseaseC15473,Lithium,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseC07185,Valproic acid,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,Allium sativum (garlic) supplementation,environment,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease3569,IL6,gene/protein,increases_activity of,MP:0001863,vascular inflammation,phenotype,Alzheimer disease7124,TNF,gene/protein,increases_activity of,MP:0001863,vascular inflammation,phenotype,Alzheimer disease125853,"Diabetes mellitus, type II",disease,increases_quantity of,3569,IL6,gene/protein,Alzheimer disease125853,"Diabetes mellitus, type II",disease,increases_quantity of,7124,TNF,gene/protein,Alzheimer disease125853,"Diabetes mellitus, type II",disease,increases_activity of,,cognitive impairment,phenotype,Alzheimer disease,APP+-ob/ob mouse,organism model,increases_activity of,MP:0001863,vascular inflammation,phenotype,Alzheimer disease,APP+-ob/ob mouse,organism model,increases_activity of,MP:0004254,cerebral amyloid angiopathy,phenotype,Alzheimer disease,high-fat diet,environment,decreases_activity of,GO:0007613,memory,process,Alzheimer disease,APP+-NSY mouse,organism model,increases_activity of,MP:0005293,impaired glucose tolerance,phenotype,Alzheimer disease,APP+-NSY mouse,organism model,increases_activity of,,cognitive impairment,phenotype,Alzheimer disease,APP+-ob/ob mouse,organism model,increases_activity of,MP:0002183,gliosis,phenotype,Alzheimer disease351,Amyloid beta peptide (soluble),gene/protein,decreases_activity of,GO:0007613,memory,process,Alzheimer disease10355719,Scyllo-Inositol,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (assemblies),gene/protein,Alzheimer disease10355719,Scyllo-Inositol,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease50661588,Latrepirdine,drug/chemical compound,decreases_activity of,MP:0006036,abnormal mitochondrial physiology,phenotype,Alzheimer disease50661588,Latrepirdine,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD07869,Donepezil,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD04292,Galantamine,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD03822,Rivastigmine,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD08555,Tacrine,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,Allium sativum (garlic) supplementation,environment,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,S-allyl-cysteine,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,Di-allyl-disulfide,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,Allium sativum (garlic) supplementation,environment,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,S-allyl-cysteine,drug/chemical compound,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,Di-allyl-disulfide,drug/chemical compound,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,Allium sativum (garlic) supplementation,environment,decreases_quantity of,351,Amyloid beta peptide (soluble),gene/protein,Alzheimer disease,S-allyl-cysteine,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (soluble),gene/protein,Alzheimer disease,Di-allyl-disulfide,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (soluble),gene/protein,Alzheimer disease,Allium sativum (garlic) supplementation,environment,decreases_quantity of,351,Amyloid beta peptide (fibrillar),gene/protein,Alzheimer disease,S-allyl-cysteine,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (fibrillar),gene/protein,Alzheimer disease,Di-allyl-disulfide,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (fibrillar),gene/protein,Alzheimer disease,Allium sativum (garlic) supplementation,environment,decreases_activity of,GO:0006954,inflammatory response,process,Alzheimer disease,S-allyl-cysteine,drug/chemical compound,decreases_activity of,GO:0006954,inflammatory response,process,Alzheimer disease,Di-allyl-disulfide,drug/chemical compound,decreases_activity of,GO:0006954,inflammatory response,process,Alzheimer disease,Allium sativum (garlic) supplementation,environment,decreases_quantity of,4137,MAPT-phos,protein modification,Alzheimer disease,S-allyl-cysteine,drug/chemical compound,decreases_quantity of,4137,MAPT-phos,protein modification,Alzheimer disease,Di-allyl-disulfide,drug/chemical compound,decreases_quantity of,4137,MAPT-phos,protein modification,Alzheimer disease,Tg2576 mouse,organism model,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,Tg2576 mouse,organism model,affects_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease,TgCRND8 mouse,organism model,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,TgCRND8 mouse,organism model,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseGO:0007568,aging,process,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,Allium sativum (garlic) supplementation,environment,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,Ginkgo biloba,drug/chemical compound,increases_activity of,GO:0007611,learning or memory,process,Alzheimer disease,Ginkgo biloba,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,affects_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease,Ginkgo biloba,drug/chemical compound,decreases_activity of,,dystrophic neurites,phenotype,Alzheimer diseaseC02477,alpha-Tocopherol,drug/chemical compound,decreases_activity of,,Dystrophic neurites,disease,Alzheimer disease,Ginkgo biloba,drug/chemical compound,decreases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseC02477,alpha-Tocopherol,drug/chemical compound,decreases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease,pomegranate juice supplementation,environment,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,23411,SIRT1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,,cognitive impairment,phenotype,Alzheimer disease23411,SIRT1,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease23411,SIRT1,gene/protein,affects_quantity of,4137,MAPT,gene/protein,Alzheimer disease,COL25A1 TG mouse,organism model,increases_expression of,84570,COL25A1,gene/protein,Alzheimer disease,COL25A1 TG mouse,organism model,increases_expression of,23621,BACE1,gene/protein,Alzheimer disease,COL25A1 TG mouse,organism model,increases_quantity of,8851,CDK5R1,gene/protein,Alzheimer disease,COL25A1 TG mouse,organism model,increases_quantity of,8851,p25,gene/protein,Alzheimer disease,COL25A1 TG mouse,organism model,affects_activity of,GO:0048143,astrocyte activation,process,Alzheimer disease,COL25A1 TG mouse,organism model,increases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease,COL25A1 TG mouse,organism model,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,COL25A1 TG mouse,organism model,increases_activity of,,synaptophysin loss,phenotype,Alzheimer disease466,Gamma-secretase complex,complex/PPI,is localized in,GO:0008021,synaptic vesicle,cellular component,Alzheimer disease466,Gamma-secretase complex,complex/PPI,interacts (colocalizes) with,GO:0097060,synaptic membrane,cellular component,Alzheimer disease466,Gamma-secretase complex,complex/PPI,is localized in,GO:0005768,endosome,cellular component,Alzheimer disease351,Amyloid beta peptide (40),gene/protein,is localized in,GO:0008021,synaptic vesicle,cellular component,Alzheimer disease466,Gamma-secretase complex,complex/PPI,is localized in,GO:0045202,synapse,cellular component,Alzheimer disease23411,SIRT1,gene/protein,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease23411,SIRT1,gene/protein,affects_activity of,,NF-kappaB complex,complex/PPI,Alzheimer disease,NF-kappaB complex,complex/PPI,affects_activity of,GO:0051402,neuron apoptotic process,process,Alzheimer diseaseC03582,Resveratrol,drug/chemical compound,increases_activity of,23411,SIRT1,gene/protein,Alzheimer diseaseC03582,Resveratrol,drug/chemical compound,decreases_activity of,,NF-kappaB complex,complex/PPI,Alzheimer disease466,Gamma-secretase complex,complex/PPI,interacts (colocalizes) with,GO:0005802,trans-Golgi network,cellular component,Alzheimer disease23385,NCSTN,gene/protein,interacts (colocalizes) with,GO:0005802,trans-Golgi network,cellular component,Alzheimer disease23385,NCSTN,gene/protein,interacts (colocalizes) with,5663,PSEN1,gene/protein,Alzheimer disease6049,Ncstn-Psen1 complex,complex/PPI,interacts (colocalizes) with,GO:0005802,trans-Golgi network,cellular component,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,1453,CSNK1D,gene/protein,Alzheimer disease1453,CSNK1D,gene/protein,interacts (colocalizes) with,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,4137,MAPT-var (exon 10),mRNA/protein variant,Alzheimer disease4137,MAPT-var (exon 10),mRNA/protein variant,increases_quantity of,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer disease,PS cDKO mouse,organism model,affects_activity of,GO:0007611,learning or memory,process,Alzheimer disease,PS cDKO mouse,organism model,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease,PS cDKO mouse,organism model,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_activity of,GO:0006954,inflammatory response,process,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,712,C1QA,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,713,C1QB,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,714,C1QC,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,719,C3AR1,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,2670,GFAP,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,928,CD9,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,1075,CTSC,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,972,CD74,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,1522,CTSZ,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,6336,SCN10A,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,2697,GJA1,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,2880,GPX5,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,1351,COX8A,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,2782,GNB1,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,4520,MTF1,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,6672,SP100,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,431707,LHX8,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,9421,HAND1,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,9055,PRC1,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,3799,KIF5B,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,368,ABCC6,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,10487,CAP1,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,54407,SLC38A2,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,23166,STAB1,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,7306,TYRP1,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,7148,TNXB,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,55364,IMPACT,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,increases_expression of,57704,GBA2,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,7252,TSHB,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,2012,EMP1,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,10220,GDF11,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,8514,KCNAB2,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,2149,F2R,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,3753,KCNE1,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,8322,FZD4,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,3292,HSD17B1,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,51635,DHRS7,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,2180,ACSL1,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,1628,DBP,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,2309,FOXO3,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,1044,CDX1,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,6619,SNAPC3,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,9051,PSTPIP1,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,398,ARHGDIG,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,9595,CYTIP,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,23031,MAST3,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,5168,ENPP2,gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,PS cDKO mouse,organism model,decreases_expression of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease1020,CDK5,gene/protein,affects_activity of,2932,GSK3B,gene/protein,Alzheimer disease1020,CDK5,gene/protein,affects_phosphorylation of,5052,PRDX1,gene/protein,Alzheimer disease1020,CDK5,gene/protein,affects_phosphorylation of,7001,PRDX2,gene/protein,Alzheimer disease1020,CDK5,gene/protein,decreases_activity of,5052,PRDX1,gene/protein,Alzheimer disease,CDK5/p25 complex,complex/PPI,decreases_activity of,7001,PRDX2,gene/protein,Alzheimer disease8851,p25,gene/protein,increases_activity of,1020,CDK5,gene/protein,Alzheimer disease,CDK5/p25 complex,complex/PPI,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,8851,p25,gene/protein,Alzheimer disease8851,CDK5R1,gene/protein,affects_activity of,1020,CDK5,gene/protein,Alzheimer disease8851,CDK5R1,gene/protein,affects_quantity of,8851,p25,gene/protein,Alzheimer disease8851,p25,gene/protein,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease8851,p25,gene/protein,interacts (colocalizes) with,1020,CDK5,gene/protein,Alzheimer disease,CDK5/p25 complex,complex/PPI,affects_activity of,1020,CDK5,gene/protein,Alzheimer disease,CDK5/p25 complex,complex/PPI,increases_phosphorylation of,4137,MAPT,gene/protein,Alzheimer disease,CDK5/p25 complex,complex/PPI,increases_quantity of,4137,MAPT-phos,protein modification,Alzheimer disease4137,MAPT-phos,protein modification,interacts (colocalizes) with,GO:0005874,microtubule,cellular component,Alzheimer disease,CDK5/p25 complex,complex/PPI,affects_activity of,GO:0051402,neuron apoptotic process,process,Alzheimer disease8851,p25,gene/protein,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease8851,p25,gene/protein,is localized in,BTO:0000938,neuron,tissue/cell line,Alzheimer disease,CDK5/p25 complex,complex/PPI,affects_phosphorylation of,7001,PRDX2,gene/protein,Alzheimer disease,CDK5/p25 complex,complex/PPI,decreases_activity of,5052,PRDX1,gene/protein,Alzheimer disease,CDK5/p25 complex,complex/PPI,affects_phosphorylation of,5052,PRDX1,gene/protein,Alzheimer disease1020,CDK5,gene/protein,affects_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer diseaseC00302,Glutamate,drug/chemical compound,increases_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease351,Amyloid beta peptide (25-35),gene/protein,increases_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease1020,CDK5,gene/protein,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease1020,CDK5,gene/protein,affects_activity of,,mitochondrial damage,phenotype,Alzheimer disease1020,CDK5,gene/protein,affects_activity of,GO:0007254,JNK cascade,process,Alzheimer disease1020,CDK5,gene/protein,affects_phosphorylation of,3725,JUN,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,GO:0006954,inflammatory response,process,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,6356,CCL11,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,1437,CSF2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,3553,IL1B,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,3557,IL1RN,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,3569,IL6,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,3458,IFNG,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,7124,TNF,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,3586,IL10,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,3576,CXCL8,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,6351,CCL4,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,6352,CCL5,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,1440,CSF3,gene/protein,Alzheimer disease351,Amyloid beta peptide,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseGO:0006954,inflammatory response,process,affects_activity of,7040,TGFB1,gene/protein,Alzheimer disease7040,TGFB1,gene/protein,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,transgenic hAPP/TGFbeta1 mouse,organism model,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,MI0000477,mir-146a,ncRNA/miRNA,Alzheimer diseaseMI0000477,mir-146a,ncRNA/miRNA,decreases_expression of,3075,CFH,gene/protein,Alzheimer disease3075,CFH,gene/protein,decreases_activity of,GO:0006954,inflammatory response,process,Alzheimer disease3075,CFH,gene/protein,decreases_activity of,GO:0006955,immune response,process,Alzheimer disease,transgenic hAPP/TGFbeta1 mouse,organism model,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,transgenic hAPP/TGFbeta1 mouse,organism model,increases_activity of,GO:0001774,microglial cell activation,process,Alzheimer disease,transgenic hAPP/TGFbeta1 mouse,organism model,increases_activity of,GO:0006954,inflammatory response,process,Alzheimer disease,transgenic hAPP mouse,organism model,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,transgenic hAPP mouse,organism model,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,transgenic hAPP mouse,organism model,decreases_quantity of,,dystrophic neurites,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,GO:0001774,microglial cell activation,process,Alzheimer disease7040,TGFB1,gene/protein,increases_activity of,GO:0001774,microglial cell activation,process,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,7040,TGFB1,gene/protein,Alzheimer disease7040,TGFB1,gene/protein,affects_activity of,MP:0004254,cerebral amyloid angiopathy,phenotype,Alzheimer diseaseC09069,Carnosol,drug/chemical compound,decreases_activity of,GO:0034440,lipid oxidation,process,Alzheimer disease,Rosmanol,drug/chemical compound,decreases_activity of,GO:0034440,lipid oxidation,process,Alzheimer disease,Epirosmanol,drug/chemical compound,decreases_activity of,GO:0034440,lipid oxidation,process,Alzheimer disease7097,TLR2,gene/protein,is localized in,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease929,CD14,gene/protein,is localized in,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease7097,TLR2,gene/protein,interacts (colocalizes) with,199,AIF1,gene/protein,Alzheimer disease929,CD14,gene/protein,interacts (colocalizes) with,199,AIF1,gene/protein,Alzheimer disease1452,CSNK1A1,gene/protein,affects_expression of,1020,CDK5,gene/protein,Alzheimer disease1453,CSNK1D,gene/protein,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease1454,CSNK1E,gene/protein,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease1454,CSNK1E,gene/protein,increases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease,IC261,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_expression of,MI0002466,mir-376b,ncRNA/miRNA,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_expression of,MIMAT0001639,mir-409-3p,ncRNA/miRNA,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_expression of,MI0001519,mir-20b,ncRNA/miRNA,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_expression of,MIMAT0000441,mir-9,ncRNA/miRNA,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_expression of,MI0000271,mir-181c,ncRNA/miRNA,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_expression of,MI0000434,let-7i,ncRNA/miRNA,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_expression of,MIMAT0000244,mir-30c,ncRNA/miRNA,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_expression of,MI0000811,mir-148b,ncRNA/miRNA,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_expression of,MI0000272,mir-182,ncRNA/miRNA,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_expression of,MI0000454,mir-137,ncRNA/miRNA,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_expression of,MI0000760,mir-361,ncRNA/miRNA,Alzheimer disease,Abeta plaque-forming APP23 mouse,organism model,decreases_expression of,MI0000434,let-7i,ncRNA/miRNA,Alzheimer disease,Abeta plaque-forming APP23 mouse,organism model,decreases_expression of,MIMAT0001639,mir-409-3p,ncRNA/miRNA,Alzheimer disease,Abeta plaque-forming APP23 mouse,organism model,decreases_expression of,MIMAT0000441,mir-9,ncRNA/miRNA,Alzheimer disease,Abeta plaque-forming APP23 mouse,organism model,increases_expression of,MI0000811,mir-148b,ncRNA/miRNA,Alzheimer disease,Abeta plaque-forming APP23 mouse,organism model,decreases_expression of,MI0000811,mir-148b,ncRNA/miRNA,Alzheimer disease,Abeta plaque-forming APP23 mouse,organism model,decreases_expression of,MI0000077,mir-21,ncRNA/miRNA,Alzheimer disease,Abeta plaque-forming APP23 mouse,organism model,decreases_expression of,MI0000760,mir-361,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,MIMAT0000441,mir-9,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,MIMAT0000423,mir-125b,ncRNA/miRNA,Alzheimer diseaseMI0000114,mir-107,ncRNA/miRNA,affects_expression of,2896,GRN,gene/protein,Alzheimer diseaseMI0000114,mir-107,ncRNA/miRNA,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease2896,GRN,gene/protein,interacts (colocalizes) with,27161,AGO2,gene/protein,Alzheimer diseaseMIMAT0000422,mir-124a,ncRNA/miRNA,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseMI0000477,mir-146a,ncRNA/miRNA,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseMIMAT0000441,mir-9,ncRNA/miRNA,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseMI0000474,mir-134,ncRNA/miRNA,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseMI0000489,mir-195,ncRNA/miRNA,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,MI0000087,mir-29a,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,89795,NAV3,gene/protein,Alzheimer diseaseMI0000087,mir-29a,ncRNA/miRNA,affects_expression of,89795,NAV3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,5037,PEBP1-nit,protein modification,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,2023,ENO1-nit,protein modification,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,2026,ENO2-nit,protein modification,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,,LDH-nit,protein modification,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,7167,TPI1-nit,protein modification,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,60,ACTB-nit,protein modification,Alzheimer diseaseMP:0004024,aneuploidy,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease,neuronal hyperploidy,phenotype,cooccurs with,MP:0008770,decreased survivor rate,phenotype,Alzheimer diseaseMP:0009937,abnormal neuron differentiation,phenotype,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease,neuronal hyperploidy,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,627,BDNF,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,4803,NGF,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,4909,NTF4,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,4908,NTF3,gene/protein,Alzheimer diseaseGO:0006979,response to oxidative stress,process,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,GO:0005739,mitochondrion,cellular component,Alzheimer disease,increased 8-hydroxyguanine level,phenotype,cooccurs with,GO:0006974,cellular response to DNA damage stimulus,process,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,,increased 8-hydroxyguanine level,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,,increased oxidized DNA bases level,phenotype,Alzheimer diseaseGO:0006979,response to oxidative stress,process,increases_quantity of,,Oxidized DNA base,drug/chemical compound,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,,DNA damage,process,Alzheimer disease,DNA oxidation,process,affects_activity of,GO:0006974,cellular response to DNA damage stimulus,process,Alzheimer disease,increased 5-hydroxyuracil level,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,GO:0006974,cellular response to DNA damage stimulus,process,Alzheimer disease,increased 8-hydroxyadenine level,phenotype,cooccurs with,,DNA oxidation,process,Alzheimer disease,increased 5-hydroxycytosine level,phenotype,cooccurs with,,DNA oxidation,process,Alzheimer disease,increased fapyadenine level,phenotype,cooccurs with,,DNA oxidation,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_activity of,2752,GLUL,gene/protein,Alzheimer disease,Creatine kinase,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_activity of,,Creatine kinase,gene/protein,Alzheimer diseaseC02477,alpha-Tocopherol,drug/chemical compound,affects_activity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,increased lipid oxidation,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease,increased protein amino acid oxidation,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease,increased 4-hydroxy-2-transnonenal level,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease,increased acrolein level,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease351,APP-mut,gene/protein mutant,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease5664,PSEN2-mut,gene/protein mutant,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,GO:0070997,neuron death,process,Alzheimer disease6342,SCP2,gene/protein,affects_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease,SCP-x (12.9K frag),gene/protein,affects_activity of,GO:0003677,DNA binding,process,Alzheimer disease,SCP-x (12.9K frag),gene/protein,is localized in,GO:0005634,nucleus,cellular component,Alzheimer disease,SCP-x (12.9K frag),gene/protein,affects_expression of,682,BSG,gene/protein,Alzheimer disease,pro-SCP-2,gene/protein,decreases_processing of,,SCP-x,gene/protein,Alzheimer disease,pro-SCP-2,gene/protein,decreases_quantity of,,SCP-x (12.9K frag),gene/protein,Alzheimer disease,SCP-x,gene/protein,affects_quantity of,,SCP-x (12.9K frag),gene/protein,Alzheimer disease,pro-SCP-2,gene/protein,affects_activity of,,cholesterol carrier,complex/PPI,Alzheimer diseaseMI0000460,mir-144,ncRNA/miRNA,affects_quantity of,6310,ATXN1,gene/protein,Alzheimer diseaseMIMAT0000099,mir-101,ncRNA/miRNA,affects_quantity of,6310,ATXN1,gene/protein,Alzheimer diseaseGO:0007568,aging,process,increases_expression of,MI0000460,mir-144,ncRNA/miRNA,Alzheimer diseaseMI0000460,mir-144,ncRNA/miRNA,is localized in,BTO:0000232,cerebellum,tissue/cell line,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,MI0000114,mir-107,ncRNA/miRNA,Alzheimer diseaseMI0000114,mir-107,ncRNA/miRNA,affects_expression of,23621,BACE1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,23621,BACE1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,BTO:0002900,monocyte-derived dendritic cell,tissue/cell line,Alzheimer diseaseBTO:0002900,monocyte-derived dendritic cell,tissue/cell line,increases_expression of,3383,ICAM1,gene/protein,Alzheimer diseaseBTO:0002900,monocyte-derived dendritic cell,tissue/cell line,decreases_expression of,958,CD40,gene/protein,Alzheimer diseaseBTO:0002900,monocyte-derived dendritic cell,tissue/cell line,decreases_activity of,GO:0042098,T cell proliferation,process,Alzheimer diseaseBTO:0002900,monocyte-derived dendritic cell,tissue/cell line,increases_expression of,3569,IL6,gene/protein,Alzheimer diseaseBTO:0000876,monocyte,tissue/cell line,increases_expression of,3383,ICAM1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer diseaseBTO:0002900,monocyte-derived dendritic cell,tissue/cell line,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_activity of,GO:0034440,lipid oxidation,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_activity of,GO:0001774,microglial cell activation,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_activity of,GO:0018158,protein oxidation,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_activity of,,tyrosine nitration,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_phosphorylation of,7409,VAV1,gene/protein,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_activity of,GO:0023052,signaling,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_activity of,GO:0006461,protein complex assembly,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases transport of,5879,RAC1,gene/protein,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_activity of,1432,MAPK14,gene/protein,Alzheimer diseaseMP:0005039,hypoxia,phenotype,increases_activity of,3091,HIF1A,gene/protein,Alzheimer disease7023,TFAP4,gene/protein,affects_expression of,51107,APH1A,gene/protein,Alzheimer disease3091,HIF1A,gene/protein,affects_expression of,51107,APH1A,gene/protein,Alzheimer disease3091,HIF1A,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease3091,HIF1A,gene/protein,increases_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_processing of,4851,NOTCH1,gene/protein,Alzheimer disease334,APLP2,gene/protein,interacts (colocalizes) with,7024,TFCP2,gene/protein,Alzheimer disease334,APLP2,gene/protein,increases_expression of,2932,GSK3B,gene/protein,Alzheimer disease351,N-APP,protein modification,interacts (colocalizes) with,27242,TNFRSF21,gene/protein,Alzheimer disease351,N-APP,protein modification,increases_activity of,27242,TNFRSF21,gene/protein,Alzheimer disease27242,TNFRSF21,gene/protein,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,increases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,increases_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease351,N-APP,protein modification,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer diseaseMP:0002229,neurodegeneration,phenotype,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,increases_activity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_activity of,GO:0023052,signaling,process,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_activity of,GO:0010467,gene expression,process,Alzheimer disease51107,APH1A-mut,gene/protein mutant,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease55851,PSENEN-mut,gene/protein mutant,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease23385,NCSTN-mut,gene/protein mutant,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease5663,PSEN1,gene/protein,affects_activity of,,PI3K/Akt cell survival signaling stimulation,process,Alzheimer disease5663,PSEN1,gene/protein,affects_activity of,,MEK/ERK cell survival signaling stimulation,process,Alzheimer disease5663,PSEN1,gene/protein,affects_activity of,2932,GSK3B,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,affects_activity of,GO:0055074,calcium ion homeostasis,process,Alzheimer disease5663,PSEN1,gene/protein,affects_activity of,GO:0007269,neurotransmitter secretion,process,Alzheimer disease5663,PSEN1,gene/protein,affects_activity of,GO:0048791,calcium ion-dependent exocytosis of neurotransmitter,process,Alzheimer disease5663,PSEN1,gene/protein,affects_activity of,GO:0048172,regulation of short-term neuronal synaptic plasticity,process,Alzheimer disease5663,PSEN1,gene/protein,affects_activity of,GO:0048169,regulation of long-term neuronal synaptic plasticity,process,Alzheimer disease5663,PSEN1,gene/protein,affects_activity of,GO:0048167,regulation of synaptic plasticity,process,Alzheimer diseaseC00076,Ca2+,drug/chemical compound,affects_activity of,GO:0007269,neurotransmitter secretion,process,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,affects_activity of,5663,PSEN1,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,increases_activity of,GO:0014065,phosphatidylinositol 3-kinase signaling,process,Alzheimer disease5663,PSEN1,gene/protein,decreases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer diseaseGO:0014065,phosphatidylinositol 3-kinase signaling,process,decreases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease5663,PSEN1,gene/protein,affects_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease5663,PSEN1,gene/protein,affects_activity of,836,CASP3,gene/protein,Alzheimer disease351,Amyloid beta peptide,gene/protein,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseGO:0006979,response to oxidative stress,process,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,Oxidizing agent,drug/chemical compound,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease351,Amyloid beta peptide,gene/protein,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseGO:0006979,response to oxidative stress,process,increases_quantity of,,Oxidizing agent,drug/chemical compound,Alzheimer disease,Oxidizing agent,drug/chemical compound,increases_expression of,23621,BACE1,gene/protein,Alzheimer diseaseGO:0034440,lipid oxidation,process,increases_expression of,23621,BACE1,gene/protein,Alzheimer diseaseGO:0034440,lipid oxidation,process,increases_quantity of,,"4-Hydroxy-2,3-nonenal",drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased levels of lipid peroxidation,phenotype,Alzheimer diseaseMP:0002229,neurodegeneration,phenotype,cooccurs with,,increased levels of lipid peroxidation,phenotype,Alzheimer diseaseGO:0007568,aging,process,affects_activity of,GO:0018158,protein oxidation,process,Alzheimer diseaseGO:0007568,aging,process,decreases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseGO:0007568,aging,process,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseMP:0001559,hyperglycemia,phenotype,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseMP:0005039,hypoxia,phenotype,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease351,Amyloid beta peptide (phenoxy radical Tyr-10),gene/protein,increases_quantity of,,Dityrosine,drug/chemical compound,Alzheimer disease,Dityrosine,drug/chemical compound,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,Reactive oxygen species,drug/chemical compound,increases_quantity of,351,Amyloid beta peptide (phenoxy radical Tyr-10),gene/protein,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,affects_activity of,GO:0051592,response to calcium ion,process,Alzheimer diseaseGO:0006979,response to oxidative stress,process,increases_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer diseaseGO:0006979,response to oxidative stress,process,increases_expression of,23621,BACE1,gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_activity of,23621,BACE1,gene/protein,Alzheimer diseaseGO:0007568,aging,process,increases_activity of,MP:0006036,abnormal mitochondrial physiology,phenotype,Alzheimer diseaseMP:0002229,neurodegeneration,phenotype,increases_activity of,MP:0006036,abnormal mitochondrial physiology,phenotype,Alzheimer diseaseMP:0006036,abnormal mitochondrial physiology,phenotype,increases_activity of,MP:0002954,abnormal aerobic energy metabolism,phenotype,Alzheimer diseaseMP:0005039,hypoxia,phenotype,increases_expression of,23621,BACE1,gene/protein,Alzheimer diseaseMP:0005039,hypoxia,phenotype,increases_activity of,23621,BACE1,gene/protein,Alzheimer diseaseMP:0005039,hypoxia,phenotype,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseMP:0005039,hypoxia,phenotype,affects_activity of,GO:0007611,learning or memory,process,Alzheimer disease3091,HIF1A,gene/protein,affects_activity of,,promoter binding (BACE1),process,Alzheimer disease3091,HIF1A,gene/protein,increases_expression of,23621,BACE1,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,decreases_activity of,1499,CTNNB1,gene/protein,Alzheimer diseaseMP:0005039,hypoxia,phenotype,increases_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease3091,HIF1A,gene/protein,interacts (colocalizes) with,51107,APH1A (promoter),gene/protein,Alzheimer disease3091,HIF1A,gene/protein,increases_expression of,51107,APH1A,gene/protein,Alzheimer diseaseMP:0005039,hypoxia,phenotype,increases_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,MP:0008811,abnormal brain iron level,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,MP:0009618,increased brain zinc level,phenotype,Alzheimer disease351,APP,gene/protein,affects_activity of,GO:0004322,ferroxidase activity,process,Alzheimer diseaseGO:0008270,zinc ion binding,process,decreases_activity of,GO:0004322,ferroxidase activity,process,Alzheimer diseaseGO:0008270,zinc ion binding,process,decreases_activity of,351,APP,gene/protein,Alzheimer disease351,APP,gene/protein,affects_activity of,GO:0016722,"oxidoreductase activity, oxidizing metal ions",process,Alzheimer disease351,APP,gene/protein,affects_activity of,GO:0005506,iron ion binding,process,Alzheimer diseaseC14819,Fe3+,drug/chemical compound,interacts (colocalizes) with,7018,TF,gene/protein,Alzheimer disease351,APP,gene/protein,interacts (colocalizes) with,30061,SLC40A1,gene/protein,Alzheimer diseaseC00038,Zn2+,drug/chemical compound,decreases_activity of,GO:0004322,ferroxidase activity,process,Alzheimer diseaseC00038,Zn2+,drug/chemical compound,decreases_activity of,351,APP,gene/protein,Alzheimer diseaseC14818,Fe2+,drug/chemical compound,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease351,APP,gene/protein,affects_quantity of,C14819,Fe3+,drug/chemical compound,Alzheimer disease,Metallothionein,gene/protein,decreases_quantity of,C00038,Zn2+,drug/chemical compound,Alzheimer disease351,APP,gene/protein,decreases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease104300,Alzheimer disease,disease,decreases_activity of,GO:0004322,ferroxidase activity,process,Alzheimer disease104300,Alzheimer disease,disease,decreases_activity of,351,APP,gene/protein,Alzheimer diseaseGO:0004322,ferroxidase activity,process,affects_quantity of,C00023,Iron,drug/chemical compound,Alzheimer diseaseC00023,Iron,drug/chemical compound,interacts (colocalizes) with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease3553,IL1B (active form),gene/protein,affects_expression of,351,APP,gene/protein,Alzheimer diseaseC00038,Zn2+,drug/chemical compound,interacts (colocalizes) with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseC00070,Cu2+,drug/chemical compound,interacts (colocalizes) with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseGO:0030350,iron-responsive element binding,process,affects_activity of,48,ACO1,gene/protein,Alzheimer diseaseC00023,Iron,drug/chemical compound,affects_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer diseaseC00032,Heme,drug/chemical compound,interacts (colocalizes) with,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseGO:0042168,heme metabolic process,process,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC00023,Iron,drug/chemical compound,is localized in,C00032,Heme,drug/chemical compound,Alzheimer diseaseC00023,Iron,drug/chemical compound,increases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer diseaseC00070,Cu2+,drug/chemical compound,increases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer diseaseC00087,Sulfur,drug/chemical compound,interacts (colocalizes) with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseC00023,Iron,drug/chemical compound,interacts (colocalizes) with,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,4504,MT3,gene/protein,Alzheimer disease4504,MT3,gene/protein,interacts (colocalizes) with,C00070,Cu2+,drug/chemical compound,Alzheimer disease4504,MT3,gene/protein,interacts (colocalizes) with,C00038,Zn2+,drug/chemical compound,Alzheimer disease4504,MT3,gene/protein,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease351,APP,gene/protein,affects_activity of,GO:0050817,coagulation,process,Alzheimer disease351,APP,gene/protein,interacts (colocalizes) with,,Factor IXa,gene/protein,Alzheimer diseaseGO:0070555,response to interleukin-1,process,increases_expression of,351,APP,gene/protein,Alzheimer disease351,APP,gene/protein,increases_activity of,GO:0043526,neuroprotection,process,Alzheimer diseaseGO:0043526,neuroprotection,process,decreases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer diseaseGO:0070555,response to interleukin-1,process,increases_activity of,,Alpha-secretase,gene/protein,Alzheimer disease,Cytokine,gene/protein,increases_activity of,GO:0048143,astrocyte activation,process,Alzheimer diseaseGO:0048143,astrocyte activation,process,increases_quantity of,351,APP,gene/protein,Alzheimer diseaseGO:0006954,inflammatory response,process,increases_activity of,,Cytokine,gene/protein,Alzheimer diseaseGO:0030350,iron-responsive element binding,process,affects_activity of,GO:0055072,iron ion homeostasis,process,Alzheimer diseaseGO:0030350,iron-responsive element binding,process,affects_activity of,3658,IREB2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,,elevated free serum copper,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,MP:0006350,increased circulating copper level,phenotype,Alzheimer diseaseC00070,Cu2+,drug/chemical compound,interacts (colocalizes) with,1356,CP,gene/protein,Alzheimer disease,increased apoceruloplasmin level,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease5468,PPARG-p.P12A,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease5468,PPARG-p.P12A,gene/protein mutant,affects_quantity of,177,AGER (soluble splice variant),mRNA/protein variant,Alzheimer diseaseC01494,Ferulate,drug/chemical compound,increases_activity of,GO:0043526,neuroprotection,process,Alzheimer diseaseC01494,Ferulate,drug/chemical compound,decreases_expression of,3383,ICAM1,gene/protein,Alzheimer diseaseC01494,Ferulate,drug/chemical compound,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseC01494,Ferulate,drug/chemical compound,decreases_activity of,GO:0006915,apoptotic process,process,Alzheimer disease351,"Amyloid beta peptide (monomer, soluble)",gene/protein,interacts (colocalizes) with,351,Amyloid beta peptide,gene/protein,Alzheimer disease351,Amyloid beta peptide (protofibrillar),gene/protein,increases_activity of,GO:0070997,neuron death,phenotype,Alzheimer disease351,Amyloid beta peptide (protofibrillar),gene/protein,affects_activity of,GO:0051899,membrane depolarization,process,Alzheimer disease351,Amyloid beta peptide (protofibrillar),gene/protein,increases_activity of,GO:0045760,positive regulation of action potential,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,interacts (colocalizes) with,C00038,Zn2+,drug/chemical compound,Alzheimer disease23621,BACE1,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,23621,BACE1,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,increases_expression of,23621,BACE1,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,affects_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease23621,BACE1,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease466,Gamma-secretase complex,complex/PPI,increases_expression of,23621,BACE1,gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_expression of,23621,BACE1,gene/protein,Alzheimer diseaseC06429,Docosahexaenoic acid,drug/chemical compound,decreases_quantity of,C00639,Prostaglandin F2alpha,drug/chemical compound,Alzheimer diseaseC06428,Eicosapentaenoic acid,drug/chemical compound,decreases_quantity of,C00639,Prostaglandin F2alpha,drug/chemical compound,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,interacts (colocalizes) with,C00070,Cu2+,drug/chemical compound,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,interacts (colocalizes) with,C14819,Fe3+,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,351,"Amyloid beta peptide (monomer, soluble)",gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,GO:0046872,metal ion binding,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,GO:0005507,copper ion binding,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,GO:0008270,zinc ion binding,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,GO:0005506,iron ion binding,process,Alzheimer disease351,APP,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease351,APP,gene/protein,interacts (colocalizes) with,27242,TNFRSF21,gene/protein,Alzheimer disease6056,APP-TNFRSF21,complex/PPI,increases_activity of,GO:0070997,neuron death,process,Alzheimer disease27242,TNFRSF21,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease6056,APP-TNFRSF21,complex/PPI,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease6056,APP-TNFRSF21,complex/PPI,increases_activity of,GO:0051402,neuron apoptotic process,process,Alzheimer disease839,CASP6,gene/protein,affects_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease581,BAX,gene/protein,affects_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer diseaseGO:0006954,inflammatory response,process,affects_quantity of,57817,HAMP,gene/protein,Alzheimer diseaseC00023,Iron,drug/chemical compound,affects_quantity of,57817,HAMP,gene/protein,Alzheimer diseaseMP:0005039,hypoxia,phenotype,affects_quantity of,57817,HAMP,gene/protein,Alzheimer disease57817,HAMP,gene/protein,affects_activity of,GO:0055072,iron ion homeostasis,process,Alzheimer disease57817,HAMP,gene/protein,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer diseaseGO:0007568,aging,process,increases_quantity of,57817,HAMP,gene/protein,Alzheimer disease57817,HAMP,gene/protein,decreases_expression of,30061,SLC40A1,gene/protein,Alzheimer diseaseMP:0001770,abnormal iron level,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer diseaseMP:0001770,abnormal iron level,phenotype,affects_activity of,GO:0055072,iron ion homeostasis,process,Alzheimer diseaseGO:0006954,inflammatory response,process,affects_activity of,GO:0055072,iron ion homeostasis,process,Alzheimer disease255022,CALHM1,gene/protein,is localized in,GO:0016021,integral component of membrane,cellular component,Alzheimer disease255022,CALHM1,gene/protein,affects_quantity of,C00076,Ca2+,drug/chemical compound,Alzheimer disease255022,CALHM1,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseasers2986017,CALHM1 rs2986017,SNP,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseasers2986017,CALHM1 rs2986017,SNP,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease255022,CALHM1,gene/protein,interacts (colocalizes) with,255022,CALHM1,gene/protein,Alzheimer disease255022,CALHM1,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer disease,SAMP8 mouse,organism model,increases_quantity of,351,APP,gene/protein,Alzheimer diseaseMI0000070,mir-16,ncRNA/miRNA,affects_expression of,351,APP,gene/protein,Alzheimer diseaseMI0000070,mir-16,ncRNA/miRNA,decreases_expression of,351,APP,gene/protein,Alzheimer disease351,Amyloid beta peptide,gene/protein,increases_activity of,GO:0006950,response to stress,process,Alzheimer diseaseGO:0070997,neuron death,process,increases_activity of,GO:0006950,response to stress,process,Alzheimer diseaseGO:0006950,response to stress,process,increases_activity of,GO:0001774,microglial cell activation,process,Alzheimer diseaseGO:0001774,microglial cell activation,process,increases_activity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease,NADPH oxidase complex,complex/PPI,increases_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,,NADPH oxidase complex,complex/PPI,Alzheimer disease,NADPH oxidase complex,complex/PPI,increases_activity of,GO:0070997,neuron death,phenotype,Alzheimer disease,Tg2576 mouse,organism model,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease351,Amyloid beta peptide,gene/protein,interacts (colocalizes) with,3028,HSD17B10,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,23621,BACE1,gene/protein,Alzheimer disease,Reactive oxygen species,drug/chemical compound,increases_expression of,23621,BACE1,gene/protein,Alzheimer disease,Reactive oxygen species,drug/chemical compound,increases_expression of,5663,PSEN1,gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,increases_activity of,23621,BACE1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,351,APP,gene/protein,Alzheimer disease351,APP,gene/protein,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease,Tg2576 mouse,organism model,increases_quantity of,C00027,H2O2,drug/chemical compound,Alzheimer disease,Tg2576 mouse,organism model,decreases_activity of,,Mitochondrial respiratory chain complex IV,complex/PPI,Alzheimer disease351,Amyloid beta peptide (40),gene/protein,is localized in,GO:0005759,mitochondrial matrix,cellular component,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,is localized in,GO:0005759,mitochondrial matrix,cellular component,Alzheimer disease351,Amyloid beta peptide (40),gene/protein,is localized in,GO:0005743,mitochondrial inner membrane,cellular component,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,is localized in,GO:0005743,mitochondrial inner membrane,cellular component,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C00027,H2O2,drug/chemical compound,Alzheimer diseaseC00027,H2O2,drug/chemical compound,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseGO:0007568,aging,process,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,Tg2576 mouse,organism model,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,Tg2576 mouse,organism model,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease351,APP-mut,gene/protein mutant,decreases_activity of,,Mitochondrial respiratory chain complex IV,complex/PPI,Alzheimer disease351,APP-mut,gene/protein mutant,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease1454,CSNK1E,gene/protein,increases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,IC261,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,Abeta plaque-forming APP23 mouse,organism model,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseMP:0006036,abnormal mitochondrial physiology,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer diseaseGO:0006979,response to oxidative stress,process,increases_activity of,MP:0004811,abnormal neuron physiology,phenotype,Alzheimer diseaseMP:0004811,abnormal neuron physiology,phenotype,increases_quantity of,GO:0000262,mitochondrial chromosome,cellular component,Alzheimer diseaseMP:0004811,abnormal neuron physiology,phenotype,affects_activity of,,Mitochondrial respiratory chain complex IV,complex/PPI,Alzheimer disease104300,Alzheimer disease,disease,decreases_activity of,,Mitochondrial respiratory chain complex IV,complex/PPI,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,C00002,ATP,drug/chemical compound,Alzheimer diseaseGO:0005739,mitochondrion,cellular component,decreases_quantity of,C00002,ATP,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,decreases_activity of,GO:0005739,mitochondrion,cellular component,Alzheimer diseaseGO:0005739,mitochondrion,cellular component,increases_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease,APP transgenic mouse,organism model,decreases_quantity of,C00002,ATP,drug/chemical compound,Alzheimer disease,APP transgenic mouse,organism model,affects_activity of,GO:0010917,negative regulation of mitochondrial membrane potential,process,Alzheimer disease,APP transgenic mouse,organism model,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease351,Amyloid beta peptide,gene/protein,decreases_activity of,,Mitochondrial respiratory chain,complex/PPI,Alzheimer disease351,Amyloid beta peptide,gene/protein,affects_activity of,,Mitochondrial permeability transition pore complex,complex/PPI,Alzheimer disease,Mitochondrial permeability transition pore complex,complex/PPI,affects_activity of,,Mitochondrial respiratory chain,complex/PPI,Alzheimer disease6058,ABAD-Abeta interaction,complex/PPI,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease6058,ABAD-Abeta interaction,complex/PPI,affects_activity of,MP:0006036,abnormal mitochondrial physiology,phenotype,Alzheimer disease6058,ABAD-Abeta interaction,complex/PPI,affects_activity of,,Mitochondrial respiratory chain,complex/PPI,Alzheimer disease3028,HSD17B10,gene/protein,interacts (colocalizes) with,GO:0005739,mitochondrion,cellular component,Alzheimer disease351,Amyloid beta peptide,gene/protein,interacts (colocalizes) with,GO:0005739,mitochondrion,cellular component,Alzheimer disease,"TOM complex, mitochondrial",complex/PPI,affects transport of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,"TOM complex, mitochondrial",complex/PPI,affects transport of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,is localized in,GO:0030061,mitochondrial crista,cellular component,Alzheimer disease351,Amyloid beta peptide (40),gene/protein,is localized in,GO:0030061,mitochondrial crista,cellular component,Alzheimer diseaseC06684,Valinomycin,drug/chemical compound,affects_activity of,,"TOM complex, mitochondrial",complex/PPI,Alzheimer diseaseGO:0051881,regulation of mitochondrial membrane potential,process,affects_activity of,,"TOM complex, mitochondrial",complex/PPI,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,23604,DAPK2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,4976,OPA1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,55669,MFN1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,9927,MFN2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,51024,FIS1,gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,is localized in,GO:0005739,mitochondrion,cellular component,Alzheimer disease,"Gamma-secretase inhibitor L-685,458",drug/chemical compound,decreases_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease,Gamma-secretase inhibitor Compound E,drug/chemical compound,decreases_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease23385,NCSTN,gene/protein,is_part_of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease51107,APH1A,gene/protein,is_part_of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease55851,PSENEN,gene/protein,is_part_of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease5663,PSEN1,gene/protein,is_part_of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease5664,PSEN2,gene/protein,is_part_of,468,Gamma-secretase complex,complex/PPI,Alzheimer disease23385,NCSTN,gene/protein,is localized in,GO:0005739,mitochondrion,cellular component,Alzheimer disease51107,APH1A,gene/protein,is localized in,GO:0005739,mitochondrion,cellular component,Alzheimer disease55851,PSENEN,gene/protein,is localized in,GO:0005739,mitochondrion,cellular component,Alzheimer disease5663,PSEN1,gene/protein,is localized in,GO:0005739,mitochondrion,cellular component,Alzheimer disease5664,PSEN2,gene/protein,is localized in,GO:0005739,mitochondrion,cellular component,Alzheimer disease4137,MAPT,gene/protein,affects_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease4137,MAPT,gene/protein,interacts (colocalizes) with,GO:0005874,microtubule,cellular component,Alzheimer disease4137,MAPT,gene/protein,affects_activity of,GO:0015630,microtubule cytoskeleton,cellular component,Alzheimer disease4137,MAPT,gene/protein,interacts (colocalizes) with,2534,FYN,gene/protein,Alzheimer disease4137,MAPT,gene/protein,interacts (colocalizes) with,1742,DLG4,gene/protein,Alzheimer disease4137,MAPT,gene/protein,interacts (colocalizes) with,GO:0030424,axon,cellular component,Alzheimer disease,NMDA receptor complex,complex/PPI,interacts (colocalizes) with,1742,DLG4,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects transport of,4137,MAPT,gene/protein,Alzheimer disease4137,MAPT,gene/protein,interacts (colocalizes) with,BTO:0000938,neuron,tissue/cell line,Alzheimer disease2534,FYN,gene/protein,affects_phosphorylation of,,NMDA receptor complex,complex/PPI,Alzheimer disease4137,MAPT,gene/protein,affects_activity of,GO:0006605,protein targeting,process,Alzheimer disease351,APP,gene/protein,is localized in,GO:0005739,mitochondrion,cellular component,Alzheimer disease351,APP,gene/protein,interacts (colocalizes) with,10452,TOMM40,gene/protein,Alzheimer disease351,APP,gene/protein,interacts (colocalizes) with,100287932,TIMM23,gene/protein,Alzheimer disease,increased APP level,phenotype,cooccurs with,,decreased importation of respiratory chain subunit level,phenotype,Alzheimer disease351,Amyloid beta peptide,gene/protein,affects_activity of,GO:0005739,mitochondrion,cellular component,Alzheimer disease351,APP,gene/protein,increases_quantity of,C00023,Iron,drug/chemical compound,Alzheimer disease351,Amyloid beta peptide,gene/protein,affects_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease3416,IDE,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease3416,IDE,gene/protein,is localized in,GO:0005739,mitochondrion,cellular component,Alzheimer disease5550,PREP,gene/protein,is localized in,GO:0005759,mitochondrial matrix,cellular component,Alzheimer disease5550,PREP,gene/protein,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease351,APP,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,351,APP,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,7276,TTR,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,3481,IGF2,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_phosphorylation of,572,BAD,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,9365,KL,gene/protein,Alzheimer diseaseGO:0007568,aging,process,affects_quantity of,9365,KL,gene/protein,Alzheimer disease7276,TTR,gene/protein,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease7276,TTR,gene/protein,decreases_folding of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,decreases_expression of,2353,FOS,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,decreases_expression of,4216,MAP3K4,gene/protein,Alzheimer disease4216,MAP3K4,gene/protein,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer disease2353,FOS,gene/protein,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2353,FOS,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,3725,JUN,gene/protein,Alzheimer disease4216,MAP3K4,gene/protein,increases_activity of,GO:0007254,JNK cascade,process,Alzheimer disease,Tg2576 mouse,organism model,decreases_expression of,5495,PPM1B,gene/protein,Alzheimer disease5495,PPM1B,gene/protein,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,1634,DCN,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,5168,ENPP2,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,3485,IGFBP2,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,2690,GHR,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,5618,PRLR,gene/protein,Alzheimer disease3481,IGF2,gene/protein,decreases_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,3479,IGF1,gene/protein,Alzheimer disease207,AKT1,gene/protein,is localized in,GO:0005634,nucleus,cellular component,Alzheimer disease207,AKT1,gene/protein,affects_phosphorylation of,2932,GSK3B,gene/protein,Alzheimer disease207,AKT1,gene/protein,decreases_activity of,2932,GSK3B,gene/protein,Alzheimer disease207,AKT1,gene/protein,increases_activity of,5595,MAPK3,gene/protein,Alzheimer disease207,AKT1,gene/protein,increases_activity of,5594,MAPK1,gene/protein,Alzheimer disease3133,"Phosphatidylinositol 3-kinase (PIK3CA, PIK3R1)",complex/PPI,affects_activity of,207,AKT1,gene/protein,Alzheimer disease207,AKT1-phos,protein modification,increases_activity of,207,AKT1,gene/protein,Alzheimer disease207,AKT1-phos,protein modification,is localized in,GO:0005634,nucleus,cellular component,Alzheimer disease,Tg2576 mouse,organism model,increases_phosphorylation of,5594,MAPK1,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_phosphorylation of,5595,MAPK3,gene/protein,Alzheimer disease5594,MAPK1-phos,protein modification,is localized in,GO:0005634,nucleus,cellular component,Alzheimer disease5595,MAPK3-phos,protein modification,increases_activity of,5595,MAPK3,gene/protein,Alzheimer disease5594,MAPK1-phos,protein modification,increases_activity of,5594,MAPK1,gene/protein,Alzheimer disease207,AKT1,gene/protein,affects_phosphorylation of,572,BAD,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,affects_activity of,GO:0070371,ERK1 and ERK2 cascade,process,Alzheimer disease572,BAD,gene/protein,affects_quantity of,598,BCL2L1,gene/protein,Alzheimer disease572,BAD,gene/protein,affects_quantity of,596,BCL2,gene/protein,Alzheimer disease5595,MAPK3-phos,protein modification,affects_phosphorylation of,572,BAD,gene/protein,Alzheimer disease5594,MAPK1-phos,protein modification,affects_phosphorylation of,572,BAD,gene/protein,Alzheimer disease572,BAD-phos,protein modification,increases_activity of,572,BAD,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,7276,TTR,gene/protein,Alzheimer diseaseC05330,Homocysteine,drug/chemical compound,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC00504,Folate,drug/chemical compound,affects_quantity of,C05330,Homocysteine,drug/chemical compound,Alzheimer disease5594,MAPK1,gene/protein,affects_activity of,GO:0070371,ERK1 and ERK2 cascade,process,Alzheimer disease5595,MAPK3,gene/protein,affects_activity of,GO:0070371,ERK1 and ERK2 cascade,process,Alzheimer disease,Tg2576 mouse,organism model,increases_quantity of,2348,FOLR1,gene/protein,Alzheimer disease2348,FOLR1,gene/protein,affects transport of,C00440,5-Methyltetrahydrofolate,drug/chemical compound,Alzheimer disease,Tg2576 mouse,organism model,decreases_quantity of,1182,CLCN3,gene/protein,Alzheimer disease1182,CLCN3-mut,gene/protein mutant,affects_activity of,GO:0007611,learning or memory,process,Alzheimer disease1182,CLCN3-mut,gene/protein mutant,increases_activity of,MP:0000807,abnormal hippocampus morphology,phenotype,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,7001,PRDX2,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,6810,STX4,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,2045,EPHA7,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,affects_activity of,GO:0005739,mitochondrion,cellular component,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease,Mitochondrial respiratory chain complex IV,complex/PPI,affects_quantity of,C00002,ATP,drug/chemical compound,Alzheimer disease,Mitochondrial respiratory chain complex IV,complex/PPI,affects_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease,Mitochondrial respiratory chain complex IV,complex/PPI,is localized in,GO:0005739,mitochondrion,cellular component,Alzheimer disease351,Amyloid beta peptide (25-35),gene/protein,decreases_activity of,GO:0005739,mitochondrion,cellular component,Alzheimer disease351,Amyloid beta peptide (25-35),gene/protein,increases_activity of,MP:0006035,abnormal mitochondrial morphology,phenotype,Alzheimer disease351,Amyloid beta peptide (25-35),gene/protein,decreases_quantity of,GO:0005739,mitochondrion,cellular component,Alzheimer disease351,Amyloid beta peptide (25-35),gene/protein,decreases_quantity of,C00002,ATP,drug/chemical compound,Alzheimer disease351,Amyloid beta peptide (25-35),gene/protein,decreases_quantity of,C00051,Glutathione,drug/chemical compound,Alzheimer disease351,Amyloid beta peptide (25-35),gene/protein,increases_activity of,MP:0006036,abnormal mitochondrial physiology,phenotype,Alzheimer disease351,Amyloid beta peptide (25-35),gene/protein,decreases_activity of,,Mitochondrial respiratory chain complex I,complex/PPI,Alzheimer disease104300,Alzheimer disease,disease,affects transport of,GO:0005739,mitochondrion,cellular component,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,10059,DNM1L,gene/protein,Alzheimer disease,APPsw PC12 cell,tissue/cell line,increases_quantity of,C00533,NO,drug/chemical compound,Alzheimer disease,APPsw PC12 cell,tissue/cell line,decreases_activity of,,Mitochondrial respiratory chain complex IV,complex/PPI,Alzheimer disease,APPsw PC12 cell,tissue/cell line,decreases_quantity of,C00002,ATP,drug/chemical compound,Alzheimer diseaseC00533,NO,drug/chemical compound,affects_activity of,GO:0005739,mitochondrion,cellular component,Alzheimer diseaseC00533,NO,drug/chemical compound,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD02356,Verapamil,drug/chemical compound,decreases_activity of,,Voltage-gated calcium channel,complex/PPI,Alzheimer diseaseD07845,Diltiazem,drug/chemical compound,decreases_activity of,,Voltage-gated calcium channel,complex/PPI,Alzheimer diseaseD00349,Isradipine,drug/chemical compound,decreases_activity of,,Voltage-gated calcium channel,complex/PPI,Alzheimer diseaseD00438,Nimodipine,drug/chemical compound,decreases_activity of,,Voltage-gated calcium channel,complex/PPI,Alzheimer diseaseD02356,Verapamil,drug/chemical compound,decreases_activity of,GO:0070997,neuron death,process,Alzheimer diseaseD07845,Diltiazem,drug/chemical compound,decreases_activity of,GO:0070997,neuron death,process,Alzheimer diseaseD00349,Isradipine,drug/chemical compound,decreases_activity of,GO:0070997,neuron death,process,Alzheimer diseaseD00438,Nimodipine,drug/chemical compound,decreases_activity of,GO:0070997,neuron death,process,Alzheimer diseaseC01375,Tacrolimus,drug/chemical compound,affects_activity of,GO:0043197,dendritic spine,cellular component,Alzheimer diseaseC01375,Tacrolimus,drug/chemical compound,decreases_activity of,6023,Calcineurin,complex/PPI,Alzheimer diseaseC01375,Tacrolimus,drug/chemical compound,decreases_activity of,MP:0009936,abnormal dendritic spine morphology,phenotype,Alzheimer diseaseGO:0005776,autophagic vacuole,cellular component,is localized in,BTO:0000938,neuron,tissue/cell line,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,MI0000071,mir-17,ncRNA/miRNA,Alzheimer diseaseMI0000071,mir-17,ncRNA/miRNA,affects_expression of,9568,GABBR2,gene/protein,Alzheimer diseaseMI0000071,mir-17,ncRNA/miRNA,affects_quantity of,C00575,cAMP,drug/chemical compound,Alzheimer diseaseMI0000071,mir-17,ncRNA/miRNA,is_expressed_in,BTO:0000142,brain,tissue/cell line,Alzheimer diseaseMI0000071,mir-17,ncRNA/miRNA,affects_activity of,GO:0007214,gamma-aminobutyric acid signaling pathway,process,Alzheimer diseaseMI0000071,mir-17,ncRNA/miRNA,is_expressed_in,BTO:0000931,neuroblastoma cell,tissue/cell line,Alzheimer diseaseMI0000071,mir-17,ncRNA/miRNA,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseMI0000071,mir-17,ncRNA/miRNA,affects_activity of,,Potassium channel complex,complex/PPI,Alzheimer diseaseMI0000071,mir-17,ncRNA/miRNA,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseGO:0006954,inflammatory response,process,affects_expression of,MI0000071,mir-17,ncRNA/miRNA,Alzheimer disease8678,BECN1,gene/protein,increases_activity of,GO:0006914,autophagy,process,Alzheimer disease836,CASP3,gene/protein,affects_processing of,8678,BECN1,gene/protein,Alzheimer disease836,CASP3,gene/protein,increases_quantity of,8678,BECN1-proc,protein modification,Alzheimer disease8678,BECN1,gene/protein,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease8678,BECN1,gene/protein,is localized in,BTO:0000099,astrocyte,tissue/cell line,Alzheimer disease207,AKT1-phosSer473,protein modification,affects_phosphorylation of,207,AKT1-phosThr308,protein modification,Alzheimer diseaseC15181,Wortmannin,drug/chemical compound,decreases_activity of,3133,"Phosphatidylinositol 3-kinase (PIK3CA, PIK3R1)",complex/PPI,Alzheimer diseaseC15181,Wortmannin,drug/chemical compound,decreases_quantity of,207,AKT1-phosSer473,protein modification,Alzheimer diseaseC15181,Wortmannin,drug/chemical compound,decreases_quantity of,207,AKT1-phosThr308,protein modification,Alzheimer disease6197,RPS6KA3,gene/protein,increases_quantity of,2932,GSK3B-phosSer9,protein modification,Alzheimer disease6198,RPS6KB1,gene/protein,increases_quantity of,2932,GSK3B-phosSer9,protein modification,Alzheimer disease5515,PPP2CA,gene/protein,decreases_quantity of,2932,GSK3B-phosSer9,protein modification,Alzheimer disease2932,GSK3B,gene/protein,increases_phosphorylation of,54704,PDP1,gene/protein,Alzheimer disease54704,PDP1,gene/protein,affects_activity of,GO:0008292,acetylcholine biosynthetic process,process,Alzheimer disease2932,GSK3B,gene/protein,interacts (colocalizes) with,324,APC,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,interacts (colocalizes) with,8312,AXIN1,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,affects_activity of,4609,MYC,gene/protein,Alzheimer disease5576,PRKAR2A,gene/protein,decreases_activity of,2932,GSK3B,gene/protein,Alzheimer diseaseC00027,H2O2,drug/chemical compound,decreases_activity of,2932,GSK3B,gene/protein,Alzheimer diseaseGO:0009408,response to heat,process,decreases_activity of,2932,GSK3B,gene/protein,Alzheimer disease3479,IGF1,gene/protein,increases_phosphorylation of,2932,GSK3B,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,decreases_activity of,4772,NFATC1,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,affects transport of,4772,NFATC1,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,affects_activity of,1375,Pyruvate dehydrogenase complex,complex/PPI,Alzheimer disease2932,GSK3B,gene/protein,affects_quantity of,C01996,Acetylcholine,drug/chemical compound,Alzheimer disease,sleep restriction,environment,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease23385,NCSTN,gene/protein,affects_quantity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease8660,IRS2,gene/protein,affects_activity of,GO:0007420,brain development,process,Alzheimer disease8660,IRS2,gene/protein,decreases_phosphorylation of,4137,MAPT-phos,protein modification,Alzheimer diseaseGO:0006950,response to stress,process,affects_activity of,GO:0016236,macroautophagy,process,Alzheimer diseaseGO:0009267,cellular response to starvation,process,affects_activity of,GO:0016236,macroautophagy,process,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,10013,HDAC6,gene/protein,Alzheimer disease10013,HDAC6,gene/protein,affects_activity of,GO:0070843,misfolded protein transport,process,Alzheimer disease10013,HDAC6,gene/protein,affects_activity of,GO:0005776,autophagic vacuole,cellular component,Alzheimer disease10013,HDAC6,gene/protein,affects_activity of,MP:0008493,alpha-synuclein inclusion body,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased inflammatory response,phenotype,Alzheimer disease351,Amyloid beta peptide,gene/protein,increases_activity of,GO:0006954,inflammatory response,process,Alzheimer disease351,Amyloid beta peptide,gene/protein,increases_activity of,BTO:0000078,microglia,tissue/cell line,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,increases_activity of,GO:0001774,microglial cell activation,process,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,BTO:0000078,microglia,tissue/cell line,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,D09617,Florbetapir F-18,drug/chemical compound,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,affects_quantity of,D09617,Florbetapir F-18,drug/chemical compound,Alzheimer disease3288103,Pittsburgh Compound B,drug/chemical compound,interacts (colocalizes) with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C00086,Urea,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C00188,Threonine,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C00302,Glutamate,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C00327,Citrulline,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C02356,(S)-2-Aminobutanoate,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C01602,Ornithine,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C00014,NH3,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C02385,Arginine,drug/chemical compound,Alzheimer diseaseC00086,Urea,drug/chemical compound,is localized in,BTO:0000237,cerebrospinal fluid,tissue/cell line,Alzheimer diseaseC00188,Threonine,drug/chemical compound,is localized in,BTO:0000237,cerebrospinal fluid,tissue/cell line,Alzheimer diseaseC00302,Glutamate,drug/chemical compound,is localized in,BTO:0000237,cerebrospinal fluid,tissue/cell line,Alzheimer diseaseC00327,Citrulline,drug/chemical compound,is localized in,BTO:0000237,cerebrospinal fluid,tissue/cell line,Alzheimer diseaseC02356,(S)-2-Aminobutanoate,drug/chemical compound,is localized in,BTO:0000237,cerebrospinal fluid,tissue/cell line,Alzheimer diseaseC01602,Ornithine,drug/chemical compound,is localized in,BTO:0000237,cerebrospinal fluid,tissue/cell line,Alzheimer diseaseC00014,NH3,drug/chemical compound,is localized in,BTO:0000237,cerebrospinal fluid,tissue/cell line,Alzheimer diseaseC02385,Arginine,drug/chemical compound,is localized in,BTO:0000237,cerebrospinal fluid,tissue/cell line,Alzheimer diseaseGO:0005313,L-glutamate transmembrane transporter activity,process,affects_activity of,GO:0051592,response to calcium ion,process,Alzheimer diseaseC00302,Glutamate,drug/chemical compound,increases_activity of,GO:0051592,response to calcium ion,process,Alzheimer diseaseBTO:0000099,astrocyte,tissue/cell line,affects_quantity of,C00302,Glutamate,drug/chemical compound,Alzheimer diseaseGO:0005313,L-glutamate transmembrane transporter activity,process,affects_quantity of,C00302,Glutamate,drug/chemical compound,Alzheimer disease,P301L tau transgenic pR5 mouse,organism model,increases_quantity of,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer disease,APPswPS2N141I double-transgenic APP152 mouse,organism model,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,transgenic triple AD mouse,organism model,affects_activity of,GO:0006119,oxidative phosphorylation,process,Alzheimer disease4137,MAPT,gene/protein,affects_activity of,,Mitochondrial respiratory chain complex I,complex/PPI,Alzheimer disease351,Amyloid beta peptide,gene/protein,affects_activity of,,Mitochondrial respiratory chain complex IV,complex/PPI,Alzheimer disease351,Amyloid beta peptide (oligomer),gene/protein,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease351,Amyloid beta peptide (oligomer),gene/protein,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,NH2-d-Trp-Aib-OH,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (oligomer),gene/protein,Alzheimer disease,NH2-d-Trp-Aib-OH,drug/chemical compound,interacts (colocalizes) with,351,Amyloid beta peptide (oligomer),gene/protein,Alzheimer disease,APPswe/ PSDeltaE9 mouse,organism model,affects_expression of,MI0000734,mir-106b,ncRNA/miRNA,Alzheimer disease,APPswe/ PSDeltaE9 mouse,organism model,affects_expression of,7048,TGFBR2,gene/protein,Alzheimer disease,APPswe/ PSDeltaE9 mouse,organism model,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,MI0000734,mir-106b,ncRNA/miRNA,Alzheimer diseaseMI0000734,mir-106b,ncRNA/miRNA,decreases_expression of,7048,TGFBR2,gene/protein,Alzheimer disease351,"Amyloid beta peptide (42, oligomer)",gene/protein,affects_expression of,MI0000734,mir-106b,ncRNA/miRNA,Alzheimer disease351,"Amyloid beta peptide (42, oligomer)",gene/protein,affects_expression of,7048,TGFBR2,gene/protein,Alzheimer diseaseMI0000734,mir-106b,ncRNA/miRNA,affects_quantity of,4087,SMAD2,gene/protein,Alzheimer diseaseMI0000734,mir-106b,ncRNA/miRNA,affects_quantity of,4088,SMAD3,gene/protein,Alzheimer diseaseMI0000734,mir-106b,ncRNA/miRNA,affects_quantity of,4091,SMAD6,gene/protein,Alzheimer diseaseMI0000734,mir-106b,ncRNA/miRNA,affects_quantity of,4092,SMAD7,gene/protein,Alzheimer diseaseMI0000734,mir-106b,ncRNA/miRNA,affects_quantity of,3000,Smad2-Smad3 complex,complex/PPI,Alzheimer diseaseMI0000734,mir-106b,ncRNA/miRNA,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease351,"Amyloid beta peptide (42, oligomer)",gene/protein,decreases_expression of,7048,TGFBR2,gene/protein,Alzheimer diseaseMI0000734,mir-106b,ncRNA/miRNA,affects_activity of,GO:0007179,transforming growth factor beta receptor signaling pathway,process,Alzheimer diseaseMI0000734,mir-106b,ncRNA/miRNA,affects_quantity of,6063,Smad6-Smad7 complex,complex/PPI,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,3654,IRAK1,gene/protein,Alzheimer diseaseMI0000477,mir-146a,ncRNA/miRNA,decreases_expression of,3654,IRAK1,gene/protein,Alzheimer diseaseMI0000477,mir-146a,ncRNA/miRNA,increases_expression of,3656,IRAK2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,3656,IRAK2,gene/protein,Alzheimer disease3553,IL1B,gene/protein,decreases_activity of,BTO:0002609,astroglial cell,tissue/cell line,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_activity of,BTO:0002609,astroglial cell,tissue/cell line,Alzheimer diseaseMI0000477,mir-146a,ncRNA/miRNA,is_expressed_in,BTO:0002609,astroglial cell,tissue/cell line,Alzheimer diseaseC10443,Curcumin,drug/chemical compound,decreases_expression of,3656,IRAK2,gene/protein,Alzheimer diseaseC10443,Curcumin,drug/chemical compound,decreases_expression of,MI0000477,mir-146a,ncRNA/miRNA,Alzheimer diseaseC10443,Curcumin,drug/chemical compound,increases_expression of,3654,IRAK1,gene/protein,Alzheimer disease,CAY10512,drug/chemical compound,decreases_expression of,3656,IRAK2,gene/protein,Alzheimer disease,CAY10512,drug/chemical compound,decreases_expression of,MI0000477,mir-146a,ncRNA/miRNA,Alzheimer disease,CAY10512,drug/chemical compound,increases_expression of,3654,IRAK1,gene/protein,Alzheimer disease4790,NFKB1,gene/protein,increases_expression of,3656,IRAK2,gene/protein,Alzheimer disease3656,IRAK2,gene/protein,increases_activity of,GO:0006954,inflammatory response,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,GO:0006950,response to stress,process,Alzheimer disease3553,IL1B,gene/protein,increases_activity of,GO:0006950,response to stress,process,Alzheimer disease4790,NFKB1,gene/protein,affects_activity of,MI0000477,mir-146a,ncRNA/miRNA,Alzheimer diseaseMI0000477,mir-146a,ncRNA/miRNA,affects_activity of,4790,NFKB1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,MI0000449,mir-132,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased Amyloid beta peptide (42) level,phenotype,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,affects_quantity of,C00533,NO,drug/chemical compound,Alzheimer diseaseC00533,NO,drug/chemical compound,affects_activity of,MP:0006036,abnormal mitochondrial physiology,phenotype,Alzheimer diseaseMP:0006036,abnormal mitochondrial physiology,phenotype,increases_activity of,4318,MMP9,gene/protein,Alzheimer disease4318,MMP9,gene/protein,affects_activity of,GO:0008219,cell death,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,cooccurs with,,transcytosis impairment,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,4318,MMP9,gene/protein,Alzheimer disease,APP/PS1 mouse,organism model,increases_quantity of,4318,MMP9,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,affects_quantity of,C00027,H2O2,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C00533,NO,drug/chemical compound,Alzheimer disease,APP/PS1 mouse,organism model,increases_quantity of,C00533,NO,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,GO:0000422,mitochondrion degradation,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_expression of,836,CASP3,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_expression of,842,CASP9,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,GO:0008219,cell death,process,Alzheimer disease,APP/PS1 mouse,organism model,increases_activity of,GO:0008219,cell death,process,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,MIMAT0000422,mir-124,ncRNA/miRNA,Alzheimer diseaseMIMAT0000422,mir-124,ncRNA/miRNA,affects_processing of,351,APP,gene/protein,Alzheimer disease5725,PTBP1,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer diseaseMI0000087,mir-29a,ncRNA/miRNA,affects_expression of,23621,BACE1,gene/protein,Alzheimer diseaseMI0000105,mir-29b-1,ncRNA/miRNA,affects_expression of,23621,BACE1,gene/protein,Alzheimer diseaseMIMAT0000441,mir-9,ncRNA/miRNA,affects_expression of,23621,BACE1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,MI0000286,mir-210,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,MI0000271,mir-181c,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,MI0000069,mir-15a,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,MIMAT0000441,mir-9,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,MI0000078,mir-22,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,MIMAT0000099,mir-101,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,MI0000239,mir-197,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,MIMAT0002808,mir-511,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,MI0000105,mir-29b-1,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,MI0000434,let-7i,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,MIMAT0000074,mir-19b,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,,mir-320,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,MI0000734,mir-106b,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,MI0000084,mir-26b,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,MI0000764,mir-363,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,MI0000095,mir-93,ncRNA/miRNA,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,MP:0004254,cerebral amyloid angiopathy,phenotype,Alzheimer disease104300,Alzheimer disease,disease,affects_folding of,351,Amyloid beta peptide,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_folding of,4137,MAPT,gene/protein,Alzheimer disease3315,HSPB1,gene/protein,is localized in,BTO:0000099,astrocyte,tissue/cell line,Alzheimer disease1410,CRYAB,gene/protein,is localized in,BTO:0000099,astrocyte,tissue/cell line,Alzheimer disease126393,HSPB6,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease3316,HSPB2,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease3316,HSPB2,gene/protein,is localized in,BTO:0000099,astrocyte,tissue/cell line,Alzheimer diseaseC19610,Mn2+,drug/chemical compound,decreases_activity of,2932,GSK3B,gene/protein,Alzheimer diseaseC00305,Mg2+,drug/chemical compound,increases_activity of,2932,GSK3B,gene/protein,Alzheimer disease,Tungstate,drug/chemical compound,decreases_activity of,2932,GSK3B,gene/protein,Alzheimer disease,Mitochondrial respiratory chain complex IV,complex/PPI,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease,Mitochondrial respiratory chain complex IV,complex/PPI,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseMP:0006036,abnormal mitochondrial physiology,phenotype,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseMP:0006036,abnormal mitochondrial physiology,phenotype,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease351,Amyloid beta peptide (soluble),gene/protein,interacts (colocalizes) with,GO:0005739,mitochondrion,cellular component,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,MP:0006035,abnormal mitochondrial morphology,phenotype,Alzheimer disease,APP/PS1 mouse,organism model,decreases_activity of,,Mitochondrial respiratory chain complex IV,complex/PPI,Alzheimer disease351,Amyloid beta peptide,gene/protein,affects_quantity of,C00533,NO,drug/chemical compound,Alzheimer diseaseC00533,NO,drug/chemical compound,affects_processing of,10059,DNM1L,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,10059,DNM1L-SNO,protein modification,Alzheimer diseaseC00533,NO,drug/chemical compound,increases_activity of,GO:0000266,mitochondrial fission,process,Alzheimer diseaseC00533,NO,drug/chemical compound,increases_activity of,GO:0042803,protein homodimerization activity,process,Alzheimer diseaseC00533,NO,drug/chemical compound,increases_quantity of,10059,DNM1L-SNO (homodimer),protein modification,Alzheimer diseaseC00533,NO,drug/chemical compound,affects_activity of,GO:0003924,GTPase activity,process,Alzheimer diseaseGO:0042803,protein homodimerization activity,process,affects_activity of,10059,DNM1L-SNO,protein modification,Alzheimer diseaseGO:0042803,protein homodimerization activity,process,affects_activity of,GO:0003924,GTPase activity,process,Alzheimer disease10059,DNM1L-SNO (homodimer),protein modification,affects_activity of,GO:0003924,GTPase activity,process,Alzheimer disease4137,MAPT,gene/protein,increases_activity of,1499,CTNNB1,gene/protein,Alzheimer disease351,Amyloid beta peptide,gene/protein,interacts (colocalizes) with,5170,PDPK1,gene/protein,Alzheimer disease,inclusion body myositis,phenotype,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease351,Amyloid beta peptide,gene/protein,increases_activity of,2932,GSK3B,gene/protein,Alzheimer disease23385,NCSTN-mut,gene/protein mutant,increases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease23385,NCSTN,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease23385,NCSTN,gene/protein,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease351,APP,gene/protein,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,APP M17 cell,tissue/cell line,increases_quantity of,351,APP,gene/protein,Alzheimer disease,APP M17 cell,tissue/cell line,increases_activity of,MP:0006035,abnormal mitochondrial morphology,phenotype,Alzheimer disease,APP M17 cell,tissue/cell line,affects_activity of,GO:0048311,mitochondrion distribution,process,Alzheimer disease351,APP,gene/protein,increases_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease351,APP,gene/protein,affects_activity of,GO:0051881,regulation of mitochondrial membrane potential,process,Alzheimer disease351,APP,gene/protein,decreases_quantity of,C00002,ATP,drug/chemical compound,Alzheimer disease351,APP,gene/protein,decreases_activity of,GO:0023041,neuronal signal transduction,process,Alzheimer disease,APP M17 cell,tissue/cell line,decreases_quantity of,10059,DNM1L,gene/protein,Alzheimer disease,APP M17 cell,tissue/cell line,decreases_quantity of,4976,OPA1,gene/protein,Alzheimer disease,APP M17 cell,tissue/cell line,increases_quantity of,51024,FIS1,gene/protein,Alzheimer disease10059,DNM1L,gene/protein,decreases_activity of,MP:0006037,abnormal mitochondrial proliferation,phenotype,Alzheimer disease10059,DNM1L,gene/protein,decreases_activity of,MP:0006035,abnormal mitochondrial morphology,phenotype,Alzheimer disease4976,OPA1,gene/protein,decreases_activity of,MP:0006036,abnormal mitochondrial physiology,phenotype,Alzheimer disease4976,OPA1,gene/protein,affects_activity of,GO:0048311,mitochondrion distribution,process,Alzheimer disease1352,COX10,gene/protein,affects_activity of,GO:0006783,heme biosynthetic process,process,Alzheimer disease1352,COX10,gene/protein,affects_activity of,GO:0017004,cytochrome complex assembly,process,Alzheimer disease,COX10 KO mouse,organism model,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,COX10 KO mouse,organism model,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,COX10 KO mouse,organism model,decreases_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease,COX10 KO mouse,organism model,decreases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease,COX10 KO mouse,organism model,decreases_quantity of,1352,COX10,gene/protein,Alzheimer disease84630,TTBK1,gene/protein,affects_phosphorylation of,4137,MAPT,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,84630,TTBK1,gene/protein,Alzheimer disease,TTBK1-Tg mouse,organism model,increases_expression of,84630,TTBK1,gene/protein,Alzheimer disease,TTBK1-Tg mouse,organism model,increases_quantity of,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer disease,TTBK1-Tg mouse,organism model,affects_activity of,GO:0007611,learning or memory,process,Alzheimer disease,TTBK1-Tg mouse,organism model,increases_phosphorylation of,4137,MAPT,gene/protein,Alzheimer disease,TTBK1-Tg mouse,organism model,increases_expression of,8851,p25,gene/protein,Alzheimer disease,TTBK1-Tg mouse,organism model,increases_expression of,8851,CDK5R1,gene/protein,Alzheimer disease8851,CDK5R1,gene/protein,increases_activity of,1020,CDK5,gene/protein,Alzheimer disease,TTBK1-Tg mouse,organism model,increases_activity of,823,CAPN1,gene/protein,Alzheimer disease,TTBK1-Tg mouse,organism model,decreases_quantity of,2904,GRIN2B,gene/protein,Alzheimer disease,TTBK1-Tg mouse,organism model,decreases_quantity of,2906,GRIN2D,gene/protein,Alzheimer disease8851,CDK5R1,gene/protein,interacts (colocalizes) with,1020,CDK5,gene/protein,Alzheimer disease8851,CDK5R1,gene/protein,interacts (colocalizes) with,GO:0031941,filamentous actin,cellular component,Alzheimer disease,TTBK1-Tg mouse,organism model,increases_quantity of,1115,CDK5/p35 complex,complex/PPI,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,MP:0000233,abnormal blood flow velocity,phenotype,Alzheimer diseaseGO:0007568,aging,process,affects_activity of,GO:0002376,immune system process,process,Alzheimer diseaseGO:0007568,aging,process,affects_activity of,GO:0045454,cell redox homeostasis,process,Alzheimer diseaseGO:0002376,immune system process,process,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer diseaseGO:0045454,cell redox homeostasis,process,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer diseaseGO:0007568,aging,process,increases_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease,Reactive oxygen species,drug/chemical compound,affects_activity of,GO:0002376,immune system process,process,Alzheimer diseaseGO:0006954,inflammatory response,process,affects_activity of,GO:0042116,macrophage activation,process,Alzheimer disease5465,PPARA,gene/protein,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer disease5465,PPARA,gene/protein,affects_activity of,GO:0007568,aging,process,Alzheimer disease5468,PPARG,gene/protein,affects_activity of,GO:0007568,aging,process,Alzheimer disease5468,PPARG,gene/protein,decreases_activity of,GO:0006954,inflammatory response,process,Alzheimer disease5468,PPARG,gene/protein,affects_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,NSAID,drug/chemical compound,affects_activity of,5468,PPARG,gene/protein,Alzheimer disease5465,PPARA,gene/protein,decreases_activity of,GO:0006954,inflammatory response,process,Alzheimer disease351,Amyloid beta peptide,gene/protein,increases_activity of,GO:0001774,microglial cell activation,process,Alzheimer diseaseGO:0001774,microglial cell activation,process,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseGO:0001774,microglial cell activation,process,increases_expression of,3553,IL1B,gene/protein,Alzheimer diseaseGO:0001774,microglial cell activation,process,increases_expression of,3569,IL6,gene/protein,Alzheimer diseaseGO:0001774,microglial cell activation,process,increases_expression of,7124,TNF,gene/protein,Alzheimer disease,Cytokine,gene/protein,interacts (colocalizes) with,GO:0045202,synapse,cellular component,Alzheimer disease5468,PPARG,gene/protein,decreases_expression of,,Cytokine,gene/protein,Alzheimer disease5465,PPARA,gene/protein,decreases_expression of,,Cytokine,gene/protein,Alzheimer disease,Cytokine,gene/protein,interacts (colocalizes) with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease1401,CRP,gene/protein,affects_activity of,,cognitive impairment,phenotype,Alzheimer disease3569,IL6,gene/protein,affects_activity of,,cognitive impairment,phenotype,Alzheimer disease7124,TNF,gene/protein,affects_activity of,,cognitive impairment,phenotype,Alzheimer diseaseGO:0006954,inflammatory response,process,affects_quantity of,5743,PTGS2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,5743,PTGS2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,5468,PPARG,gene/protein,Alzheimer disease5468,PPARG,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease,NSAID,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,is_part_of,,NSAID,drug/chemical compound,Alzheimer diseaseC01926,Indomethacin,drug/chemical compound,is_part_of,,NSAID,drug/chemical compound,Alzheimer diseaseC01926,Indomethacin,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD00118,Naproxen,drug/chemical compound,is_part_of,,NSAID,drug/chemical compound,Alzheimer diseaseD00118,Naproxen,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC00051,Glutathione,drug/chemical compound,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer disease2729,GCLC,gene/protein,affects_quantity of,C00051,Glutathione,drug/chemical compound,Alzheimer diseaseC04543,"S-Butyl-DL-homocysteine-[S,R]-sulfoximine",drug/chemical compound,affects_quantity of,C00051,Glutathione,drug/chemical compound,Alzheimer diseaseC04543,"S-Butyl-DL-homocysteine-[S,R]-sulfoximine",drug/chemical compound,affects_activity of,2729,GCLC,gene/protein,Alzheimer diseaseGO:0006750,glutathione biosynthetic process,process,affects_quantity of,C00051,Glutathione,drug/chemical compound,Alzheimer diseaseGO:0006750,glutathione biosynthetic process,process,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseC04543,"S-Butyl-DL-homocysteine-[S,R]-sulfoximine",drug/chemical compound,decreases_activity of,GO:0006750,glutathione biosynthetic process,process,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,BTO:0000078,microglia,tissue/cell line,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,BTO:0000099,astrocyte,tissue/cell line,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,BTO:0001370,THP-1 cell,tissue/cell line,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,,p38 MAPK,gene/protein,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,,JUN kinase kinase,gene/protein,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,,NF-kappaB complex,complex/PPI,Alzheimer diseaseC04543,"S-Butyl-DL-homocysteine-[S,R]-sulfoximine",drug/chemical compound,increases_quantity of,C00076,Ca2+,drug/chemical compound,Alzheimer diseaseD00282,Clotrimazole,drug/chemical compound,decreases_activity of,,Calcium channel,complex/PPI,Alzheimer diseaseD00282,Clotrimazole,drug/chemical compound,decreases_quantity of,C00076,Ca2+,drug/chemical compound,Alzheimer disease7226,TRPM2,gene/protein,is_expressed_in,BTO:0002606,glial cell,tissue/cell line,Alzheimer disease7226,TRPM2,gene/protein,is_part_of,,Calcium channel,complex/PPI,Alzheimer disease7226,TRPM2,gene/protein,affects_activity of,,Calcium channel,complex/PPI,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,GO:0006897,endocytosis,process,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease351,Amyloid beta peptide (40),gene/protein,affects_activity of,GO:0007611,learning or memory,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,affects_activity of,GO:0007611,learning or memory,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,interacts (colocalizes) with,GO:0005771,multivesicular body,cellular component,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,interacts (colocalizes) with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease351,Amyloid beta peptide (40),gene/protein,interacts (colocalizes) with,GO:0005771,multivesicular body,cellular component,Alzheimer disease351,Amyloid beta peptide (40),gene/protein,interacts (colocalizes) with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease23621,BACE1,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer disease351,APP-mut,gene/protein mutant,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease23621,BACE1,gene/protein,affects_activity of,GO:0034205,beta-amyloid formation,process,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_activity of,GO:0034205,beta-amyloid formation,process,Alzheimer disease351,APP-mut,gene/protein mutant,affects_activity of,GO:0034205,beta-amyloid formation,process,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,affects_activity of,GO:0034205,beta-amyloid formation,process,Alzheimer disease5664,PSEN2-mut,gene/protein mutant,affects_activity of,GO:0034205,beta-amyloid formation,process,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease5664,PSEN2-mut,gene/protein mutant,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,increases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease5664,PSEN2-mut,gene/protein mutant,increases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease351,APP-mut,gene/protein mutant,increases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer diseaseGO:0034205,beta-amyloid formation,process,increases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease351,Amyloid beta peptide,gene/protein,decreases_activity of,GO:0060291,long-term synaptic potentiation,process,Alzheimer disease351,Amyloid beta peptide,gene/protein,increases_activity of,GO:0060292,long term synaptic depression,process,Alzheimer diseaseGO:0060291,long-term synaptic potentiation,process,affects_activity of,GO:0007611,learning or memory,process,Alzheimer diseaseGO:0060291,long-term synaptic potentiation,process,affects_activity of,GO:0016310,phosphorylation,process,Alzheimer diseaseGO:0060291,long-term synaptic potentiation,process,affects_activity of,,Glutamate receptor,complex/PPI,Alzheimer diseaseGO:0060292,long term synaptic depression,process,affects_activity of,GO:0016310,phosphorylation,process,Alzheimer diseaseGO:0060292,long term synaptic depression,process,affects_activity of,,Glutamate receptor,complex/PPI,Alzheimer disease351,Amyloid beta peptide,gene/protein,is localized in,BTO:0004345,entorhinal cortex,tissue/cell line,Alzheimer disease351,Amyloid beta peptide,gene/protein,is localized in,BTO:0002807,prefrontal cortex,tissue/cell line,Alzheimer disease351,Amyloid beta peptide,gene/protein,decreases_activity of,GO:0007611,learning or memory,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,affects_activity of,,NMDA receptor complex,complex/PPI,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,,NMDA receptor complex,complex/PPI,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_quantity of,,NMDA receptor complex,complex/PPI,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,2902,GRIN1,gene/protein,Alzheimer disease351,Amyloid beta peptide,gene/protein,interacts (colocalizes) with,1139,CHRNA7,gene/protein,Alzheimer disease351,Amyloid beta peptide,gene/protein,affects_activity of,GO:0035585,calcium-mediated signaling using extracellular calcium source,process,Alzheimer diseaseC08699,Methyllycaconitine,drug/chemical compound,increases_quantity of,2902,GRIN1,gene/protein,Alzheimer disease1139,CHRNA7,gene/protein,increases_activity of,5530,PPP3CA,gene/protein,Alzheimer diseaseC16068,Humanin,drug/chemical compound,affects_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC16068,Humanin,drug/chemical compound,decreases_activity of,GO:0070997,neuron death,process,Alzheimer disease351,Amyloid beta peptide (soluble),gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease,Humanin derivative,drug/chemical compound,increases_activity of,3717,JAK2,gene/protein,Alzheimer disease,Humanin derivative,drug/chemical compound,increases_activity of,6774,STAT3,gene/protein,Alzheimer disease,Colivelin,drug/chemical compound,decreases_activity of,,cognitive impairment,phenotype,Alzheimer disease10105,PPIF,gene/protein,is localized in,GO:0005739,mitochondrion,cellular component,Alzheimer disease3028,HSD17B10,gene/protein,is localized in,GO:0005739,mitochondrion,cellular component,Alzheimer disease,Colivelin,drug/chemical compound,increases_activity of,GO:0007259,JAK-STAT cascade,process,Alzheimer diseaseGO:0007568,aging,process,affects_quantity of,6774,STAT3-phos,protein modification,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,affects_quantity of,6774,STAT3-phos,protein modification,Alzheimer diseaseMP:0001544,abnormal cardiovascular system physiology,phenotype,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,antioxidant diet,environment,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,polyunsaturated fatty acids diet,environment,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,exercise,environment,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,Diabetes mellitus,disease,Alzheimer disease,Antiinflammatory agent,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseGO:0008152,metabolic process,process,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease348,APOE (isoform E4),gene/protein mutant,affects_activity of,GO:0008152,metabolic process,process,Alzheimer diseaseGO:0007568,aging,process,affects_activity of,GO:0008152,metabolic process,process,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,GO:0008152,metabolic process,process,Alzheimer disease,Reactive oxygen species,drug/chemical compound,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseGO:0043364,catalysis of free radical formation,process,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseC00704,O2-,drug/chemical compound,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseC00533,NO,drug/chemical compound,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseC16845,Peroxynitrite,drug/chemical compound,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseGO:0006099,tricarboxylic acid cycle,process,affects_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer diseaseGO:0022904,respiratory electron transport chain,process,affects_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer diseaseGO:0008152,metabolic process,process,affects_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer diseaseC01471,Acrolein,drug/chemical compound,interacts (colocalizes) with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseC01471,Acrolein,drug/chemical compound,interacts (colocalizes) with,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,,Lipoxygenase,gene/protein,Alzheimer disease,Lipoxygenase,gene/protein,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer diseaseC00586,2-Deoxy-D-glucose,drug/chemical compound,decreases_activity of,GO:0008152,metabolic process,process,Alzheimer disease,Insulin,complex/PPI,decreases_activity of,GO:0008152,metabolic process,process,Alzheimer diseaseC05669,beta-Nitropropanoate,drug/chemical compound,decreases_activity of,GO:0008152,metabolic process,process,Alzheimer diseaseC12819,Kainic acid,drug/chemical compound,decreases_activity of,GO:0008152,metabolic process,process,Alzheimer diseaseC00586,2-Deoxy-D-glucose,drug/chemical compound,increases_quantity of,23621,BACE1,gene/protein,Alzheimer disease,Insulin,complex/PPI,increases_quantity of,23621,BACE1,gene/protein,Alzheimer diseaseC05669,beta-Nitropropanoate,drug/chemical compound,increases_quantity of,23621,BACE1,gene/protein,Alzheimer diseaseC12819,Kainic acid,drug/chemical compound,increases_quantity of,23621,BACE1,gene/protein,Alzheimer diseaseC00586,2-Deoxy-D-glucose,drug/chemical compound,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,Insulin,complex/PPI,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseC05669,beta-Nitropropanoate,drug/chemical compound,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseC12819,Kainic acid,drug/chemical compound,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,GO:0018158,protein oxidation,process,Alzheimer diseaseGO:0034440,lipid oxidation,process,affects_quantity of,C01471,Acrolein,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0006099,tricarboxylic acid cycle,process,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,1375,Pyruvate dehydrogenase complex,complex/PPI,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,,Isocitrate dehydrogenase complex,complex/PPI,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,6389,SDHA,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,4191,MDH2,gene/protein,Alzheimer disease351,APP-mut670/671,gene/protein mutant,decreases_quantity of,4967,OGDH,gene/protein,Alzheimer disease351,APP-mut670/671,gene/protein mutant,decreases_quantity of,1743,DLST,gene/protein,Alzheimer diseaseC16845,Peroxynitrite,drug/chemical compound,decreases_activity of,,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,Alzheimer diseaseC00533,NO,drug/chemical compound,decreases_activity of,,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,Alzheimer disease,Hydroxynonenal,drug/chemical compound,decreases_activity of,,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,Alzheimer diseaseC00027,H2O2,drug/chemical compound,decreases_activity of,,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,Alzheimer disease,chloroamine,drug/chemical compound,decreases_activity of,,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,Alzheimer diseaseD01711,Sodium hypochlorite,drug/chemical compound,decreases_activity of,,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,,Hydroxynonenal,drug/chemical compound,Alzheimer disease,Hydroxynonenal,drug/chemical compound,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,,Hydroxynonenal,drug/chemical compound,Alzheimer disease351,APP-mut670/671,gene/protein mutant,affects_activity of,351,APP,gene/protein,Alzheimer disease1375,Pyruvate dehydrogenase complex,complex/PPI,affects_activity of,GO:0006099,tricarboxylic acid cycle,process,Alzheimer disease,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,affects_activity of,GO:0006099,tricarboxylic acid cycle,process,Alzheimer disease4967,OGDH,gene/protein,affects_activity of,,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,Alzheimer disease1743,DLST,gene/protein,affects_activity of,,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,Alzheimer disease,Isocitrate dehydrogenase complex,complex/PPI,affects_activity of,GO:0006099,tricarboxylic acid cycle,process,Alzheimer disease1738,DLD,gene/protein,affects_activity of,,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,Alzheimer diseaseC00127,Glutathione disulfide,drug/chemical compound,affects_activity of,,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,Alzheimer diseaseC00051,Glutathione,drug/chemical compound,affects_activity of,,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,Alzheimer diseaseC00127,Glutathione disulfide,drug/chemical compound,affects_processing of,4967,OGDH,gene/protein,Alzheimer diseaseC00127,Glutathione disulfide,drug/chemical compound,affects_processing of,1743,DLST,gene/protein,Alzheimer diseaseC00127,Glutathione disulfide,drug/chemical compound,affects_processing of,1738,DLD,gene/protein,Alzheimer disease1743,DLST,gene/protein,affects_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer diseaseC00027,H2O2,drug/chemical compound,affects_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer diseaseC00027,H2O2,drug/chemical compound,affects_activity of,GO:0070997,neuron death,process,Alzheimer disease,Reactive oxygen species,drug/chemical compound,affects_activity of,GO:0070997,neuron death,process,Alzheimer disease,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,affects_quantity of,C00027,H2O2,drug/chemical compound,Alzheimer disease1743,DLST,gene/protein,affects_activity of,,MDH,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0006816,calcium ion transport,process,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0032469,endoplasmic reticulum calcium ion homeostasis,process,Alzheimer disease104300,Alzheimer disease,disease,decreases_activity of,GO:0070509,calcium ion import,process,Alzheimer disease1953,Alpha-keto-beta-methyl valerate,drug/chemical compound,decreases_activity of,,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,Alzheimer disease,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,affects_activity of,GO:0001836,release of cytochrome c from mitochondria,process,Alzheimer disease1953,Alpha-keto-beta-methyl valerate,drug/chemical compound,decreases_activity of,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,process,Alzheimer disease1953,Alpha-keto-beta-methyl valerate,drug/chemical compound,affects_activity of,GO:0032469,endoplasmic reticulum calcium ion homeostasis,process,Alzheimer disease1953,Alpha-keto-beta-methyl valerate,drug/chemical compound,decreases_activity of,GO:0051882,mitochondrial depolarization,process,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C19440,Malonaldehyde,drug/chemical compound,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_quantity of,C19440,Malonaldehyde,drug/chemical compound,Alzheimer disease,Alpha-ketoglutarate dehydrogenase complex,complex/PPI,affects_activity of,GO:0007611,learning or memory,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_activity of,GO:0008340,determination of adult lifespan,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_expression of,581,BAX,gene/protein,Alzheimer disease351,Amyloid beta peptide (Met35-ox),protein modification,increases_expression of,581,BAX,gene/protein,Alzheimer disease581,BAX,gene/protein,increases_activity of,GO:0006915,apoptotic process,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_expression of,596,BCL2,gene/protein,Alzheimer disease596,BCL2,gene/protein,decreases_activity of,GO:0006915,apoptotic process,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,836,CASP3,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,GO:0070997,neuron death,phenotype,Alzheimer disease581,BAX,gene/protein,increases_activity of,GO:0070997,neuron death,phenotype,Alzheimer disease596,BCL2,gene/protein,increases_activity of,GO:0070997,neuron death,phenotype,Alzheimer disease836,CASP3,gene/protein,increases_activity of,GO:0070997,neuron death,phenotype,Alzheimer diseaseC10524,Puerarin,drug/chemical compound,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseC10524,Puerarin,drug/chemical compound,decreases_activity of,GO:0006915,apoptotic process,process,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer disease,SAD cybrid cell,tissue/cell line,increases_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease,SAD cybrid cell,tissue/cell line,increases_activity of,GO:0051402,neuron apoptotic process,process,Alzheimer diseaseC10524,Puerarin,drug/chemical compound,decreases_activity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease,SAD cybrid cell,tissue/cell line,increases_activity of,836,CASP3,gene/protein,Alzheimer disease,SAD cybrid cell,tissue/cell line,increases_activity of,,p38 MAPK,gene/protein,Alzheimer disease,SAD cybrid cell,tissue/cell line,increases_activity of,5599,MAPK8,gene/protein,Alzheimer diseaseC10524,Puerarin,drug/chemical compound,decreases_activity of,5599,MAPK8,gene/protein,Alzheimer diseaseC10524,Puerarin,drug/chemical compound,decreases_activity of,,p38 MAPK,gene/protein,Alzheimer diseaseC10524,Puerarin,drug/chemical compound,decreases_activity of,836,CASP3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,728642,CDK11A,gene/protein,Alzheimer disease351,APP,gene/protein,increases_expression of,728642,CDK11A,gene/protein,Alzheimer disease728642,CDK11A,gene/protein,affects_quantity of,351,Amyloid beta peptide (25-35),gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,BTO:0000938,neuron,tissue/cell line,Alzheimer disease351,"Amyloid beta peptide (dimer, soluble)",gene/protein,increases_quantity of,4137,MAPT-hyperphos,protein modification,Alzheimer disease351,"Amyloid beta peptide (dimer, soluble)",gene/protein,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease4137,MAPT,gene/protein,affects_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease23411,SIRT1,gene/protein,affects_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease102,ADAM10,gene/protein,is_part_of,,Alpha-secretase,gene/protein,Alzheimer disease23411,SIRT1,gene/protein,increases_activity of,102,ADAM10,gene/protein,Alzheimer disease,Alpha-secretase,gene/protein,increases_processing of,351,APP,gene/protein,Alzheimer disease,Alpha-secretase,gene/protein,decreases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer diseaseGO:0006950,response to stress,process,affects_expression of,23411,SIRT1,gene/protein,Alzheimer diseaseGO:0016310,phosphorylation,process,affects_activity of,23411,SIRT1,gene/protein,Alzheimer disease23411,SIRT1,gene/protein,decreases_acetylation of,3297,HSF1,gene/protein,Alzheimer disease23411,SIRT1,gene/protein,increases_activity of,3297,HSF1,gene/protein,Alzheimer disease3297,HSF1-deacyl,protein modification,affects_expression of,,Chaperone,gene/protein,Alzheimer disease23411,SIRT1,gene/protein,affects_activity of,GO:0019213,deacetylase activity,process,Alzheimer disease23411,SIRT1,gene/protein,increases_expression of,,Alpha-secretase,gene/protein,Alzheimer disease,calorie restriction,environment,increases_expression of,23411,SIRT1,gene/protein,Alzheimer disease,calorie restriction,environment,increases_quantity of,C00003,NAD+,drug/chemical compound,Alzheimer disease23411,SIRT1,gene/protein,increases_activity of,,Alpha-secretase,gene/protein,Alzheimer disease23411,SIRT1,gene/protein,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC00003,NAD+,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease6093,ROCK1,gene/protein,affects_activity of,,Alpha-secretase,gene/protein,Alzheimer disease4040,LRP6-mut,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease4040,LRP6,gene/protein,is localized in,BTO:0000601,hippocampus,tissue/cell line,Alzheimer disease4040,LRP6,gene/protein,affects_activity of,348,APOE,gene/protein,Alzheimer diseaseGO:0034440,lipid oxidation,process,affects_quantity of,DLD0051,4-Hydroxy-2-nonenal,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,DLD0051,4-Hydroxy-2-nonenal,drug/chemical compound,Alzheimer diseaseDLD0051,4-Hydroxy-2-nonenal,drug/chemical compound,interacts (colocalizes) with,GO:0005739,mitochondrion,cellular component,Alzheimer diseaseGO:0006979,response to oxidative stress,process,increases_expression of,4843,NOS2,gene/protein,Alzheimer diseaseGO:0006979,response to oxidative stress,process,increases_expression of,4842,NOS1,gene/protein,Alzheimer disease4842,NOS1,gene/protein,increases_quantity of,117644140,3-Nitrotyrosine,drug/chemical compound,Alzheimer disease4843,NOS2,gene/protein,increases_quantity of,117644140,3-Nitrotyrosine,drug/chemical compound,Alzheimer diseaseGO:0018158,protein oxidation,process,affects_quantity of,117644140,3-Nitrotyrosine,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,117644140,3-Nitrotyrosine,drug/chemical compound,Alzheimer disease117644140,3-Nitrotyrosine,drug/chemical compound,is localized in,GO:0005739,mitochondrion,cellular component,Alzheimer diseaseMP:0004254,cerebral amyloid angiopathy,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer diseaseMP:0004254,cerebral amyloid angiopathy,phenotype,affects_quantity of,C00023,Iron,drug/chemical compound,Alzheimer diseaseC00023,Iron,drug/chemical compound,is localized in,BTO:0004378,blood vessel wall,tissue/cell line,Alzheimer diseaseMP:0004254,cerebral amyloid angiopathy,phenotype,increases_quantity of,C00038,Zn2+,drug/chemical compound,Alzheimer diseaseMP:0004254,cerebral amyloid angiopathy,phenotype,decreases_quantity of,C00070,Cu2+,drug/chemical compound,Alzheimer diseaseC00070,Cu2+,drug/chemical compound,is localized in,BTO:0003718,vasculature,tissue/cell line,Alzheimer diseaseC00023,Iron,drug/chemical compound,is localized in,BTO:0001997,arteriole,tissue/cell line,Alzheimer diseaseMP:0004254,cerebral amyloid angiopathy,phenotype,increases_activity of,GO:0042167,heme catabolic process,process,Alzheimer diseaseMP:0004254,cerebral amyloid angiopathy,phenotype,increases_quantity of,3162,HMOX1,gene/protein,Alzheimer diseaseMP:0004254,cerebral amyloid angiopathy,phenotype,increases_quantity of,645,BLVRB,gene/protein,Alzheimer diseaseMP:0004254,cerebral amyloid angiopathy,phenotype,affects_quantity of,644,BLVRA,gene/protein,Alzheimer diseaseMP:0001770,abnormal iron level,phenotype,affects_quantity of,C00023,Iron,drug/chemical compound,Alzheimer disease645,BLVRB,gene/protein,is localized in,BTO:0000999,parenchyma,tissue/cell line,Alzheimer diseaseC00038,Zn2+,drug/chemical compound,is localized in,BTO:0000823,cerebral gray matter,tissue/cell line,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,C00070,Cu2+,drug/chemical compound,Alzheimer diseaseGO:0007568,aging,process,increases_activity of,MP:0000066,osteoporosis,phenotype,Alzheimer diseaseMP:0000063,decreased bone mineral density,phenotype,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseMP:0005669,increased circulating leptin level,phenotype,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseMP:0005668,decreased circulating leptin level,phenotype,increases_activity of,MP:0000066,osteoporosis,phenotype,Alzheimer disease,cigarette smoking,environment,increases_activity of,MP:0000066,osteoporosis,phenotype,Alzheimer disease,cigarette smoking,environment,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseMP:0000063,decreased bone mineral density,phenotype,increases_activity of,MP:0000066,osteoporosis,phenotype,Alzheimer disease351,Amyloid beta peptide (oligomer),gene/protein,decreases_expression of,4313,MMP2,gene/protein,Alzheimer disease351,Amyloid beta peptide (oligomer),gene/protein,decreases_activity of,4313,MMP2,gene/protein,Alzheimer disease,APP/PS1 mouse,organism model,increases_expression of,4313,MMP2,gene/protein,Alzheimer disease4313,MMP2,gene/protein,increases_activity of,,Cytokine,gene/protein,Alzheimer disease3553,IL1B,gene/protein,is_part_of,,Cytokine,gene/protein,Alzheimer disease7040,TGFB1,gene/protein,is_part_of,,Cytokine,gene/protein,Alzheimer disease351,Amyloid beta peptide (3pE-42),protein modification,affects_activity of,GO:0070997,neuron death,process,Alzheimer disease25797,QPCT,gene/protein,affects_processing of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,5XFAD/hQC bigenic mouse,organism model,increases_quantity of,351,Amyloid beta peptide (3pE-42),protein modification,Alzheimer disease,5XFAD/hQC bigenic mouse,organism model,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease25797,QPCT,gene/protein,increases_quantity of,351,Amyloid beta peptide (3pE-42),protein modification,Alzheimer disease,PQ150,drug/chemical compound,decreases_activity of,25797,QPCT,gene/protein,Alzheimer diseaseC01879,Pyroglutamate,drug/chemical compound,interacts (colocalizes) with,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC01879,Pyroglutamate,drug/chemical compound,affects_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease25797,QPCT,gene/protein,increases_quantity of,351,Amyloid beta peptide (3pE-40),protein modification,Alzheimer disease351,Amyloid beta peptide (3pE-42),protein modification,increases_activity of,GO:0070997,neuron death,process,Alzheimer disease351,Amyloid beta peptide (3pE-40),protein modification,increases_activity of,GO:0070997,neuron death,process,Alzheimer disease,QPCT ihhibitor,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (3pE-42),protein modification,Alzheimer disease,QPCT ihhibitor,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (3pE-40),protein modification,Alzheimer disease,Glutaminyl cyclase inhibitor PBD150,drug/chemical compound,is_part_of,,QPCT ihhibitor,drug/chemical compound,Alzheimer disease,Glutaminyl cyclase inhibitor PBD150,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (3pE-42),protein modification,Alzheimer disease,Glutaminyl cyclase inhibitor PBD150,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (3pE-40),protein modification,Alzheimer diseaseD05127,Nebivolol,drug/chemical compound,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseD05127,Nebivolol,drug/chemical compound,affects_activity of,GO:0030284,estrogen receptor activity,process,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,BTO:0000947,neuronal cell line,tissue/cell line,Alzheimer diseaseD05127,Nebivolol,drug/chemical compound,decreases_activity of,MP:0000231,hypertension,phenotype,Alzheimer diseaseD05127,Nebivolol,drug/chemical compound,decreases_activity of,GO:0071875,adrenergic receptor signaling pathway,process,Alzheimer diseaseD05127,Nebivolol,drug/chemical compound,affects_activity of,GO:0042311,vasodilation,process,Alzheimer diseaseGO:0042311,vasodilation,process,affects_activity of,MP:0000231,hypertension,phenotype,Alzheimer diseaseD05127,Nebivolol,drug/chemical compound,affects_activity of,153,ADRB1,gene/protein,Alzheimer disease153,ADRB1,gene/protein,affects_activity of,GO:0071875,adrenergic receptor signaling pathway,process,Alzheimer diseaseD05127,Nebivolol,drug/chemical compound,affects_processing of,351,APP,gene/protein,Alzheimer diseaseD05127,Nebivolol,drug/chemical compound,increases_activity of,,Alpha-secretase,gene/protein,Alzheimer diseaseD05127,Nebivolol,drug/chemical compound,increases_quantity of,351,sAPP-alpha,gene/protein,Alzheimer disease351,sAPP-alpha,gene/protein,decreases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease351,sAPP-alpha,gene/protein,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseC01879,Pyroglutamate,drug/chemical compound,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease25797,QPCT,gene/protein,affects_processing of,C01879,Pyroglutamate,drug/chemical compound,Alzheimer disease,Glutaminyl cyclase inhibitor PBD150,drug/chemical compound,decreases_activity of,25797,QPCT,gene/protein,Alzheimer disease,Glutaminyl cyclase inhibitor PBD150,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (pE-modified),protein modification,Alzheimer disease25797,QPCT,gene/protein,is localized in,GO:0005794,Golgi apparatus,cellular component,Alzheimer disease25797,QPCT,gene/protein,interacts (colocalizes) with,,Glutaminyl cyclase inhibitor PBD150,drug/chemical compound,Alzheimer disease25797,QPCT,gene/protein,increases_quantity of,351,Amyloid beta peptide (pE-modified),protein modification,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,25797,QPCT,gene/protein,Alzheimer disease25797,QPCT,gene/protein,affects_activity of,351,Amyloid beta peptide (pE-modified),protein modification,Alzheimer disease351,Amyloid beta peptide (3pE-42),protein modification,increases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease,Glutaminyl cyclase inhibitor,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (pE-modified),protein modification,Alzheimer disease351,Amyloid beta peptide (3pE-42),protein modification,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,ApoE4 transgenic mouse,organism model,increases_activity of,MP:0000233,abnormal blood flow velocity,phenotype,Alzheimer disease,ApoE4 transgenic mouse,organism model,increases_activity of,MP:0006080,CNS ischemia,phenotype,Alzheimer disease348,APOE (isoform E4),gene/protein mutant,increases_activity of,MP:0000233,abnormal blood flow velocity,phenotype,Alzheimer disease,ApoE4 transgenic mouse,organism model,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,ApoE4 transgenic mouse,organism model,decreases_activity of,,cognitive impairment,phenotype,Alzheimer diseaseC02571,O-Acetylcarnitine,drug/chemical compound,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease3812068,R-alpha-lipoic acid,drug/chemical compound,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease3812068,R-alpha-lipoic acid,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC02571,O-Acetylcarnitine,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,ApoE4 transgenic mouse,organism model,affects_activity of,GO:0006950,response to stress,process,Alzheimer disease,ApoE4 transgenic mouse,organism model,affects_activity of,BTO:0001853,vascular endothelium,tissue/cell line,Alzheimer diseaseGO:0006950,response to stress,process,affects_activity of,BTO:0001853,vascular endothelium,tissue/cell line,Alzheimer diseaseD03753,Perindopril,drug/chemical compound,decreases_activity of,1636,ACE,gene/protein,Alzheimer diseaseD07892,Enalapril,drug/chemical compound,decreases_activity of,1636,ACE,gene/protein,Alzheimer diseaseD08068,Imidapril,drug/chemical compound,decreases_activity of,1636,ACE,gene/protein,Alzheimer disease,Abeta (2535) injected mouse,organism model,decreases_activity of,GO:0007611,learning or memory,process,Alzheimer diseaseD03753,Perindopril,drug/chemical compound,increases_activity of,GO:0007611,learning or memory,process,Alzheimer diseaseD07892,Enalapril,drug/chemical compound,increases_activity of,GO:0007611,learning or memory,process,Alzheimer diseaseD08068,Imidapril,drug/chemical compound,increases_activity of,GO:0007611,learning or memory,process,Alzheimer disease,ACE inhibitor,drug/chemical compound,decreases_activity of,MP:0000231,hypertension,phenotype,Alzheimer diseaseD02598,Infliximab,drug/chemical compound,decreases_quantity of,7124,TNF,gene/protein,Alzheimer diseaseD02598,Infliximab,drug/chemical compound,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseD02598,Infliximab,drug/chemical compound,decreases_quantity of,4137,MAPT-phos,protein modification,Alzheimer diseaseD02598,Infliximab,drug/chemical compound,increases_expression of,3687,ITGAX,gene/protein,Alzheimer diseaseD02598,Infliximab,drug/chemical compound,affects_activity of,,APP/PS1 mouse,organism model,Alzheimer diseaseD02598,Infliximab,drug/chemical compound,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease,high-fat diet,environment,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,high-fat diet,environment,increases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease,3xTg-AD mouse,organism model,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,high-fat diet,environment,increases_quantity of,MP:0004250,tau protein deposits,phenotype,Alzheimer disease,high-fat diet,environment,decreases_quantity of,1627,DBN1,gene/protein,Alzheimer disease,high-fat diet,environment,affects_quantity of,6855,SYP,gene/protein,Alzheimer disease,high-fat diet,environment,affects_quantity of,6616,SNAP25,gene/protein,Alzheimer disease,high-fat diet,environment,affects_quantity of,6809,STX3,gene/protein,Alzheimer disease,high-fat diet,environment,increases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease,high-fat diet,environment,increases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,high-fat diet,environment,increases_quantity of,4137,MAPT,gene/protein,Alzheimer disease,3xTg-AD mouse,organism model,affects_quantity of,1072,CFL1,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_activity of,GO:0006955,immune response,process,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_activity of,GO:0010467,gene expression,process,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_activity of,GO:0006956,complement activation,process,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,,MHC protein complex,complex/PPI,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_activity of,GO:0006914,autophagy,process,Alzheimer diseaseGO:0006954,inflammatory response,process,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease,AD11 anti-NGF mouse,organism model,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_activity of,4803,NGF,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,627,BDNF,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,4804,NGFR,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,4914,NTRK1,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,1137,CHRNA4,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,1128,CHRM1,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,1131,CHRM3,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,1139,CHRNA7,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,decreases_expression of,2555,GABRA2,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,7781,SLC30A3,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,decreases_expression of,23237,ARC,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,increases_expression of,718,C3,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,increases_expression of,712,C1QA,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,increases_expression of,713,C1QB,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,decreases_expression of,717,C2,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,decreases_expression of,6352,CCL5,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,3553,IL1B,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,7124,TNF,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,961,CD47,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,146722,CD300LF,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,971,CD72,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,5743,PTGS2,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,decreases_expression of,7473,WNT3,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,7472,WNT2,gene/protein,Alzheimer disease,AD11 anti-NGF mouse,organism model,affects_expression of,27120,DKKL1,gene/protein,Alzheimer diseasers1799983,NOS3 rs1799983,SNP,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC00533,NO,drug/chemical compound,affects_expression of,351,APP,gene/protein,Alzheimer diseaseC00533,NO,drug/chemical compound,affects_processing of,351,APP,gene/protein,Alzheimer disease180795,L-NAME,drug/chemical compound,decreases_activity of,4846,NOS3,gene/protein,Alzheimer disease4846,NOS3,gene/protein,affects_quantity of,C00533,NO,drug/chemical compound,Alzheimer disease4846,NOS3,gene/protein,affects_quantity of,23621,BACE1,gene/protein,Alzheimer disease4846,NOS3,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_quantity of,351,Amyloid beta peptide (17 and longer),gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_quantity of,351,Amyloid beta peptide (14),gene/protein,Alzheimer disease,Alpha-secretase,gene/protein,increases_quantity of,351,Amyloid beta peptide (15),gene/protein,Alzheimer disease,Alpha-secretase,gene/protein,increases_quantity of,351,Amyloid beta peptide (14),gene/protein,Alzheimer disease23621,BACE1,gene/protein,increases_quantity of,351,Amyloid beta peptide (15),gene/protein,Alzheimer disease23621,BACE1,gene/protein,increases_quantity of,351,Amyloid beta peptide (14),gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,decreases_quantity of,351,Amyloid beta peptide (38),gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,decreases_quantity of,351,Amyloid beta peptide (17),gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,increases_quantity of,351,sAPP-alpha,gene/protein,Alzheimer disease23621,BACE1,gene/protein,increases_quantity of,351,sAPP-alpha,gene/protein,Alzheimer disease23621,BACE1,gene/protein,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease23621,BACE1,gene/protein,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease23621,BACE1,gene/protein,decreases_quantity of,351,Amyloid beta peptide (38),gene/protein,Alzheimer disease23621,BACE1,gene/protein,decreases_quantity of,351,Amyloid beta peptide (14),gene/protein,Alzheimer disease,Alpha-secretase,gene/protein,increases_quantity of,351,sAPP-alpha,gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_quantity of,351,Amyloid beta peptide (15),gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_quantity of,351,Amyloid beta peptide (16),gene/protein,Alzheimer disease23621,BACE1,gene/protein,decreases_quantity of,351,Amyloid beta peptide (15),gene/protein,Alzheimer disease23621,BACE1,gene/protein,decreases_quantity of,351,Amyloid beta peptide (16),gene/protein,Alzheimer disease5054,SERPINE1,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseGO:0007568,aging,process,increases_expression of,5054,SERPINE1,gene/protein,Alzheimer disease5054,SERPINE1,gene/protein,affects_quantity of,351,APP,gene/protein,Alzheimer disease5054,SERPINE1,gene/protein,affects_activity of,5327,PLAT,gene/protein,Alzheimer disease5054,SERPINE1,gene/protein,affects_activity of,,Plasmin,complex/PPI,Alzheimer disease,Plasmin,complex/PPI,is_part_of,5340,PLG,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,decreases_activity of,,Plasmin,complex/PPI,Alzheimer disease351,Amyloid beta peptide (40),gene/protein,decreases_activity of,,Plasmin,complex/PPI,Alzheimer disease351,Amyloid beta peptide (endogenous),gene/protein,increases_phosphorylation of,4137,MAPT,gene/protein,Alzheimer disease351,Amyloid beta peptide (endogenous),gene/protein,increases_activity of,GO:0070997,neuron death,process,Alzheimer disease4137,MAPT-hyperphos,protein modification,affects_activity of,GO:0005874,microtubule,cellular component,Alzheimer disease4137,MAPT-hyperphos,protein modification,affects_activity of,GO:0005739,mitochondrion,cellular component,Alzheimer disease351,Amyloid beta peptide (endogenous),gene/protein,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer diseaseD05246,Olmesartan,drug/chemical compound,decreases_activity of,,cognitive impairment,phenotype,Alzheimer diseaseD05246,Olmesartan,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseD05246,Olmesartan,drug/chemical compound,decreases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseC07040,Hydralazine,drug/chemical compound,decreases_activity of,,cognitive impairment,phenotype,Alzheimer diseaseD00437,Nifedipine,drug/chemical compound,decreases_activity of,,cognitive impairment,phenotype,Alzheimer diseaseD05246,Olmesartan,drug/chemical compound,decreases_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer diseaseD05246,Olmesartan,drug/chemical compound,affects_activity of,GO:0048167,regulation of synaptic plasticity,process,Alzheimer diseaseD05246,Olmesartan,drug/chemical compound,affects_activity of,,hyperemia,phenotype,Alzheimer diseaseMP:0005668,decreased circulating leptin level,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,,CD34+ progenitor cell,tissue/cell line,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,9370,ADIPOQ,gene/protein,Alzheimer diseaseMP:0005668,decreased circulating leptin level,phenotype,cooccurs with,,CD34+ progenitor cell (increased),phenotype,Alzheimer diseaseMP:0005669,increased circulating leptin level,phenotype,cooccurs with,,CD34+ progenitor cell (reduced),phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,183,AGT,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,1636,ACE,gene/protein,Alzheimer diseaseC15610,27-Hydroxycholesterol,drug/chemical compound,affects_activity of,1636,ACE,gene/protein,Alzheimer diseaseC15610,27-Hydroxycholesterol,drug/chemical compound,increases_expression of,183,AGT,gene/protein,Alzheimer disease1636,ACE,gene/protein,increases_activity of,GO:0002035,brain renin-angiotensin system,process,Alzheimer disease183,AGT,gene/protein,increases_activity of,GO:0002035,brain renin-angiotensin system,process,Alzheimer disease4248,MGAT3,gene/protein,affects_activity of,GO:0006909,phagocytosis,process,Alzheimer disease351,Amyloid beta peptide,gene/protein,affects_expression of,4248,MGAT3,gene/protein,Alzheimer disease4248,MGAT3,gene/protein,affects_activity of,BTO:0000801,macrophage,tissue/cell line,Alzheimer diseaseC17743,Bisdemethoxycurcumin,drug/chemical compound,affects_expression of,4248,MGAT3,gene/protein,Alzheimer disease274,BIN1-mut,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseasers744373,BIN1 rs744373,SNP,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease274,BIN1,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease1191,CLU,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease1378,CR1,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease90332,EXOC3L2,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease8301,PICALM,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease9846,GAB2,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease8711,TNK1,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease84547,PGBD1,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease253738,EBF3,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease79068,FTO,gene/protein,interacts (colocalizes) with,348,APOE,gene/protein,Alzheimer disease79068,FTO,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease79068,FTO,gene/protein,affects_activity of,MP:0006087,increased body mass index,phenotype,Alzheimer disease79068,FTO,gene/protein,affects_activity of,125853,"Diabetes mellitus, type II",disease,Alzheimer disease,Cotinine,drug/chemical compound,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,Cotinine,drug/chemical compound,increases_activity of,GO:0007613,memory,process,Alzheimer disease,Cotinine,drug/chemical compound,affects_activity of,GO:0018933,nicotine metabolic process,process,Alzheimer disease,Cotinine,drug/chemical compound,decreases_activity of,GO:0051259,protein oligomerization,process,Alzheimer disease,Cotinine,drug/chemical compound,decreases_activity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,Cotinine,drug/chemical compound,increases_activity of,GO:0043491,protein kinase B signaling,process,Alzheimer disease,Cotinine,drug/chemical compound,decreases_activity of,2932,GSK3B,gene/protein,Alzheimer disease207,AKT1,gene/protein,affects_activity of,GO:0043491,protein kinase B signaling,process,Alzheimer disease,Cotinine,drug/chemical compound,increases_phosphorylation of,2932,GSK3B,gene/protein,Alzheimer disease,Cotinine,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide (soluble),gene/protein,Alzheimer disease,Cotinine,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (oligomer),gene/protein,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,125853,"Diabetes mellitus, type II",disease,Alzheimer diseaseC00187,Cholesterol,drug/chemical compound,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD00434,Simvastatin,drug/chemical compound,decreases_activity of,,cognitive impairment,phenotype,Alzheimer diseaseD00434,Simvastatin,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseD00434,Simvastatin,drug/chemical compound,affects_quantity of,4137,MAPT,gene/protein,Alzheimer disease125853,"Diabetes mellitus, type II",disease,cooccurs with,MP:0001547,abnormal lipid level,phenotype,Alzheimer diseaseMP:0001547,abnormal lipid level,phenotype,cooccurs with,MP:0005317,increased triglyceride level,phenotype,Alzheimer disease125853,"Diabetes mellitus, type II",disease,cooccurs with,MP:0000186,decreased circulating HDL cholesterol level,phenotype,Alzheimer disease125853,"Diabetes mellitus, type II",disease,affects_activity of,,abnormal Abeta metabolism,phenotype,Alzheimer diseaseC06834,Atorvastatin,drug/chemical compound,increases_activity of,GO:0007613,memory,process,Alzheimer diseaseC06834,Atorvastatin,drug/chemical compound,decreases_quantity of,,LDL,complex/PPI,Alzheimer diseaseC06834,Atorvastatin,drug/chemical compound,decreases_quantity of,,HDL,complex/PPI,Alzheimer diseaseC06834,Atorvastatin,drug/chemical compound,decreases_quantity of,C00422,Triacylglycerol,drug/chemical compound,Alzheimer diseaseC06834,Atorvastatin,drug/chemical compound,decreases_quantity of,C00187,Cholesterol,drug/chemical compound,Alzheimer diseaseC00187,Cholesterol,drug/chemical compound,affects_activity of,23621,BACE1,gene/protein,Alzheimer diseaseC06834,Atorvastatin,drug/chemical compound,affects_quantity of,36009,Omega-6 fatty acid,drug/chemical compound,Alzheimer diseaseC06834,Atorvastatin,drug/chemical compound,affects_quantity of,25681,Omega-3 fatty acid,drug/chemical compound,Alzheimer diseaseC06834,Atorvastatin,drug/chemical compound,affects_quantity of,351,APP,gene/protein,Alzheimer disease,NSAID,drug/chemical compound,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease,NSAID,drug/chemical compound,decreases_activity of,GO:0006954,inflammatory response,process,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,interacts (colocalizes) with,BTO:0000078,microglia,tissue/cell line,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,interacts (colocalizes) with,BTO:0000099,astrocyte,tissue/cell line,Alzheimer diseaseGO:0001774,microglial cell activation,process,increases_activity of,GO:0050663,cytokine secretion,process,Alzheimer diseaseGO:0001774,microglial cell activation,process,increases_activity of,GO:0090195,chemokine secretion,process,Alzheimer diseaseGO:0001774,microglial cell activation,process,increases_quantity of,3553,IL1B,gene/protein,Alzheimer diseaseGO:0001774,microglial cell activation,process,increases_quantity of,3569,IL6,gene/protein,Alzheimer diseaseGO:0001774,microglial cell activation,process,increases_quantity of,6347,CCL2,gene/protein,Alzheimer diseaseGO:0001774,microglial cell activation,process,increases_quantity of,7124,TNF,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,5468,PPARG,gene/protein,Alzheimer disease,NSAID,drug/chemical compound,increases_activity of,5468,PPARG,gene/protein,Alzheimer disease5468,PPARG,gene/protein,decreases_expression of,4843,NOS2,gene/protein,Alzheimer disease5468,PPARG,gene/protein,is localized in,BTO:0000078,microglia,tissue/cell line,Alzheimer disease5468,PPARG,gene/protein,decreases_quantity of,C00533,NO,drug/chemical compound,Alzheimer disease5468,PPARG,gene/protein,decreases_activity of,5743,PTGS2,gene/protein,Alzheimer disease5468,PPARG,gene/protein,affects_quantity of,26347,Prostanoid,drug/chemical compound,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseC07675,Pioglitazone,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseC07675,Pioglitazone,drug/chemical compound,decreases_activity of,GO:0001774,microglial cell activation,process,Alzheimer diseaseC07675,Pioglitazone,drug/chemical compound,decreases_activity of,GO:0048143,astrocyte activation,process,Alzheimer diseaseC07675,Pioglitazone,drug/chemical compound,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseC07675,Pioglitazone,drug/chemical compound,decreases_activity of,,cerebral dysfunction,phenotype,Alzheimer diseaseC07675,Pioglitazone,drug/chemical compound,affects_activity of,GO:0001774,microglial cell activation,process,Alzheimer diseaseC07675,Pioglitazone,drug/chemical compound,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseC07675,Pioglitazone,drug/chemical compound,affects_activity of,GO:0060384,innervation,process,Alzheimer diseaseC07675,Pioglitazone,drug/chemical compound,decreases_expression of,23621,BACE1,gene/protein,Alzheimer disease5468,PPARG,gene/protein,affects_activity of,GO:0034205,beta-amyloid formation,process,Alzheimer diseaseD08491,Rosiglitazone,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD08491,Rosiglitazone,drug/chemical compound,affects_activity of,GO:0007610,behavior,process,Alzheimer diseaseD08491,Rosiglitazone,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseD08491,Rosiglitazone,drug/chemical compound,increases_activity of,GO:0007613,memory,process,Alzheimer diseaseD08491,Rosiglitazone,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease3416,IDE,gene/protein,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease3416,IDE,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD08491,Rosiglitazone,drug/chemical compound,decreases_activity of,,cognitive impairment,phenotype,Alzheimer diseaseMP:0002079,increased circulating insulin level,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,MP:0002063,abnormal learning/memory/conditioning,phenotype,Alzheimer disease,NSAID,drug/chemical compound,affects_activity of,5742,PTGS1,gene/protein,Alzheimer disease,NSAID,drug/chemical compound,affects_activity of,5743,PTGS2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,C00806,Tryptophan,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,22395914,Kynurenic acid,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0019441,tryptophan catabolic process to kynurenine,process,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C03722,Quinolinic acid,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,1509,CTSD,gene/protein,Alzheimer disease,RAS oncogene,gene/protein,affects_activity of,1509,CTSD,gene/protein,Alzheimer disease,RAS oncogene,gene/protein,decreases_expression of,1509,CTSD,gene/protein,Alzheimer disease,ST101,drug/chemical compound,affects_activity of,GO:0042987,amyloid precursor protein catabolic process,process,Alzheimer disease,ST101,drug/chemical compound,affects_quantity of,351,"APP (17K, C-terminal fragment)",protein modification,Alzheimer disease,ST101,drug/chemical compound,increases_activity of,GO:0007613,memory,process,Alzheimer disease,ST101,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,ST101,drug/chemical compound,decreases_quantity of,351,"Amyloid beta peptide (42, soluble)",gene/protein,Alzheimer disease,ST101,drug/chemical compound,decreases_quantity of,351,"Amyloid beta peptide (40, soluble)",gene/protein,Alzheimer disease,ST101,drug/chemical compound,decreases_quantity of,351,"Amyloid beta peptide (40, insoluble)",gene/protein,Alzheimer disease,ST101,drug/chemical compound,decreases_quantity of,351,"Amyloid beta peptide (42, insoluble)",gene/protein,Alzheimer disease,ST101,drug/chemical compound,affects_quantity of,23621,BACE1,gene/protein,Alzheimer disease,ST101,drug/chemical compound,affects_quantity of,102,ADAM10,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,,Cytokine,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_activity of,GO:0006954,inflammatory response,process,Alzheimer diseaseC00338,Lipopolysaccharide,drug/chemical compound,increases_activity of,GO:0006954,inflammatory response,process,Alzheimer disease,Tg2576 mouse,organism model,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,increases_activity of,GO:0006954,inflammatory response,process,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,3553,IL1B,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,3552,IL1A,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,7124,TNF,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,6347,CCL2,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,2670,GFAP,gene/protein,Alzheimer diseaseGO:0007568,aging,process,affects_activity of,GO:0010467,gene expression,process,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,712,C1QA,gene/protein,Alzheimer disease,Tg2576 mouse,organism model,increases_expression of,718,C3,gene/protein,Alzheimer diseaseC00338,Lipopolysaccharide,drug/chemical compound,increases_expression of,3553,IL1B,gene/protein,Alzheimer diseaseC00338,Lipopolysaccharide,drug/chemical compound,increases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease1191,CLU,gene/protein,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease1378,CR1,gene/protein,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease8301,PICALM,gene/protein,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseD08491,Rosiglitazone,drug/chemical compound,increases_activity of,GO:0007611,learning or memory,process,Alzheimer diseaseD08491,Rosiglitazone,drug/chemical compound,decreases_quantity of,C02140,Corticosterone,drug/chemical compound,Alzheimer diseaseD00410,Metyrapone,drug/chemical compound,increases_activity of,GO:0007611,learning or memory,process,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,GO:0019372,lipoxygenase pathway,process,Alzheimer disease240,ALOX5,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease240,ALOX5,gene/protein,increases_activity of,1385,CREB1,gene/protein,Alzheimer disease1385,CREB1,gene/protein,increases_expression of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease50104244,AA-861 (ALOX5 inhibitor),drug/chemical compound,decreases_activity of,240,ALOX5,gene/protein,Alzheimer disease50104244,AA-861 (ALOX5 inhibitor),drug/chemical compound,decreases_quantity of,C02165,Leukotriene B4,drug/chemical compound,Alzheimer disease50104244,AA-861 (ALOX5 inhibitor),drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease114815,SORCS1,gene/protein,affects_activity of,GO:0042987,amyloid precursor protein catabolic process,process,Alzheimer disease114815,SORCS1-mut,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease114815,SORCS1,gene/protein,affects_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease114815,SORCS1,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease4318,MMP9,gene/protein,affects_activity of,GO:0042987,amyloid precursor protein catabolic process,process,Alzheimer disease4803,NGF,gene/protein,interacts (colocalizes) with,4914,NTRK1,gene/protein,Alzheimer disease4803,NGF,gene/protein,decreases_expression of,23621,BACE1,gene/protein,Alzheimer disease4803,NGF,gene/protein,increases_expression of,,A disintegrin,gene/protein,Alzheimer disease4803,NGF,gene/protein,increases_expression of,6868,ADAM17,gene/protein,Alzheimer disease4803,NGF,gene/protein,increases_expression of,4318,MMP9,gene/protein,Alzheimer disease4318,MMP9,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer diseaseGO:0042987,amyloid precursor protein catabolic process,process,affects_processing of,351,APP,gene/protein,Alzheimer disease,Alpha-secretase,gene/protein,affects_activity of,GO:0042987,amyloid precursor protein catabolic process,process,Alzheimer disease,Masitinib,drug/chemical compound,decreases_activity of,BTO:0000830,mast cell,tissue/cell line,Alzheimer disease,Masitinib,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease4254,KITLG,gene/protein,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease1440,CSF3,gene/protein,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease4254,KITLG,gene/protein,increases_quantity of,BTO:0004052,bone marrow stem cell,tissue/cell line,Alzheimer disease1440,CSF3,gene/protein,increases_quantity of,BTO:0004052,bone marrow stem cell,tissue/cell line,Alzheimer disease4254,KITLG,gene/protein,increases_quantity of,BTO:0000078,microglia,tissue/cell line,Alzheimer disease1440,CSF3,gene/protein,increases_quantity of,BTO:0000078,microglia,tissue/cell line,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,interacts (colocalizes) with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseD07474,Atorvastatin,drug/chemical compound,decreases_activity of,GO:0034440,lipid oxidation,process,Alzheimer diseaseD07474,Atorvastatin,drug/chemical compound,decreases_activity of,GO:0018158,protein oxidation,process,Alzheimer diseaseD07474,Atorvastatin,drug/chemical compound,decreases_activity of,,protein nitration,process,Alzheimer diseaseD07474,Atorvastatin,drug/chemical compound,increases_quantity of,C00051,Glutathione,drug/chemical compound,Alzheimer diseaseD07474,Atorvastatin,drug/chemical compound,affects_activity of,GO:0006707,cholesterol catabolic process,process,Alzheimer diseaseGO:0006979,response to oxidative stress,process,affects_activity of,GO:0008542,visual learning,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease1020,CDK5,gene/protein,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease,COX10 KO mouse,organism model,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease3952,LEP,gene/protein,decreases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease3952,LEP,gene/protein,increases_activity of,GO:0008283,cell proliferation,process,Alzheimer disease3952,LEP,gene/protein,increases_activity of,GO:0022008,neurogenesis,process,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased neurodegeneration,phenotype,Alzheimer diseaseBTO:0000099,astrocyte,tissue/cell line,increases_activity of,GO:0070997,neuron death,process,Alzheimer diseaseBTO:0000099,astrocyte,tissue/cell line,increases_activity of,836,CASP3,gene/protein,Alzheimer diseaseBTO:0000099,astrocyte,tissue/cell line,increases_processing of,4137,MAPT,gene/protein,Alzheimer diseaseBTO:0000099,astrocyte,tissue/cell line,increases_phosphorylation of,4137,MAPT,gene/protein,Alzheimer diseaseBTO:0000099,astrocyte,tissue/cell line,increases_activity of,GO:0006954,inflammatory response,process,Alzheimer diseaseD05045,Minocycline,drug/chemical compound,decreases_activity of,BTO:0000099,astrocyte,tissue/cell line,Alzheimer diseaseD05045,Minocycline,drug/chemical compound,decreases_activity of,GO:0006954,inflammatory response,process,Alzheimer diseaseD05045,Minocycline,drug/chemical compound,decreases_activity of,836,CASP3,gene/protein,Alzheimer diseaseD05045,Minocycline,drug/chemical compound,decreases_processing of,4137,MAPT,gene/protein,Alzheimer diseaseGO:0004672,protein kinase activity,process,affects_phosphorylation of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseGO:0034205,beta-amyloid formation,process,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseGO:0034205,beta-amyloid formation,process,affects_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer diseaseGO:0034205,beta-amyloid formation,process,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,351,Amyloid beta peptide (phosphorylated),protein modification,Alzheimer diseaseGO:0004672,protein kinase activity,process,affects_quantity of,351,Amyloid beta peptide (phosphorylated),protein modification,Alzheimer disease351,Amyloid beta peptide (phosphorylated),protein modification,increases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease351,Amyloid beta peptide (phosphorylated),protein modification,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease10062,NR1H3,gene/protein,affects_activity of,GO:0008203,cholesterol metabolic process,process,Alzheimer disease10062,NR1H3,gene/protein,affects_activity of,GO:0002263,cell activation involved in immune response,process,Alzheimer diseaseGO:0008203,cholesterol metabolic process,process,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseGO:0002263,cell activation involved in immune response,process,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease,TO901317,drug/chemical compound,affects_activity of,,NR1H,gene/protein,Alzheimer disease,TO901317,drug/chemical compound,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease,TO901317,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (soluble),gene/protein,Alzheimer disease,TO901317,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (insoluble),gene/protein,Alzheimer disease,TO901317,drug/chemical compound,affects_activity of,GO:0042987,amyloid precursor protein catabolic process,process,Alzheimer disease,TO901317,drug/chemical compound,affects_activity of,GO:0008542,visual learning,process,Alzheimer disease,TO901317,drug/chemical compound,increases_expression of,19,ABCA1,gene/protein,Alzheimer disease348,APOE,gene/protein,is localized in,BTO:0000099,astrocyte,tissue/cell line,Alzheimer disease,TO901317,drug/chemical compound,increases_expression of,348,APOE,gene/protein,Alzheimer disease19,ABCA1,gene/protein,is localized in,BTO:0000099,astrocyte,tissue/cell line,Alzheimer disease,TO901317,drug/chemical compound,affects_activity of,GO:0006909,phagocytosis,process,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,affects_activity of,BTO:0000078,microglia,tissue/cell line,Alzheimer diseaseD07869,Donepezil,drug/chemical compound,decreases_activity of,,Cholinesterase,gene/protein,Alzheimer diseaseD04292,Galantamine,drug/chemical compound,decreases_activity of,,Cholinesterase,gene/protein,Alzheimer diseaseD03822,Rivastigmine,drug/chemical compound,decreases_activity of,,Cholinesterase,gene/protein,Alzheimer disease,Schisandrin B,drug/chemical compound,decreases_activity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,GO:0051402,neuron apoptotic process,process,Alzheimer disease,Schisandrin B,drug/chemical compound,decreases_activity of,GO:0070997,neuron death,process,Alzheimer disease,Schisandrin B,drug/chemical compound,decreases_activity of,GO:0051402,neuron apoptotic process,process,Alzheimer disease,Schisandrin B,drug/chemical compound,increases_expression of,596,BCL2,gene/protein,Alzheimer disease,Schisandrin B,drug/chemical compound,decreases_expression of,581,BAX,gene/protein,Alzheimer disease581,BAX,gene/protein,increases_activity of,GO:0051402,neuron apoptotic process,process,Alzheimer disease596,BCL2,gene/protein,decreases_activity of,GO:0051402,neuron apoptotic process,process,Alzheimer disease,Schisandrin B,drug/chemical compound,decreases_activity of,GO:0001836,release of cytochrome c from mitochondria,process,Alzheimer disease,Schisandrin B,drug/chemical compound,decreases_activity of,842,CASP9,gene/protein,Alzheimer disease,Schisandrin B,drug/chemical compound,decreases_activity of,836,CASP3,gene/protein,Alzheimer disease,Schisandrin B,drug/chemical compound,increases_activity of,C00051,Glutathione,drug/chemical compound,Alzheimer disease,Schisandrin B,drug/chemical compound,decreases_quantity of,C00127,Glutathione disulfide,drug/chemical compound,Alzheimer disease,anosognosia,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease,anosognosia,phenotype,cooccurs with,,apathy,phenotype,Alzheimer disease,apathy,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,6507,SLC1A3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,6506,SLC1A2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,6506,SLC1A2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,6507,SLC1A3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2900,GRIK4,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,81488,POLR2M,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,2893,GRIA4,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2892,GRIA3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,2897,GRIK1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,2901,GRIK5,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2673,GFPT1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2746,GLUD1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,51704,GPRC5B,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,55890,GPRC5C,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,55507,GPRC5D,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,23426,GRIP1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2911,GRM1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,5188,GATB,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,5471,PPAT,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,5625,PRODH,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,5859,QARS,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,9052,GPRC5A,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,2571,GAD1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,2572,GAD2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,2752,GLUL,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,2902,GRIN1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,2905,GRIN2C,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,2356,FPGS,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,2744,GLS,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,2895,GRID2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,80852,GRIP2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,2918,GRM8,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,10404,CPQ,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,5832,ALDH18A1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,81488,POLR2M,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2893,GRIA4,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,23657,SLC7A11,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2730,GCLM,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,6512,SLC1A7,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,2058,EPRS,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,10841,FTCD,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2905,GRIN2C,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,6512,SLC1A7,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2058,EPRS,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0034651,cortisol biosynthetic process,process,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C00735,Cortisol,drug/chemical compound,Alzheimer disease3827,KNG1,gene/protein,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease3827,Bradykinin,gene/protein,is_part_of,3827,KNG1,gene/protein,Alzheimer disease6750,SST,gene/protein,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease1906,EDN1,gene/protein,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,Neuropeptide,gene/protein,increases_activity of,BTO:0000078,microglia,tissue/cell line,Alzheimer disease,Neuropeptide,gene/protein,increases_activity of,GO:0001774,microglial cell activation,process,Alzheimer disease3827,Bradykinin,gene/protein,decreases_expression of,4843,NOS2,gene/protein,Alzheimer disease3827,Bradykinin,gene/protein,decreases_expression of,5743,PTGS2,gene/protein,Alzheimer disease1906,EDN1,gene/protein,decreases_expression of,6347,CCL2,gene/protein,Alzheimer disease1906,EDN1,gene/protein,decreases_expression of,3569,IL6,gene/protein,Alzheimer disease3827,Bradykinin,gene/protein,is_part_of,,Neuropeptide,gene/protein,Alzheimer disease1906,EDN1,gene/protein,is_part_of,,Neuropeptide,gene/protein,Alzheimer disease6750,SST,gene/protein,is_part_of,,Neuropeptide,gene/protein,Alzheimer disease6750,SST,gene/protein,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer disease1906,EDN1,gene/protein,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer disease3827,Bradykinin,gene/protein,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer diseaseGO:0001774,microglial cell activation,process,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer diseaseD07460,Apomorphine,drug/chemical compound,increases_activity of,GO:0007614,short-term memory,process,Alzheimer diseaseD07460,Apomorphine,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseD07460,Apomorphine,drug/chemical compound,decreases_quantity of,4137,MAPT-hyperphos,protein modification,Alzheimer diseaseD07460,Apomorphine,drug/chemical compound,decreases_quantity of,7157,TP53,gene/protein,Alzheimer diseaseD07460,Apomorphine,drug/chemical compound,decreases_quantity of,3162,HMOX1,gene/protein,Alzheimer diseaseD07460,Apomorphine,drug/chemical compound,increases_activity of,,proteasome,complex/PPI,Alzheimer diseaseD07460,Apomorphine,drug/chemical compound,increases_activity of,3416,IDE,gene/protein,Alzheimer diseaseD07460,Apomorphine,drug/chemical compound,decreases_activity of,C00027,H2O2,drug/chemical compound,Alzheimer disease,3xTg-AD mouse,organism model,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,3xTg-AD mouse,organism model,decreases_activity of,GO:0007613,memory,process,Alzheimer diseaseD07460,Apomorphine,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseGO:0006629,lipid metabolic process,process,affects_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,MP:0001547,abnormal lipid level,phenotype,Alzheimer disease348,APOE,gene/protein,affects_activity of,GO:0008203,cholesterol metabolic process,process,Alzheimer disease348,APOE (isoform E4),gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,HSP70,gene/protein,decreases_quantity of,4137,MAPT-hyperphos,protein modification,Alzheimer disease10273,STUB1,gene/protein,decreases_quantity of,4137,MAPT-hyperphos,protein modification,Alzheimer disease2932,GSK3B,gene/protein,increases_quantity of,4137,MAPT-hyperphos,protein modification,Alzheimer disease2931,GSK3A,gene/protein,increases_quantity of,4137,MAPT-hyperphos,protein modification,Alzheimer disease348,APOE,gene/protein,affects_activity of,GO:0006641,triglyceride metabolic process,process,Alzheimer disease348,APOE,gene/protein,affects_activity of,GO:0042953,lipoprotein transport,process,Alzheimer disease348,APOE,gene/protein,interacts (colocalizes) with,351,Amyloid beta peptide,gene/protein,Alzheimer disease,"CP-113,818",drug/chemical compound,decreases_activity of,38,ACAT1,gene/protein,Alzheimer disease38,ACAT1,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease38,ACAT1,gene/protein,affects_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease38,ACAT1,gene/protein,affects_activity of,,cognitive impairment,phenotype,Alzheimer disease38,ACAT1,gene/protein,increases_quantity of,C13550,24-Hydroxycholesterol,drug/chemical compound,Alzheimer diseaseGO:0033344,cholesterol efflux,process,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease19,ABCA1,gene/protein,affects_quantity of,348,APOE,gene/protein,Alzheimer disease19,ABCA1,gene/protein,affects_processing of,348,APOE,gene/protein,Alzheimer disease19,ABCA1,gene/protein,affects transport of,348,APOE,gene/protein,Alzheimer disease19,ABCA1,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease53786818,Beta-methyl cyclodextrin,drug/chemical compound,decreases_quantity of,C00187,Cholesterol,drug/chemical compound,Alzheimer diseaseC00187,Cholesterol,drug/chemical compound,decreases_activity of,23621,BACE1,gene/protein,Alzheimer diseaseC00187,Cholesterol,drug/chemical compound,decreases_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer diseaseC00187,Cholesterol,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,Sphingolipids,drug/chemical compound,increases_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer diseaseGO:0045121,membrane raft,cellular component,affects_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease23621,BACE1,gene/protein,interacts (colocalizes) with,GO:0045121,membrane raft,cellular component,Alzheimer diseaseC00187,Cholesterol,drug/chemical compound,affects_activity of,GO:0042987,amyloid precursor protein catabolic process,process,Alzheimer diseaseC00187,Cholesterol,drug/chemical compound,affects_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer diseaseMP:0000604,amyloidosis,phenotype,affects_activity of,GO:0042987,amyloid precursor protein catabolic process,process,Alzheimer diseaseC00187,Cholesterol,drug/chemical compound,affects_activity of,GO:0006897,endocytosis,process,Alzheimer disease23621,BACE1,gene/protein,interacts (colocalizes) with,351,APP,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,interacts (colocalizes) with,GO:0045121,membrane raft,cellular component,Alzheimer disease5664,PSEN2,gene/protein,interacts (colocalizes) with,GO:0045121,membrane raft,cellular component,Alzheimer disease466,Gamma-secretase complex,complex/PPI,interacts (colocalizes) with,GO:0045121,membrane raft,cellular component,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_quantity of,351,APP (C-terminal fragment),gene/protein,Alzheimer diseaseC00195,N-Acylsphingosine,drug/chemical compound,is_part_of,,Sphingolipid,drug/chemical compound,Alzheimer diseaseC00550,Sphingomyelin,drug/chemical compound,is_part_of,,Sphingolipid,drug/chemical compound,Alzheimer diseaseC00195,N-Acylsphingosine,drug/chemical compound,is localized in,GO:0045121,membrane raft,cellular component,Alzheimer diseaseC00550,Sphingomyelin,drug/chemical compound,is localized in,GO:0045121,membrane raft,cellular component,Alzheimer disease,Glycosphingolipid,drug/chemical compound,is localized in,GO:0045121,membrane raft,cellular component,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C00195,N-Acylsphingosine,drug/chemical compound,Alzheimer diseaseC00195,N-Acylsphingosine,drug/chemical compound,affects_processing of,351,APP,gene/protein,Alzheimer disease,Sphingomyelinase,gene/protein,affects_processing of,C00550,Sphingomyelin,drug/chemical compound,Alzheimer disease,Sphingomyelinase,gene/protein,affects_quantity of,C00195,N-Acylsphingosine,drug/chemical compound,Alzheimer disease,Serine C-palmitoyltransferase complex,complex/PPI,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,Serine C-palmitoyltransferase complex,complex/PPI,affects_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease,Sphingolipid,drug/chemical compound,affects_activity of,23621,BACE1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,,GGPP,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,,FPP,drug/chemical compound,Alzheimer diseaseC15181,Wortmannin,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,"Phosphatidylinositol-4,5-bisphosphate",drug/chemical compound,affects_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease,"Phosphatidylinositol-4,5-bisphosphate",drug/chemical compound,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease5337,PLD1,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer disease5337,PLD1,gene/protein,interacts (colocalizes) with,5663,PSEN1,gene/protein,Alzheimer disease,Sphingolipid,drug/chemical compound,affects_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer diseaseC04911,D-Galactosyl-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-,drug/chemical compound,interacts (colocalizes) with,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC04911,D-Galactosyl-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-,drug/chemical compound,affects_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer diseaseGO:0007568,aging,process,affects_activity of,C04911,D-Galactosyl-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-,drug/chemical compound,Alzheimer disease2583,B4GALNT1,gene/protein,affects_quantity of,C04730,GM3,drug/chemical compound,Alzheimer disease2583,B4GALNT1,gene/protein,affects_quantity of,C04911,D-Galactosyl-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-,drug/chemical compound,Alzheimer disease6489,ST8SIA1,gene/protein,affects_activity of,,cognitive impairment,phenotype,Alzheimer disease6489,ST8SIA1,gene/protein,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseGO:0046872,metal ion binding,process,increases_activity of,GO:0043157,response to cation stress,process,Alzheimer disease351,Amyloid beta peptide,gene/protein,affects_activity of,GO:0046872,metal ion binding,process,Alzheimer diseaseGO:0046872,metal ion binding,process,cooccurs with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,GO:0046872,metal ion binding,process,Alzheimer disease351,Amyloid beta peptide,gene/protein,affects_quantity of,C00027,H2O2,drug/chemical compound,Alzheimer disease351,Amyloid beta peptide (oligomer),gene/protein,increases_activity of,5338,PLD2,gene/protein,Alzheimer disease5338,PLD2,gene/protein,affects_activity of,GO:0007613,memory,process,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,5338,PLD2,gene/protein,Alzheimer disease5338,PLD2,gene/protein,affects_quantity of,351,APP,gene/protein,Alzheimer disease5338,PLD2,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease2619,GAS1,gene/protein,interacts (colocalizes) with,351,APP,gene/protein,Alzheimer disease2619,GAS1,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer disease255022,CALHM1,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease255022,CALHM1,gene/protein,affects_activity of,GO:0050435,beta-amyloid metabolic process,process,Alzheimer disease2619,GAS1,gene/protein,affects_glucosylation of,351,APP,gene/protein,Alzheimer disease2619,GAS1,gene/protein,affects_activity of,GO:0006810,transport,process,Alzheimer disease2619,GAS1,gene/protein,affects_expression of,351,Amyloid beta peptide,gene/protein,Alzheimer disease102,ADAM10,gene/protein,affects_activity of,GO:0042987,amyloid precursor protein catabolic process,process,Alzheimer disease102,ADAM10,gene/protein,decreases_activity of,,cognitive impairment,phenotype,Alzheimer disease102,ADAM10,gene/protein,decreases_expression of,6279,S100A8,gene/protein,Alzheimer disease102,ADAM10,gene/protein,decreases_expression of,6280,S100A9,gene/protein,Alzheimer disease6279,S100A8,gene/protein,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer disease6280,S100A9,gene/protein,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer diseaseGO:0001309,age-dependent telomere shortening,process,increases_activity of,GO:0008542,visual learning,process,Alzheimer diseaseGO:0001309,age-dependent telomere shortening,process,increases_activity of,GO:0001774,microglial cell activation,process,Alzheimer diseaseGO:0001309,age-dependent telomere shortening,process,decreases_activity of,MP:0008918,microgliosis,phenotype,Alzheimer diseaseGO:0001309,age-dependent telomere shortening,process,decreases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease,G3Terc-/- mouse,organism model,decreases_activity of,GO:0021542,dentate gyrus development,process,Alzheimer disease,G3Terc-/- mouse,organism model,increases_activity of,GO:0070997,neuron death,process,Alzheimer disease,G3Terc-/- mouse,organism model,decreases_activity of,GO:0007614,short-term memory,process,Alzheimer disease351,Amyloid beta peptide,gene/protein,increases_activity of,GO:0034976,response to endoplasmic reticulum stress,process,Alzheimer disease351,Amyloid beta peptide,gene/protein,increases_activity of,7494,XBP1,gene/protein,Alzheimer diseaseGO:0034976,response to endoplasmic reticulum stress,process,increases_quantity of,7494,XBP1,gene/protein,Alzheimer disease7494,XBP1,gene/protein,increases_activity of,GO:0043526,neuroprotection,process,Alzheimer disease7494,XBP1,gene/protein,decreases_quantity of,C00076,Ca2+,drug/chemical compound,Alzheimer disease6263,RYR3,gene/protein,affects_activity of,7494,XBP1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,MP:0000947,convulsive seizures,phenotype,Alzheimer disease102,ADAM10,gene/protein,affects_activity of,GO:0043526,neuroprotection,process,Alzheimer diseaseC10107,Myricetin,drug/chemical compound,is_part_of,C01579,Flavonoid,drug/chemical compound,Alzheimer diseaseC10107,Myricetin,drug/chemical compound,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseC10107,Myricetin,drug/chemical compound,decreases_activity of,GO:0070997,neuron death,process,Alzheimer diseaseC10107,Myricetin,drug/chemical compound,decreases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer diseaseC10107,Myricetin,drug/chemical compound,decreases_activity of,836,CASP3,gene/protein,Alzheimer diseaseC10107,Myricetin,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseC10107,Myricetin,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer diseaseC10107,Myricetin,drug/chemical compound,increases_activity of,102,ADAM10,gene/protein,Alzheimer diseaseC10107,Myricetin,drug/chemical compound,increases_expression of,102,ADAM10,gene/protein,Alzheimer diseaseC10107,Myricetin,drug/chemical compound,affects_activity of,23621,BACE1,gene/protein,Alzheimer diseaseC00291,Nickel,drug/chemical compound,increases_quantity of,3091,HIF1A,gene/protein,Alzheimer disease3091,HIF1A,gene/protein,interacts (colocalizes) with,405,ARNT,gene/protein,Alzheimer disease3091,HIF1A,gene/protein,is_part_of,5382,ARNT-HIF1A complex,complex/PPI,Alzheimer disease405,ARNT,gene/protein,is_part_of,5382,ARNT-HIF1A complex,complex/PPI,Alzheimer diseaseD07520,Bepridil,drug/chemical compound,decreases_activity of,C00076,Ca2+,drug/chemical compound,Alzheimer diseaseD02910,Amiodarone,drug/chemical compound,decreases_activity of,C00076,Ca2+,drug/chemical compound,Alzheimer diseaseD07520,Bepridil,drug/chemical compound,decreases_activity of,23621,BACE1,gene/protein,Alzheimer diseaseD02910,Amiodarone,drug/chemical compound,decreases_activity of,23621,BACE1,gene/protein,Alzheimer diseaseD07520,Bepridil,drug/chemical compound,increases_activity of,GO:0051454,intracellular pH elevation,process,Alzheimer diseaseD02910,Amiodarone,drug/chemical compound,increases_activity of,GO:0051454,intracellular pH elevation,process,Alzheimer diseaseGO:0051454,intracellular pH elevation,process,decreases_activity of,23621,BACE1,gene/protein,Alzheimer disease23621,BACE1,gene/protein,affects_activity of,GO:0042987,amyloid precursor protein catabolic process,process,Alzheimer diseaseD07520,Bepridil,drug/chemical compound,affects_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer diseaseD02910,Amiodarone,drug/chemical compound,affects_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease351,Amyloid beta peptide (oligomer),gene/protein,decreases_quantity of,C04637,"1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate",drug/chemical compound,Alzheimer disease351,Amyloid beta peptide (oligomer),gene/protein,decreases_activity of,,"Phosphatidylinositol-4,5-bisphosphate 5-phosphatase",gene/protein,Alzheimer diseaseC04637,"1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate",drug/chemical compound,affects_activity of,,"Phosphatidylinositol-4,5-bisphosphate 5-phosphatase",gene/protein,Alzheimer diseaseC00076,Ca2+,drug/chemical compound,affects_activity of,,"Phosphatidylinositol-4,5-bisphosphate 5-phosphatase",gene/protein,Alzheimer disease8867,SYNJ1,gene/protein,affects_quantity of,C04637,"1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate",drug/chemical compound,Alzheimer disease8867,SYNJ1,gene/protein,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease8867,SYNJ1,gene/protein,is localized in,GO:0045202,synapse,cellular component,Alzheimer disease,calorie restriction,environment,increases_phosphorylation of,83939,EIF2A,gene/protein,Alzheimer diseaseGO:0006468,protein phosphorylation,process,increases_quantity of,83939,EIF2A-P,protein modification,Alzheimer disease83939,EIF2A-P,protein modification,increases_activity of,83939,EIF2A,gene/protein,Alzheimer diseaseGO:0006468,protein phosphorylation,process,increases_activity of,83939,EIF2A,gene/protein,Alzheimer disease83939,EIF2A-P,protein modification,increases_expression of,23621,BACE1,gene/protein,Alzheimer disease,Salubrinal,drug/chemical compound,decreases_activity of,,eIF2a-PPP1CC,gene/protein,Alzheimer disease,Salubrinal,drug/chemical compound,increases_quantity of,23621,BACE1,gene/protein,Alzheimer disease,Salubrinal,drug/chemical compound,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease823,CAPN1,gene/protein,increases_processing of,8851,CDK5R1,gene/protein,Alzheimer disease823,CAPN1,gene/protein,affects_quantity of,8851,p25,gene/protein,Alzheimer disease8851,p25,gene/protein,is_part_of,8851,CDK5R1,gene/protein,Alzheimer disease8851,CDK5R1,gene/protein,is_part_of,1115,CDK5/p35 complex,complex/PPI,Alzheimer disease1020,CDK5,gene/protein,is_part_of,1115,CDK5/p35 complex,complex/PPI,Alzheimer diseaseGO:0031941,filamentous actin,cellular component,affects_quantity of,1115,CDK5/p35 complex,complex/PPI,Alzheimer diseaseGO:0031941,filamentous actin,cellular component,interacts (colocalizes) with,8851,CDK5R1,gene/protein,Alzheimer disease,G-actin,cellular component,interacts (colocalizes) with,1020,CDK5,gene/protein,Alzheimer diseaseGO:0031941,filamentous actin,cellular component,interacts (colocalizes) with,8851,p25,gene/protein,Alzheimer diseaseGO:0031941,filamentous actin,cellular component,interacts (colocalizes) with,1020,CDK5,gene/protein,Alzheimer disease,G-actin,cellular component,decreases_quantity of,,CDK5/p25 complex,complex/PPI,Alzheimer disease,G-actin,cellular component,decreases_quantity of,1115,CDK5/p35 complex,complex/PPI,Alzheimer disease,G-actin,cellular component,decreases_activity of,,CDK5/p25 complex,complex/PPI,Alzheimer disease,G-actin,cellular component,decreases_activity of,1115,CDK5/p35 complex,complex/PPI,Alzheimer disease,G-actin,cellular component,decreases_activity of,1020,CDK5,gene/protein,Alzheimer disease102,ADAM10 (5'-UTR),gene/protein,decreases_expression of,102,ADAM10,gene/protein,Alzheimer disease9528,TMEM59,gene/protein,affects_glucosylation of,351,APP,gene/protein,Alzheimer disease9528,TMEM59,gene/protein,decreases_activity of,GO:0034205,beta-amyloid formation,process,Alzheimer disease9528,TMEM59,gene/protein,decreases_quantity of,351,APP,gene/protein,Alzheimer disease9528,TMEM59,gene/protein,is localized in,GO:0031985,Golgi cisterna,cellular component,Alzheimer disease9528,TMEM59,gene/protein,affects_activity of,GO:0033578,protein glycosylation in Golgi,process,Alzheimer disease5463,POU6F1,gene/protein,affects_activity of,9528,TMEM59,gene/protein,Alzheimer disease1636,ACE,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease358,AQP1,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease57561,ARRDC3,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease929,CD14,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease12509,Cd59a,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease1040,CDS1,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease9076,CLDN1,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease12869,Cox8b,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease2348,FOLR1,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease245913,DEFB110,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease4314,MMP3,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease2665,GDI2,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease4256,MGP,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease25924,MYRIP,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease54101,RIPK4,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease390,RND3,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease6623,SNCG,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease12509,Cd59a,gene/protein,affects_activity of,9528,TMEM59,gene/protein,Alzheimer disease25924,MYRIP,gene/protein,affects_activity of,9528,TMEM59,gene/protein,Alzheimer disease6623,SNCG,gene/protein,affects_activity of,9528,TMEM59,gene/protein,Alzheimer diseaseGO:0030162,regulation of proteolysis,process,affects_activity of,GO:0007154,cell communication,process,Alzheimer diseaseGO:0030162,regulation of proteolysis,process,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseGO:0030162,regulation of proteolysis,process,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseGO:0030162,regulation of proteolysis,process,affects_processing of,351,APP,gene/protein,Alzheimer diseaseGO:0006509,membrane protein ectodomain proteolysis,process,affects_processing of,351,APP,gene/protein,Alzheimer diseaseGO:0030162,regulation of proteolysis,process,affects_processing of,102,ADAM10,gene/protein,Alzheimer disease102,ADAM10,gene/protein,affects_processing of,4851,NOTCH1,gene/protein,Alzheimer disease102,ADAM10,gene/protein,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease6868,ADAM17,gene/protein,affects_processing of,4851,NOTCH1,gene/protein,Alzheimer disease7076,TIMP1,gene/protein,decreases_activity of,102,ADAM10,gene/protein,Alzheimer disease7076,TIMP1,gene/protein,decreases_activity of,6868,ADAM17,gene/protein,Alzheimer disease7078,TIMP3,gene/protein,decreases_activity of,6868,ADAM17,gene/protein,Alzheimer disease7078,TIMP3,gene/protein,decreases_activity of,102,ADAM10,gene/protein,Alzheimer diseaseC05151,12-O-Tetradecanoylphorbol 13-acetate,drug/chemical compound,affects_activity of,6868,ADAM17,gene/protein,Alzheimer disease,p38 MAPK,gene/protein,increases_phosphorylation of,6868,ADAM17,gene/protein,Alzheimer disease23621,BACE1,gene/protein,increases_processing of,334,APLP2,gene/protein,Alzheimer disease102,ADAM10,gene/protein,affects_processing of,334,APLP2,gene/protein,Alzheimer disease6868,ADAM17,gene/protein,affects_processing of,334,APLP2,gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,increases_processing of,334,APLP2,gene/protein,Alzheimer disease55851,PSENEN,gene/protein,affects_processing of,5663,PSEN1,gene/protein,Alzheimer disease55851,PSENEN,gene/protein,affects_processing of,5664,PSEN2,gene/protein,Alzheimer diseaseC05151,12-O-Tetradecanoylphorbol 13-acetate,drug/chemical compound,increases_activity of,6868,ADAM17,gene/protein,Alzheimer disease6868,ADAM17,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer diseasers3764650,ABCA7 rs3764650,SNP,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseasers610932,MS4A6A / MS4A4E rs610932,SNP,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease2041,EPHA1-mut,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease945,CD33-mut,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease23607,CD2AP-mut,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease1378,CR1,gene/protein,affects_activity of,,cognitive impairment,phenotype,Alzheimer disease,sGSM,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseC07610,Silibinin,drug/chemical compound,decreases_activity of,,Amyloid beta peptide (25-35)-induced memory impairment,phenotype,Alzheimer diseaseC07610,Silibinin,drug/chemical compound,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseC07610,Silibinin,drug/chemical compound,decreases_quantity of,C19440,Malonaldehyde,drug/chemical compound,Alzheimer diseaseC07610,Silibinin,drug/chemical compound,affects_quantity of,C00051,Glutathione,drug/chemical compound,Alzheimer disease102,ADAM10,gene/protein,affects_processing of,6376,CX3CL1,gene/protein,Alzheimer disease102,ADAM10,gene/protein,affects_activity of,GO:0098609,cell-cell adhesion,process,Alzheimer disease6376,CX3CL1 (soluble),mRNA/protein variant,affects_activity of,GO:0030595,leukocyte chemotaxis,process,Alzheimer disease,CX3CL1 upregulation,phenotype,cooccurs with,MP:0003991,arteriosclerosis,phenotype,Alzheimer disease,CX3CL1 upregulation,phenotype,cooccurs with,MP:0005671,abnormal response to transplant,phenotype,Alzheimer disease,CX3CL1 upregulation,phenotype,cooccurs with,MP:0001193,psoriasis,phenotype,Alzheimer disease,CX3CL1 upregulation,phenotype,cooccurs with,MP:0001654,hepatic necrosis,phenotype,Alzheimer disease,CX3CL1 upregulation,phenotype,cooccurs with,MP:0001859,kidney inflammation,phenotype,Alzheimer disease,CX3CL1 upregulation,phenotype,cooccurs with,,ischemia reperfusion-injured brain,phenotype,Alzheimer disease7076,TIMP1,gene/protein,decreases_quantity of,6376,CX3CL1 (soluble),mRNA/protein variant,Alzheimer disease7077,TIMP2,gene/protein,affects_activity of,102,ADAM10,gene/protein,Alzheimer disease4363,ABCC1,gene/protein,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease4363,ABCC1,gene/protein,affects transport of,351,Amyloid beta peptide,gene/protein,Alzheimer disease4363,ABCC1,gene/protein,decreases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,1116,CHI3L1,gene/protein,Alzheimer disease1116,CHI3L1,gene/protein,interacts (colocalizes) with,BTO:0000237,cerebrospinal fluid,tissue/cell line,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,affects_quantity of,1116,CHI3L1,gene/protein,Alzheimer diseaseGO:0000380,"alternative mRNA splicing, via spliceosome",process,affects_activity of,4137,MAPT,gene/protein,Alzheimer diseaseGO:0000380,"alternative mRNA splicing, via spliceosome",process,affects_activity of,6434,TRA2B1,mRNA/protein variant,Alzheimer diseaseGO:0000380,"alternative mRNA splicing, via spliceosome",process,affects_activity of,5664,PSEN2,gene/protein,Alzheimer diseaseGO:0000380,"alternative mRNA splicing, via spliceosome",process,affects_activity of,1196,CLK2,gene/protein,Alzheimer disease6434,TRA2B1,mRNA/protein variant,affects_activity of,GO:0000380,"alternative mRNA splicing, via spliceosome",process,Alzheimer disease1196,CLK2,gene/protein,affects_activity of,GO:0000380,"alternative mRNA splicing, via spliceosome",process,Alzheimer disease6434,TRA2B1,mRNA/protein variant,affects_activity of,4137,MAPT,gene/protein,Alzheimer disease1196,CLK2,gene/protein,affects_activity of,4137,MAPT,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0000380,"alternative mRNA splicing, via spliceosome",process,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,4137,MAPT-var (4R),mRNA/protein variant,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,6434,TRA2B1,mRNA/protein variant,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,5664,PSEN2-var,mRNA/protein variant,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,1196,CLK2-var (inactive),mRNA/protein variant,Alzheimer diseaseGO:0000380,"alternative mRNA splicing, via spliceosome",process,affects_quantity of,4137,MAPT-var (4R),mRNA/protein variant,Alzheimer diseaseGO:0000380,"alternative mRNA splicing, via spliceosome",process,affects_quantity of,6434,TRA2B1,mRNA/protein variant,Alzheimer diseaseGO:0000380,"alternative mRNA splicing, via spliceosome",process,affects_quantity of,1196,CLK2-var (inactive),mRNA/protein variant,Alzheimer diseaseGO:0000380,"alternative mRNA splicing, via spliceosome",process,affects_quantity of,5664,PSEN2-var,mRNA/protein variant,Alzheimer disease1196,CLK2,gene/protein,affects_quantity of,6434,TRA2B3 (inactive),mRNA/protein variant,Alzheimer disease6434,TRA2B1,mRNA/protein variant,affects_quantity of,1196,CLK2-tr (inactive),mRNA/protein variant,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0043484,regulation of RNA splicing,process,Alzheimer disease6434,TRA2B1,mRNA/protein variant,increases_quantity of,4137,MAPT-var (4R),mRNA/protein variant,Alzheimer disease1196,CLK2,gene/protein,interacts (colocalizes) with,6434,TRA2B1,mRNA/protein variant,Alzheimer disease1196,CLK2,gene/protein,increases_phosphorylation of,6434,TRA2B1,mRNA/protein variant,Alzheimer disease6427,SRSF2,gene/protein,affects_activity of,GO:0000380,"alternative mRNA splicing, via spliceosome",process,Alzheimer disease6427,SRSF2,gene/protein,affects_quantity of,4137,MAPT-var (3R/4R),mRNA/protein variant,Alzheimer disease4137,MAPT-mut (enhancer),gene/protein mutant,affects_activity of,GO:0036002,pre-mRNA binding,process,Alzheimer disease4137,MAPT-mut (enhancer),gene/protein mutant,affects_activity of,GO:0000380,"alternative mRNA splicing, via spliceosome",process,Alzheimer disease1859,DYRK1A,gene/protein,increases_phosphorylation of,6427,SRSF2,gene/protein,Alzheimer disease1859,DYRK1A,gene/protein,interacts (colocalizes) with,6427,SRSF2,gene/protein,Alzheimer disease1859,DYRK1A,gene/protein,affects_activity of,6427,SRSF2,gene/protein,Alzheimer disease1859,DYRK1A,gene/protein,increases_expression of,4137,MAPT-var (4R),mRNA/protein variant,Alzheimer diseaseMP:0002079,increased circulating insulin level,phenotype,affects_activity of,,abnormal Abeta metabolism,phenotype,Alzheimer diseaseMP:0001547,abnormal lipid level,phenotype,affects_activity of,,abnormal Abeta metabolism,phenotype,Alzheimer disease5664,PSEN2-mut,gene/protein mutant,affects_activity of,5664,PSEN2,gene/protein,Alzheimer disease5566,PRKACA,gene/protein,increases_phosphorylation of,6426,SRSF1,gene/protein,Alzheimer disease5567,PRKACB,gene/protein,interacts (colocalizes) with,6426,SRSF1,gene/protein,Alzheimer disease5566,PRKACA,gene/protein,affects_activity of,GO:0036002,pre-mRNA binding,process,Alzheimer disease5566,PRKACA,gene/protein,increases_activity of,GO:0000380,"alternative mRNA splicing, via spliceosome",process,Alzheimer disease6426,SRSF1,gene/protein,affects_activity of,GO:0000380,"alternative mRNA splicing, via spliceosome",process,Alzheimer disease5566,PRKACA,gene/protein,affects_quantity of,4137,MAPT-var (3R),mRNA/protein variant,Alzheimer disease5566,PRKACA,gene/protein,interacts (colocalizes) with,6426,SRSF1,gene/protein,Alzheimer disease4137,MAPT-var (4R),mRNA/protein variant,decreases_activity of,GO:0009790,embryo development,process,Alzheimer disease4137,MAPT-var (4R),mRNA/protein variant,increases_activity of,GO:0031175,neuron projection development,process,Alzheimer disease4137,MAPT-var,mRNA/protein variant,is_expressed_in,BTO:0000793,SH-SY5Y cell,tissue/cell line,Alzheimer disease4137,MAPT-var (4R),mRNA/protein variant,increases_activity of,5880,RAC2,gene/protein,Alzheimer disease4137,MAPT-var (4R),mRNA/protein variant,affects_activity of,GO:0035567,non-canonical Wnt signaling pathway,process,Alzheimer disease5880,RAC2,gene/protein,affects_activity of,GO:0035567,non-canonical Wnt signaling pathway,process,Alzheimer disease84034,EMILIN2,gene/protein,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer disease4137,MAPT-var (4R),mRNA/protein variant,increases_expression of,84034,EMILIN2,gene/protein,Alzheimer disease4257,MGST1,gene/protein,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer disease4137,MAPT-var (4R),mRNA/protein variant,increases_expression of,4257,MGST1,gene/protein,Alzheimer disease4745,NELL1,gene/protein,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer disease4137,MAPT-var (4R),mRNA/protein variant,increases_expression of,4745,NELL1,gene/protein,Alzheimer disease5521,PPP2R2B,gene/protein,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer disease4137,MAPT-var (4R),mRNA/protein variant,increases_expression of,5521,PPP2R2B,gene/protein,Alzheimer disease5880,RAC2,gene/protein,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer disease4137,MAPT-var (4R),mRNA/protein variant,increases_expression of,5880,RAC2,gene/protein,Alzheimer disease6447,SCG5,gene/protein,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer disease4137,MAPT-var (4R),mRNA/protein variant,increases_expression of,6447,SCG5,gene/protein,Alzheimer disease6446,SGK1,gene/protein,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer disease4137,MAPT-var (4R),mRNA/protein variant,increases_expression of,6446,SGK1,gene/protein,Alzheimer disease1902,LPAR1,gene/protein,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer disease4137,MAPT-var (4R),mRNA/protein variant,decreases_expression of,1902,LPAR1,gene/protein,Alzheimer disease5979,RET,gene/protein,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer disease4137,MAPT-var (4R),mRNA/protein variant,decreases_expression of,5979,RET,gene/protein,Alzheimer disease5578,PRKCA,gene/protein,affects_activity of,GO:0006915,apoptotic process,process,Alzheimer disease4137,MAPT-var (4R),mRNA/protein variant,decreases_expression of,5578,PRKCA,gene/protein,Alzheimer disease6667,SP1,gene/protein,affects_expression of,102,ADAM10,gene/protein,Alzheimer disease,USF,gene/protein,affects_expression of,102,ADAM10,gene/protein,Alzheimer disease,Retinoic acid-responsive element,gene/protein,affects_expression of,102,ADAM10,gene/protein,Alzheimer disease102,ADAM10-p.Q170H,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease102,ADAM10-p.R181G,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease102,ADAM10-p.Q170H,gene/protein mutant,decreases_activity of,102,ADAM10,gene/protein,Alzheimer disease102,ADAM10-p.R181G,gene/protein mutant,decreases_activity of,102,ADAM10,gene/protein,Alzheimer disease102,ADAM10-p.Q170H,gene/protein mutant,increases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease102,ADAM10-p.R181G,gene/protein mutant,increases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease6421,SFPQ,gene/protein,decreases_quantity of,4137,MAPT-var (4R),mRNA/protein variant,Alzheimer disease6421,SFPQ,gene/protein,affects_activity of,GO:0035613,RNA stem-loop binding,process,Alzheimer disease5936,RBM4,gene/protein,increases_quantity of,4137,MAPT-var (4R),mRNA/protein variant,Alzheimer disease5936,RBM4,gene/protein,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease5936,RBM4,gene/protein,affects_activity of,GO:0000380,"alternative mRNA splicing, via spliceosome",process,Alzheimer disease5936,RBM4-mut,gene/protein mutant,decreases_activity of,5936,RBM4,gene/protein,Alzheimer disease6427,SRSF2,gene/protein,increases_expression of,4137,MAPT,gene/protein,Alzheimer disease6427,SRSF2,gene/protein,interacts (colocalizes) with,4137,MAPT,gene/protein,Alzheimer disease6427,SRSF2,gene/protein,increases_quantity of,4137,MAPT-var (4R),mRNA/protein variant,Alzheimer diseaseGO:0006468,protein phosphorylation,process,affects_activity of,6427,SRSF2,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,increases_phosphorylation of,6427,SRSF2,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,affects_activity of,6427,SRSF2,gene/protein,Alzheimer disease2931,GSK3A,gene/protein,increases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease27429,HTRA2,gene/protein,is localized in,GO:0005758,mitochondrial intermembrane space,cellular component,Alzheimer disease27429,HTRA2,gene/protein,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease27429,HTRA2,gene/protein,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease27429,HTRA2,gene/protein,decreases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease27429,HTRA2,gene/protein,decreases_activity of,GO:0051259,protein oligomerization,process,Alzheimer diseaseGO:0051259,protein oligomerization,process,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease27429,HTRA2,gene/protein,affects_activity of,GO:0061077,chaperone-mediated protein folding,process,Alzheimer disease928,CD9,gene/protein,interacts (colocalizes) with,6868,ADAM17,gene/protein,Alzheimer disease928,CD9,gene/protein,affects_activity of,6868,ADAM17,gene/protein,Alzheimer disease3159,HMGA1,gene/protein,affects_activity of,5664,PSEN2,gene/protein,Alzheimer disease3159,HMGA1,gene/protein,affects_processing of,5664,PSEN2,gene/protein,Alzheimer disease3159,HMGA1,gene/protein,decreases_activity of,GO:0000245,spliceosomal complex assembly,process,Alzheimer diseaseGO:0000245,spliceosomal complex assembly,process,affects_expression of,5664,PSEN2,gene/protein,Alzheimer disease3159,HMGA1,gene/protein,interacts (colocalizes) with,GO:0005685,U1 snRNP,cellular component,Alzheimer disease,HMGA1a-U1 snRNP complex,complex/PPI,decreases_expression of,5664,PSEN2,gene/protein,Alzheimer disease,HMGA1a-U1 snRNP complex,complex/PPI,increases_expression of,5664,PSEN2-var (deleterious form),mRNA/protein variant,Alzheimer disease5664,PSEN2-var (deleterious form),mRNA/protein variant,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease3159,HMGA1,gene/protein,is_part_of,,HMGA1a-U1 snRNP complex,complex/PPI,Alzheimer diseaseGO:0005685,U1 snRNP,cellular component,is_part_of,,HMGA1a-U1 snRNP complex,complex/PPI,Alzheimer disease102,ADAM10,gene/protein,affects_activity of,,Alpha-secretase,gene/protein,Alzheimer disease102,ADAM10,gene/protein,affects_activity of,GO:0008237,metallopeptidase activity,process,Alzheimer disease102,ADAM10,gene/protein,affects_activity of,GO:0009306,protein secretion,process,Alzheimer diseaseGO:0044027,hypermethylation of CpG island,process,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseGO:0000183,chromatin silencing at rDNA,process,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease6070,CD36-Abeta interaction,complex/PPI,increases_activity of,GO:0001774,microglial cell activation,process,Alzheimer diseaseC08988,Ursolic acid,drug/chemical compound,affects_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease351,Amyloid beta peptide,gene/protein,interacts (colocalizes) with,948,CD36,gene/protein,Alzheimer disease4481,MSR1,gene/protein,interacts (colocalizes) with,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC08988,Ursolic acid,drug/chemical compound,decreases_quantity of,6070,CD36-Abeta interaction,complex/PPI,Alzheimer disease6070,CD36-Abeta interaction,complex/PPI,increases_activity of,GO:0001816,cytokine production,process,Alzheimer disease6070,CD36-Abeta interaction,complex/PPI,increases_activity of,,neurotoxin production,process,Alzheimer diseaseGO:0001816,cytokine production,process,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease,neurotoxin production,process,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease949,SCARB1,gene/protein,interacts (colocalizes) with,351,Amyloid beta peptide,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,4137,MAPT-phosThr231,protein modification,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,2932,GSK3B (activated),protein modification,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,GO:0005769,early endosome,cellular component,Alzheimer disease4137,MAPT,gene/protein,affects_activity of,GO:0060053,neurofilament cytoskeleton,cellular component,Alzheimer disease4137,MAPT-var,mRNA/protein variant,affects_quantity of,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer diseaseMP:0003214,neurofibrillary tangles,phenotype,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer diseaseGO:0000380,"alternative mRNA splicing, via spliceosome",process,affects_quantity of,4137,MAPT-var,mRNA/protein variant,Alzheimer diseaseGO:0000380,"alternative mRNA splicing, via spliceosome",process,affects_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease4137,MAPT-var,mRNA/protein variant,affects_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease6428,SRSF3,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease6426,SRSF1,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease8683,SRSF9,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease6427,SRSF2,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease6430,SRSF5,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease6432,SRSF7,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease6431,SRSF6,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease6429,SRSF4,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease,U2AF,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease5725,PTBP1,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease58155,PTBP2,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease3178,HNRNPA1,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease27316,RBMX,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease6433,SFSWAP,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease6434,TRA2B1,mRNA/protein variant,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease4857,NOVA1,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease8570,KHSRP,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease202559,KHDRBS2,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease10656,KHDRBS3,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease11189,CELF3,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease56853,CELF4,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease,young coconut juice supplementation,environment,increases_quantity of,C00951,Estradiol,drug/chemical compound,Alzheimer disease,young coconut juice supplementation,environment,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease2670,GFAP,gene/protein,is localized in,BTO:0000099,astrocyte,tissue/cell line,Alzheimer disease2670,GFAP,gene/protein,is localized in,BTO:0000233,cerebral cortex,tissue/cell line,Alzheimer disease,young coconut juice supplementation,environment,decreases_quantity of,2670,GFAP,gene/protein,Alzheimer disease2670,GFAP,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,2670,GFAP-mod,protein modification,Alzheimer diseaseD08518,beta-Sitosterol,drug/chemical compound,is_part_of,,Young coconut juice,drug/chemical compound,Alzheimer disease,Stigmastatrienol,drug/chemical compound,is_part_of,,Young coconut juice,drug/chemical compound,Alzheimer diseaseC05442,Stigmasterol,drug/chemical compound,is_part_of,,Young coconut juice,drug/chemical compound,Alzheimer diseaseC08817,Fucosterol,drug/chemical compound,is_part_of,,Young coconut juice,drug/chemical compound,Alzheimer diseaseC08840,alpha-Spinasterol,drug/chemical compound,is_part_of,,Young coconut juice,drug/chemical compound,Alzheimer diseaseD07913,Escitalopram,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD00426,Risperidone,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease682,BSG,gene/protein,is_part_of,142,CD147-gamma-secretase complex,complex/PPI,Alzheimer disease682,BSG,gene/protein,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease1655,DDX5,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease1655,DDX5,gene/protein,increases_activity of,GO:0000380,"alternative mRNA splicing, via spliceosome",process,Alzheimer disease1655,DDX5,gene/protein,affects_quantity of,4137,MAPT-var (exon 10),mRNA/protein variant,Alzheimer disease5936,RBM4,gene/protein,affects_processing of,4137,MAPT,gene/protein,Alzheimer disease5936,RBM4,gene/protein,interacts (colocalizes) with,1655,DDX5,gene/protein,Alzheimer disease5936,RBM4,gene/protein,interacts (colocalizes) with,4137,MAPT,gene/protein,Alzheimer disease1655,DDX5,gene/protein,increases_activity of,GO:0035613,RNA stem-loop binding,process,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased caspase activity,phenotype,Alzheimer diseaseGO:0071731,response to nitric oxide,process,decreases_activity of,331,XIAP,gene/protein,Alzheimer disease,CASP,gene/protein,is localized in,BTO:0000237,cerebrospinal fluid,tissue/cell line,Alzheimer diseaseGO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,process,affects_activity of,,synaptic loss,phenotype,Alzheimer disease,CASP,gene/protein,affects_activity of,GO:0097153,cysteine-type endopeptidase activity involved in apoptotic process,process,Alzheimer diseaseGO:0006915,apoptotic process,process,affects_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease,CASP,gene/protein,affects_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer diseaseGO:0006915,apoptotic process,process,affects_activity of,,synaptic loss,phenotype,Alzheimer disease,Protein kinase C,gene/protein,increases_activity of,331,XIAP,gene/protein,Alzheimer disease,Protein kinase C,gene/protein,increases_phosphorylation of,331,XIAP,gene/protein,Alzheimer disease331,XIAP-phosSer87,protein modification,decreases_activity of,GO:0006915,apoptotic process,process,Alzheimer diseaseGO:0006915,apoptotic process,process,increases_activity of,GO:0008219,cell death,process,Alzheimer diseaseC05151,12-O-Tetradecanoylphorbol 13-acetate,drug/chemical compound,increases_activity of,,Protein kinase C,gene/protein,Alzheimer diseaseC05151,12-O-Tetradecanoylphorbol 13-acetate,drug/chemical compound,increases_phosphorylation of,331,XIAP,gene/protein,Alzheimer disease331,XIAP,gene/protein,decreases_activity of,GO:0097153,cysteine-type endopeptidase activity involved in apoptotic process,process,Alzheimer disease,CASP,gene/protein,increases_processing of,5663,PSEN1,gene/protein,Alzheimer disease5663,PSEN1-proc,protein modification,affects_quantity of,351,Amyloid beta peptide (42/40),gene/protein,Alzheimer disease5663,PSEN1-proc,protein modification,increases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,CASP,gene/protein,increases_quantity of,5663,PSEN1-proc,protein modification,Alzheimer disease5663,PSEN1-proc,protein modification,affects_activity of,5663,PSEN1,gene/protein,Alzheimer disease5663,PSEN1-proc,protein modification,affects_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease5663,PSEN1,gene/protein,affects_activity of,GO:0010468,regulation of gene expression,process,Alzheimer disease5663,PSEN1-mut,gene/protein mutant,increases_expression of,7157,TP53,gene/protein,Alzheimer diseaseGO:0010468,regulation of gene expression,process,affects_quantity of,7157,TP53,gene/protein,Alzheimer disease5663,PSEN1,gene/protein,affects_activity of,GO:0030162,regulation of proteolysis,process,Alzheimer disease5663,PSEN1,gene/protein,affects_activity of,GO:0010506,regulation of autophagy,process,Alzheimer disease836,CASP3,gene/protein,affects_processing of,5663,PSEN1,gene/protein,Alzheimer disease839,CASP6,gene/protein,affects_processing of,5663,PSEN1,gene/protein,Alzheimer disease836,CASP3,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease839,CASP6,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease,CASP,gene/protein,affects_quantity of,5663,PSEN1-proc,protein modification,Alzheimer disease,CASP,gene/protein,affects_processing of,5663,PSEN1,gene/protein,Alzheimer disease4137,MAPT-proc (1-421),protein modification,increases_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer diseaseC06973,Doxycycline,drug/chemical compound,increases_expression of,4137,MAPT-proc (1-421),protein modification,Alzheimer disease4137,MAPT-proc (1-421),protein modification,increases_activity of,MP:0006036,abnormal mitochondrial physiology,phenotype,Alzheimer disease4137,MAPT-proc (1-421),protein modification,affects_activity of,GO:0051562,negative regulation of mitochondrial calcium ion concentration,process,Alzheimer disease4137,MAPT-proc (1-421),protein modification,affects_activity of,GO:0051881,regulation of mitochondrial membrane potential,process,Alzheimer diseaseC09561,Thapsigargin,drug/chemical compound,affects_activity of,,T4C3 cell,tissue/cell line,Alzheimer disease,T4C3 cell,tissue/cell line,increases_quantity of,4137,MAPT-proc (1-421),protein modification,Alzheimer diseaseC05086,Cyclosporin A,drug/chemical compound,affects_activity of,,T4C3 cell,tissue/cell line,Alzheimer diseaseC01375,Tacrolimus,drug/chemical compound,affects_activity of,,T4C3 cell,tissue/cell line,Alzheimer diseaseC05086,Cyclosporin A,drug/chemical compound,decreases_activity of,GO:0043653,mitochondrial fragmentation involved in apoptotic process,process,Alzheimer diseaseC01375,Tacrolimus,drug/chemical compound,decreases_activity of,GO:0043653,mitochondrial fragmentation involved in apoptotic process,process,Alzheimer diseaseMP:0006036,abnormal mitochondrial physiology,phenotype,increases_activity of,GO:0043653,mitochondrial fragmentation involved in apoptotic process,process,Alzheimer disease4137,MAPT-proc (1-421),protein modification,increases_activity of,6023,Calcineurin,complex/PPI,Alzheimer diseaseC00076,Ca2+,drug/chemical compound,affects_activity of,6023,Calcineurin,complex/PPI,Alzheimer disease,increased calcineurin activity,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease5868,RAB5A,gene/protein,affects_activity of,GO:0005769,early endosome,cellular component,Alzheimer disease7879,RAB7A,gene/protein,affects_activity of,GO:0005770,late endosome,cellular component,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,5868,RAB5A,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,7879,RAB7A,gene/protein,Alzheimer disease5868,RAB5A,gene/protein,decreases_expression of,4915,NTRK2,gene/protein,Alzheimer disease5867,RAB4A,gene/protein,affects_activity of,GO:0005769,early endosome,cellular component,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,5867,RAB4A,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,,RAB3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,4915,NTRK2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,4916,NTRK3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,53917,RAB24,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,1509,CTSD,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,8411,EEA1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,5595,MAPK3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,8655,DYNLL1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,3916,LAMP1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,831,CAST,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,535,ATP6V0A1,gene/protein,Alzheimer disease,12/15-Lipoxygenase,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,12/15-Lipoxygenase,gene/protein,affects_activity of,,cognitive impairment,phenotype,Alzheimer diseaseGO:0019372,lipoxygenase pathway,process,affects_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease5743,PTGS2,gene/protein,is localized in,BTO:0000938,neuron,tissue/cell line,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,5743,PTGS2,gene/protein,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,increases_expression of,5742,PTGS1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,5742,PTGS1,gene/protein,Alzheimer diseaseD07142,Triflusal,drug/chemical compound,decreases_activity of,5742,PTGS1,gene/protein,Alzheimer diseaseD07142,Triflusal,drug/chemical compound,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer diseaseD07142,Triflusal,drug/chemical compound,decreases_activity of,,cognitive impairment,phenotype,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,affects_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer diseaseC01926,Indomethacin,drug/chemical compound,affects_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease,(R)-flurbiprofen,cellular component,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease333,APLP1,gene/protein,interacts (colocalizes) with,351,APP,gene/protein,Alzheimer disease334,APLP2,gene/protein,interacts (colocalizes) with,351,APP,gene/protein,Alzheimer diseaseC09731,Epigallocatechin 3-gallate,drug/chemical compound,increases_quantity of,351,APP-alpha (C-terminal fragment),gene/protein,Alzheimer disease23621,BACE1,gene/protein,increases_quantity of,351,sAPP-beta,gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,increases_processing of,351,APP (C-terminal fragment C100),gene/protein,Alzheimer disease,"Amyloid beta peptide (42, homodimer)",complex/PPI,increases_activity of,351,"Amyloid beta peptide (42, monomer)",gene/protein,Alzheimer disease351,APP-mutG33A,gene/protein mutant,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide (38),gene/protein,Alzheimer diseaseC01926,Indomethacin,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseC01926,Indomethacin,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide (38),gene/protein,Alzheimer disease,Sulindac sulfide,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,Sulindac sulfide,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide (38),gene/protein,Alzheimer disease,Sulindac sulfide,drug/chemical compound,is_part_of,,NSAID,drug/chemical compound,Alzheimer disease,Sulindac sulfide,drug/chemical compound,is_part_of,,GSM,drug/chemical compound,Alzheimer diseaseC01926,Indomethacin,drug/chemical compound,is_part_of,,GSM,drug/chemical compound,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,is_part_of,,GSM,drug/chemical compound,Alzheimer diseaseC00925,Heparan sulfate,drug/chemical compound,decreases_activity of,23621,BACE1,gene/protein,Alzheimer diseaseC00925,Heparan sulfate,drug/chemical compound,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease348,APOE (isoform E4),gene/protein mutant,affects_activity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease351,Amyloid beta peptide (40),gene/protein,increases_expression of,5743,PTGS2,gene/protein,Alzheimer disease351,Amyloid beta peptide (40),gene/protein,increases_quantity of,C00584,Prostaglandin E2,drug/chemical compound,Alzheimer disease351,Amyloid beta peptide (12-28),gene/protein,interacts (colocalizes) with,348,APOE (isoform E4),gene/protein mutant,Alzheimer disease351,Amyloid beta peptide (12-28),gene/protein,affects_activity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease,S-Nitroso-N-acetylpenicillamine,drug/chemical compound,increases_quantity of,C00584,Prostaglandin E2,drug/chemical compound,Alzheimer disease,S-Nitroso-N-acetylpenicillamine,drug/chemical compound,increases_quantity of,C00533,NO,drug/chemical compound,Alzheimer disease,S-Nitroso-N-acetylpenicillamine,drug/chemical compound,affects_activity of,5743,PTGS2,gene/protein,Alzheimer diseaseGO:0051409,response to nitrosative stress,process,increases_quantity of,C00584,Prostaglandin E2,drug/chemical compound,Alzheimer disease348,APOE (isoform E4),gene/protein mutant,increases_activity of,GO:0051409,response to nitrosative stress,process,Alzheimer diseaseC00533,NO,drug/chemical compound,affects_activity of,GO:0051409,response to nitrosative stress,process,Alzheimer disease,mediterranean-type diet,environment,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,Diabetes mellitus,disease,affects_activity of,GO:0006950,response to stress,process,Alzheimer diseaseMP:0001559,hyperglycemia,phenotype,affects_activity of,GO:0006950,response to stress,process,Alzheimer diseaseMP:0001559,hyperglycemia,phenotype,affects_quantity of,5621,PRNP,gene/protein,Alzheimer disease,Diabetes mellitus,disease,affects_quantity of,5621,PRNP,gene/protein,Alzheimer diseaseMP:0001559,hyperglycemia,phenotype,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,Diabetes mellitus,disease,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseMP:0001559,hyperglycemia,phenotype,affects_quantity of,4842,NOS1,gene/protein,Alzheimer disease,Diabetes mellitus,disease,affects_quantity of,4842,NOS1,gene/protein,Alzheimer diseaseMP:0001559,hyperglycemia,phenotype,affects_quantity of,6647,SOD1,gene/protein,Alzheimer disease,Diabetes mellitus,disease,affects_quantity of,6647,SOD1,gene/protein,Alzheimer diseaseMP:0001559,hyperglycemia,phenotype,affects_quantity of,4843,NOS2,gene/protein,Alzheimer disease,Diabetes mellitus,disease,affects_quantity of,4843,NOS2,gene/protein,Alzheimer disease,Diabetes mellitus,disease,affects_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease,Diabetes mellitus,disease,cooccurs with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,Tg2576 mouse,organism model,increases_quantity of,351,Amyloid beta peptide (oligomer),gene/protein,Alzheimer disease,Tg2576 mouse,organism model,decreases_activity of,GO:0007613,memory,process,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,cooccurs with,,increased N(epsilon)-carboxymethyl lysine level,phenotype,Alzheimer diseaseGO:0002532,production of molecular mediator involved in inflammatory response,process,cooccurs with,,increased N(epsilon)-carboxymethyl lysine level,phenotype,Alzheimer disease6647,SOD1,gene/protein,affects_phosphorylation of,4137,MAPT,gene/protein,Alzheimer disease6647,SOD1,gene/protein,affects_quantity of,6855,SYP,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,6647,SOD1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,6648,SOD2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,6649,SOD3,gene/protein,Alzheimer disease351,Amyloid beta peptide (aggregated),gene/protein,increases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease,2-benzoxazolinone derivative,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,2-benzoxazolinone derivative,drug/chemical compound,decreases_activity of,43,ACHE,gene/protein,Alzheimer diseaseD08555,Tacrine,drug/chemical compound,decreases_activity of,43,ACHE,gene/protein,Alzheimer diseaseD07869,Donepezil,drug/chemical compound,decreases_activity of,43,ACHE,gene/protein,Alzheimer diseaseD03822,Rivastigmine,drug/chemical compound,decreases_activity of,43,ACHE,gene/protein,Alzheimer diseaseD04292,Galantamine,drug/chemical compound,decreases_activity of,43,ACHE,gene/protein,Alzheimer disease348,APOE (isoform E4),gene/protein mutant,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease351,APP,gene/protein,interacts (colocalizes) with,351,APP,gene/protein,Alzheimer disease351,APP,gene/protein,affects_activity of,GO:0042803,protein homodimerization activity,process,Alzheimer diseaseGO:0042803,protein homodimerization activity,process,affects_activity of,351,APP,gene/protein,Alzheimer diseaseGO:0042803,protein homodimerization activity,process,affects_processing of,351,APP,gene/protein,Alzheimer disease197135,PATL2,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer disease197135,PATL2,gene/protein,affects transport of,351,APP,gene/protein,Alzheimer disease197135,PATL2,gene/protein,affects_processing of,333,APLP1,gene/protein,Alzheimer disease197135,PATL2,gene/protein,affects transport of,333,APLP1,gene/protein,Alzheimer disease197135,PATL2,gene/protein,affects_processing of,334,APLP2,gene/protein,Alzheimer disease197135,PATL2,gene/protein,affects transport of,334,APLP2,gene/protein,Alzheimer disease197135,PATL2,gene/protein,interacts (colocalizes) with,351,APP,gene/protein,Alzheimer disease197135,PATL2,gene/protein,interacts (colocalizes) with,333,APLP1,gene/protein,Alzheimer disease197135,PATL2,gene/protein,interacts (colocalizes) with,334,APLP2,gene/protein,Alzheimer disease197135,PATL2,gene/protein,interacts (colocalizes) with,GO:0030140,trans-Golgi network transport vesicle,cellular component,Alzheimer disease197135,PATL2,gene/protein,interacts (colocalizes) with,GO:0005768,endosome,cellular component,Alzheimer disease10891,PPARGC1A,gene/protein,affects_activity of,GO:0007005,mitochondrion organization,process,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,10891,PPARGC1A,gene/protein,Alzheimer disease,APPswe M17 cell,tissue/cell line,decreases_activity of,,Mitochondrial respiratory chain complex IV,complex/PPI,Alzheimer disease,PGC1A-NRF-TFAM pathway,process,affects_activity of,GO:0007005,mitochondrion organization,process,Alzheimer disease7019,TFAM,gene/protein,affects_activity of,GO:0007005,mitochondrion organization,process,Alzheimer disease4899,NRF1,gene/protein,affects_activity of,GO:0007005,mitochondrion organization,process,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,4899,NRF1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,4780,NFE2L2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,7019,TFAM,gene/protein,Alzheimer diseaseC00575,cAMP,drug/chemical compound,increases_expression of,10891,PPARGC1A,gene/protein,Alzheimer diseaseC00575,cAMP,drug/chemical compound,increases_expression of,1385,CREB1,gene/protein,Alzheimer disease,APPswe M17 cell,tissue/cell line,decreases_expression of,1385,CREB1,gene/protein,Alzheimer disease,APPswe M17 cell,tissue/cell line,decreases_expression of,10891,PPARGC1A,gene/protein,Alzheimer diseaseC00575,cAMP,drug/chemical compound,increases_activity of,,Protein kinase A,complex/PPI,Alzheimer disease,PKA inhibitor H89,drug/chemical compound,decreases_activity of,,Protein kinase A,complex/PPI,Alzheimer disease,PKA inhibitor H89,drug/chemical compound,decreases_expression of,10891,PPARGC1A,gene/protein,Alzheimer disease,PKA inhibitor H89,drug/chemical compound,decreases_expression of,1385,CREB1,gene/protein,Alzheimer disease,APPswe M17 cell,tissue/cell line,affects_activity of,,PKA/CREB pathway,process,Alzheimer disease,PKA/CREB pathway,process,affects_expression of,10891,PPARGC1A,gene/protein,Alzheimer disease,Protein kinase A,complex/PPI,affects_activity of,,PKA/CREB pathway,process,Alzheimer disease1385,CREB1,gene/protein,affects_activity of,,PKA/CREB pathway,process,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,1385,CREB1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,1385,CREB1-phos,protein modification,Alzheimer disease104300,Alzheimer disease,disease,decreases_activity of,,Protein kinase A,complex/PPI,Alzheimer disease,Protein kinase A,complex/PPI,affects_phosphorylation of,4137,MAPT-hyperphos,protein modification,Alzheimer disease10891,PPARGC1A,gene/protein,affects_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2309,FOXO3,gene/protein,Alzheimer disease,increased FOXO3 level,phenotype,cooccurs with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseasers1800896,IL10 rs1800896,SNP,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease1956,EGFR,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease1271,CNTFR,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease2891,GRIA2,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease1499,CTNNB1,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease348,APOE-mut,gene/protein mutant,affects_expression of,1956,EGFR,gene/protein,Alzheimer disease51157,ZNF580,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease63943,FKBPL,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease3956,LGALS1,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease5705,PSMC5,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease348,APOE-mut,gene/protein mutant,affects_expression of,1271,CNTFR,gene/protein,Alzheimer disease348,APOE-mut,gene/protein mutant,affects_expression of,839,CASP6,gene/protein,Alzheimer disease348,APOE-mut,gene/protein mutant,affects_expression of,2891,GRIA2,gene/protein,Alzheimer disease348,APOE-mut,gene/protein mutant,affects_expression of,1499,CTNNB1,gene/protein,Alzheimer disease348,APOE-mut,gene/protein mutant,affects_expression of,63943,FKBPL,gene/protein,Alzheimer disease348,APOE-mut,gene/protein mutant,affects_expression of,3956,LGALS1,gene/protein,Alzheimer disease348,APOE-mut,gene/protein mutant,affects_expression of,5705,PSMC5,gene/protein,Alzheimer disease348,APOE-mut,gene/protein mutant,affects_expression of,51157,ZNF580,gene/protein,Alzheimer disease348,APOE-mut,gene/protein mutant,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease27429,HTRA2,gene/protein,interacts (colocalizes) with,351,APP,gene/protein,Alzheimer disease27429,HTRA2,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer disease27429,HTRA2,gene/protein,interacts (colocalizes) with,GO:0005789,endoplasmic reticulum membrane,cellular component,Alzheimer disease351,APP,gene/protein,interacts (colocalizes) with,79139,DERL1,gene/protein,Alzheimer disease351,APP,gene/protein,interacts (colocalizes) with,,SEC23,gene/protein,Alzheimer disease27429,HTRA2,gene/protein,affects_activity of,GO:0042982,amyloid precursor protein metabolic process,process,Alzheimer disease5743,PTGS2,gene/protein,affects_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease5743,PTGS2,gene/protein,affects_activity of,GO:0048169,regulation of long-term neuronal synaptic plasticity,process,Alzheimer disease351,Amyloid beta peptide,gene/protein,affects_activity of,GO:0048169,regulation of long-term neuronal synaptic plasticity,process,Alzheimer disease,MF tricyclic,drug/chemical compound,decreases_activity of,5743,PTGS2,gene/protein,Alzheimer disease,COX-2 inhibitor NS398,drug/chemical compound,decreases_activity of,5743,PTGS2,gene/protein,Alzheimer disease,MF tricyclic,drug/chemical compound,affects_activity of,GO:0048169,regulation of long-term neuronal synaptic plasticity,process,Alzheimer disease,PTGS2 inhibitor NS398,drug/chemical compound,affects_activity of,GO:0048169,regulation of long-term neuronal synaptic plasticity,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_activity of,5743,PTGS2,gene/protein,Alzheimer diseaseC01517,Naproxen,drug/chemical compound,decreases_activity of,5743,PTGS2,gene/protein,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,increases_activity of,GO:0007613,memory,process,Alzheimer diseaseC01517,Naproxen,drug/chemical compound,increases_activity of,GO:0007613,memory,process,Alzheimer disease,PTGS2 inhibitor MF tricyclic,drug/chemical compound,increases_activity of,GO:0007613,memory,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,affects_activity of,GO:0048169,regulation of long-term neuronal synaptic plasticity,process,Alzheimer diseaseC01517,Naproxen,drug/chemical compound,affects_activity of,GO:0048169,regulation of long-term neuronal synaptic plasticity,process,Alzheimer diseaseC00584,Prostaglandin E2,drug/chemical compound,affects_activity of,GO:0007613,memory,process,Alzheimer diseaseGO:0006950,response to stress,process,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0048167,regulation of synaptic plasticity,process,Alzheimer diseaseGO:0006950,response to stress,process,affects_activity of,GO:0048167,regulation of synaptic plasticity,process,Alzheimer diseaseGO:0006950,response to stress,process,affects_activity of,GO:0022008,neurogenesis,process,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0022008,neurogenesis,process,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0060291,long-term synaptic potentiation,process,Alzheimer diseaseGO:0006950,response to stress,process,affects_activity of,GO:0060291,long-term synaptic potentiation,process,Alzheimer diseaseGO:0006950,response to stress,process,increases_activity of,,cognitive impairment,phenotype,Alzheimer diseaseGO:0006950,response to stress,process,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,12/15-Lipoxygenase,gene/protein,affects_expression of,23621,BACE1,gene/protein,Alzheimer disease6667,SP1,gene/protein,affects_expression of,23621,BACE1,gene/protein,Alzheimer disease,12/15-Lipoxygenase,gene/protein,increases_activity of,6667,SP1,gene/protein,Alzheimer disease23621,BACE1,gene/protein,affects_activity of,,cognitive impairment,phenotype,Alzheimer disease,mild cognitive impairment,phenotype,decreases_expression of,23411,SIRT1,gene/protein,Alzheimer disease,12/15-Lipoxygenase,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer disease3553,IL1B,gene/protein,increases_expression of,6868,ADAM17,gene/protein,Alzheimer disease3553,IL1B,gene/protein,increases_quantity of,6868,ADAM17 (proform),gene/protein,Alzheimer disease3553,IL1B,gene/protein,increases_quantity of,6868,ADAM17 (mature),gene/protein,Alzheimer disease,TAPI-2,drug/chemical compound,decreases_activity of,6868,ADAM17,gene/protein,Alzheimer disease,TAPI-2,drug/chemical compound,affects_quantity of,351,sAPP-beta,gene/protein,Alzheimer disease,TAPI-2,drug/chemical compound,affects_quantity of,351,sAPP-alpha,gene/protein,Alzheimer disease3557,IL1RN,gene/protein,affects_activity of,3554,IL1R1,gene/protein,Alzheimer disease3557,IL1RN,gene/protein,affects_activity of,3553,IL1B,gene/protein,Alzheimer disease,Thiamet-G,drug/chemical compound,increases_quantity of,,GlcNAc,drug/chemical compound,Alzheimer disease,Thiamet-G,drug/chemical compound,decreases_phosphorylation of,4137,MAPT,gene/protein,Alzheimer disease,Thiamet-G,drug/chemical compound,decreases_activity of,10724,MGEA5,gene/protein,Alzheimer disease10724,MGEA5,gene/protein,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC10443,Curcumin,drug/chemical compound,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer diseaseC10443,Curcumin,drug/chemical compound,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseC10443,Curcumin,drug/chemical compound,affects_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer disease,GSPE,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,GSPE,drug/chemical compound,decreases_quantity of,351,"Amyloid beta peptide (oligomer, soluble)",gene/protein,Alzheimer disease,GSPE,drug/chemical compound,decreases_activity of,GO:0051259,protein oligomerization,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,GO:0051259,protein oligomerization,process,Alzheimer disease351,Amyloid beta peptide (40),gene/protein,increases_activity of,GO:0051259,protein oligomerization,process,Alzheimer disease351,Amyloid beta peptide (40),gene/protein,increases_quantity of,351,Amyloid beta peptide (oligomer),gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_quantity of,351,Amyloid beta peptide (oligomer),gene/protein,Alzheimer diseaseGO:0006914,autophagy,process,increases_processing of,351,APP,gene/protein,Alzheimer diseaseGO:0006914,autophagy,process,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseGO:0005764,lysosome,cellular component,increases_processing of,351,Amyloid beta peptide,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,GO:0005776,autophagic vacuole,cellular component,Alzheimer disease143,APP-FE65-LRP complex,complex/PPI,affects_processing of,351,APP,gene/protein,Alzheimer disease143,APP-FE65-LRP complex,complex/PPI,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease4035,LRP1,gene/protein,interacts (colocalizes) with,322,APBB1,gene/protein,Alzheimer disease6714,SRC,gene/protein,increases_phosphorylation of,4035,LRP1,gene/protein,Alzheimer disease6714,SRC,gene/protein,increases_activity of,4035,LRP1,gene/protein,Alzheimer disease351,APP,gene/protein,is_part_of,143,APP-FE65-LRP complex,complex/PPI,Alzheimer disease322,APBB1,gene/protein,is_part_of,143,APP-FE65-LRP complex,complex/PPI,Alzheimer disease4035,LRP1,gene/protein,is_part_of,143,APP-FE65-LRP complex,complex/PPI,Alzheimer disease351,APP,gene/protein,interacts (colocalizes) with,322,APBB1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_activity of,GO:0030431,sleep,process,Alzheimer diseaseGO:0030431,sleep,process,affects_quantity of,7124,TNF,gene/protein,Alzheimer disease,anosognosia,phenotype,cooccurs with,,agitation,phenotype,Alzheimer diseaseD07913,Escitalopram,drug/chemical compound,decreases_activity of,,agitation,phenotype,Alzheimer diseaseD00426,Risperidone,drug/chemical compound,decreases_activity of,,agitation,phenotype,Alzheimer disease,anosognosia,phenotype,cooccurs with,,aberrant motor behavior,phenotype,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,BTO:0001408,locus ceruleus,tissue/cell line,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,C00547,Noradrenaline,drug/chemical compound,Alzheimer disease,DSP4,drug/chemical compound,affects_quantity of,BTO:0001408,locus ceruleus,tissue/cell line,Alzheimer diseaseC00547,Noradrenaline,drug/chemical compound,affects_expression of,153,ADRB1,gene/protein,Alzheimer diseaseGO:0007568,aging,process,affects_expression of,153,ADRB1,gene/protein,Alzheimer diseaseGO:0007568,aging,process,affects_expression of,146,ADRA1D,gene/protein,Alzheimer disease351,APP,gene/protein,affects_expression of,146,ADRA1D,gene/protein,Alzheimer disease,DSP4,drug/chemical compound,increases_expression of,6347,CCL2,gene/protein,Alzheimer disease,APP/PS1 mouse,organism model,increases_expression of,6347,CCL2,gene/protein,Alzheimer disease,DSP4,drug/chemical compound,increases_expression of,3553,IL1B,gene/protein,Alzheimer disease,APP/PS1 mouse,organism model,increases_expression of,3553,IL1B,gene/protein,Alzheimer disease,APP/PS1 mouse,organism model,increases_expression of,3552,IL1A,gene/protein,Alzheimer disease,APP/PS1 mouse,organism model,increases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseC00070,Cu2+,drug/chemical compound,affects_activity of,,Mitochondrial respiratory chain complex IV,complex/PPI,Alzheimer disease2,A2M-n.88G/25G,gene/protein mutant,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease2,A2M-n.88A/25T,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease2,A2M-2,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease2,A2M,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseGO:0007568,aging,process,affects_activity of,2,A2M-2,gene/protein mutant,Alzheimer disease2,A2M,gene/protein,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC00038,Zn2+,drug/chemical compound,affects_folding of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC00070,Cu2+,drug/chemical compound,affects_folding of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,increased Zn2+ level,phenotype,cooccurs with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,Al3+,drug/chemical compound,affects_folding of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC14819,Fe3+,drug/chemical compound,affects_folding of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,increased Cu2+ level,phenotype,cooccurs with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,increased Fe3+ level,phenotype,cooccurs with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,increased Al3+ level,phenotype,cooccurs with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease3290,HSD11B1-mut,gene/protein mutant,affects_activity of,,cognitive impairment,phenotype,Alzheimer diseasers846911,HSD11B1 rs846911,SNP,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseasers846911,HSD11B1 rs846911,SNP,affects_activity of,,cognitive impairment,phenotype,Alzheimer diseasers846910,HSD11B1 rs846910,SNP,affects_activity of,,cognitive impairment,phenotype,Alzheimer diseasers12086634,HSD11B1 rs12086634,SNP,affects_activity of,,cognitive impairment,phenotype,Alzheimer diseasers846911,HSD11B1 rs846911,SNP,decreases_expression of,3290,HSD11B1,gene/protein,Alzheimer disease,Glucocorticoid,drug/chemical compound,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseGO:0034650,cortisol metabolic process,process,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease,increased cortisol level,phenotype,affects_activity of,GO:0007611,learning or memory,process,Alzheimer disease,increased cortisol level,phenotype,affects_activity of,GO:0008542,visual learning,process,Alzheimer diseaseC00735,Cortisol,drug/chemical compound,is_part_of,,Glucocorticoid,drug/chemical compound,Alzheimer disease351,Amyloid beta peptide (3pE-42),protein modification,interacts (colocalizes) with,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease351,Amyloid beta peptide (3pE-42),protein modification,increases_quantity of,351,Amyloid beta peptide (LNO),gene/protein,Alzheimer disease351,Amyloid beta peptide (LNO),gene/protein,is_part_of,351,Amyloid beta peptide (oligomer),gene/protein,Alzheimer disease351,Amyloid beta peptide (3pE-42),protein modification,is_part_of,351,Amyloid beta peptide (LNO),gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,is_part_of,351,Amyloid beta peptide (LNO),gene/protein,Alzheimer disease351,Amyloid beta peptide (LNO),gene/protein,increases_activity of,GO:0070997,neuron death,process,Alzheimer disease351,APP,gene/protein,interacts (colocalizes) with,C00187,Cholesterol,drug/chemical compound,Alzheimer disease5663,PSEN1 (TM9),gene/protein,affects_activity of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease5663,PSEN1 (TM9),gene/protein,interacts (colocalizes) with,5663,PSEN1 (TM6),gene/protein,Alzheimer disease5663,PSEN1-p.I437C,gene/protein mutant,affects_processing of,351,APP,gene/protein,Alzheimer disease5663,PSEN1-p.P433C,gene/protein mutant,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease5663,PSEN1-p.G442C,gene/protein mutant,affects_processing of,351,APP,gene/protein,Alzheimer disease5663,PSEN1-p.P433C,gene/protein mutant,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease5663,PSEN1-p.A434C,gene/protein mutant,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease5663,PSEN1-p.A434C,gene/protein mutant,increases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease5663,PSEN1-p.P436C,gene/protein mutant,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease5663,PSEN1-p.P436C,gene/protein mutant,increases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease5663,PSEN1-p.I439C,gene/protein mutant,increases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease5663,PSEN1-p.F441C,gene/protein mutant,increases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease5663,PSEN1-p.F441C,gene/protein mutant,affects_processing of,351,APP,gene/protein,Alzheimer disease5663,PSEN1-p.P433C,gene/protein mutant,affects_processing of,351,APP,gene/protein,Alzheimer disease5663,PSEN1-p.G442C,gene/protein mutant,affects_processing of,4851,NOTCH1,gene/protein,Alzheimer disease5663,PSEN1-p.P433C,gene/protein mutant,affects_processing of,4851,NOTCH1,gene/protein,Alzheimer disease5663,PSEN1-p.F441C,gene/protein mutant,affects_processing of,4851,NOTCH1,gene/protein,Alzheimer disease5663,PSEN1-p.P436C,gene/protein mutant,affects_processing of,4851,NOTCH1,gene/protein,Alzheimer disease5663,PSEN1-p.I437C,gene/protein mutant,affects_processing of,4851,NOTCH1,gene/protein,Alzheimer disease5663,PSEN1 (TM9),gene/protein,affects_processing of,4851,NOTCH1,gene/protein,Alzheimer disease5663,PSEN1 (TM9),gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer disease5663,PSEN1 (TM9),gene/protein,affects_activity of,5663,PSEN1,gene/protein,Alzheimer disease7124,TNF-mut,gene/protein mutant,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease7040,TGFB1-mut,gene/protein mutant,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease3586,IL10-mut,gene/protein mutant,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease3569,IL6-mut,gene/protein mutant,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease3458,IFNG-mut,gene/protein mutant,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseMIMAT0000422,mir-124,ncRNA/miRNA,affects_expression of,23621,BACE1,gene/protein,Alzheimer disease4738,NEDD8,gene/protein,affects_activity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,interacts (colocalizes) with,322,APBB1,gene/protein,Alzheimer disease4738,NEDD8,gene/protein,affects_activity of,,AICD-FE65-TIP60 complex,complex/PPI,Alzheimer disease4738,NEDD8,gene/protein,affects_activity of,GO:0006461,protein complex assembly,process,Alzheimer disease466,Gamma-secretase complex,complex/PPI,increases_quantity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,is_part_of,351,APP,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,is_part_of,,AICD-FE65-TIP60 complex,complex/PPI,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,affects_activity of,GO:0009299,mRNA transcription,process,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,is localized in,GO:0005634,nucleus,cellular component,Alzheimer disease,Alpha-secretase,gene/protein,affects_activity of,GO:0030162,regulation of proteolysis,process,Alzheimer disease23621,BACE1,gene/protein,affects_activity of,GO:0030162,regulation of proteolysis,process,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_activity of,GO:0030162,regulation of proteolysis,process,Alzheimer diseaseGO:0006509,membrane protein ectodomain proteolysis,process,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseGO:0006509,membrane protein ectodomain proteolysis,process,affects_activity of,GO:0030162,regulation of proteolysis,process,Alzheimer diseaseGO:0031293,membrane protein intracellular domain proteolysis,process,affects_activity of,GO:0030162,regulation of proteolysis,process,Alzheimer disease466,Gamma-secretase complex,complex/PPI,affects_activity of,GO:0031293,membrane protein intracellular domain proteolysis,process,Alzheimer disease,Alpha-secretase,gene/protein,affects_activity of,GO:0006509,membrane protein ectodomain proteolysis,process,Alzheimer disease23621,BACE1,gene/protein,affects_activity of,GO:0006509,membrane protein ectodomain proteolysis,process,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease351,APP-p.Y682G,gene/protein mutant,interacts (colocalizes) with,322,APBB1,gene/protein,Alzheimer disease351,APP-p.Y682G,gene/protein mutant,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease351,APP-p.Y682G,gene/protein mutant,increases_quantity of,351,sAPP-alpha,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,interacts (colocalizes) with,5300,PIN1,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,interacts (colocalizes) with,320,APBA1,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,interacts (colocalizes) with,1600,DAB1,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,interacts (colocalizes) with,6464,SHC1,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,interacts (colocalizes) with,9479,MAPK8IP1,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,interacts (colocalizes) with,323,APBB2,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,interacts (colocalizes) with,10307,APBB3,gene/protein,Alzheimer disease5649,RELN,gene/protein,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseGO:0034205,beta-amyloid formation,process,affects_quantity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease25,ABL1,gene/protein,increases_phosphorylation of,322,APBB1,gene/protein,Alzheimer disease322,APBB1-phosTyr547,protein modification,affects_activity of,GO:0009299,mRNA transcription,process,Alzheimer disease,AICD-FE65 complex,complex/PPI,affects_expression of,351,APP,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,interacts (colocalizes) with,4311,MME (promoter),gene/protein,Alzheimer disease322,APBB1,gene/protein,interacts (colocalizes) with,10524,KAT5,gene/protein,Alzheimer disease,AICD-FE65 complex,complex/PPI,is_part_of,,AICD-FE65-TIP60 complex,complex/PPI,Alzheimer disease10524,KAT5,gene/protein,is_part_of,,AICD-FE65-TIP60 complex,complex/PPI,Alzheimer disease322,APBB1,gene/protein,is_part_of,,AICD-FE65-TIP60 complex,complex/PPI,Alzheimer disease322,APBB1,gene/protein,increases_activity of,GO:0006302,double-strand break repair,process,Alzheimer disease322,APBB1,gene/protein,is localized in,BTO:000014,brain,tissue/cell line,Alzheimer disease322,APBB1,gene/protein,affects_activity of,GO:0043967,histone H4 acetylation,process,Alzheimer disease322,APBB1,gene/protein,affects_activity of,GO:0006302,double-strand break repair,process,Alzheimer disease322,APBB1,gene/protein,is localized in,GO:0005634,nucleus,cellular component,Alzheimer disease322,APBB1,gene/protein,interacts (colocalizes) with,GO:0000785,chromatin,cellular component,Alzheimer disease9479,MAPK8IP1,gene/protein,affects_activity of,351,APP,gene/protein,Alzheimer disease322,APBB1,gene/protein,affects_activity of,351,APP,gene/protein,Alzheimer disease320,APBA1,gene/protein,affects_activity of,351,APP,gene/protein,Alzheimer disease10524,KAT5,gene/protein,affects_activity of,351,APP,gene/protein,Alzheimer disease10524,KAT5,gene/protein,interacts (colocalizes) with,GO:0000785,chromatin,cellular component,Alzheimer disease351,APP,gene/protein,affects_quantity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease,AICD-FE65 complex,complex/PPI,is localized in,GO:0005634,nucleus,cellular component,Alzheimer disease,AICD-FE65 complex,complex/PPI,interacts (colocalizes) with,10524,KAT5,gene/protein,Alzheimer disease9479,MAPK8IP1,gene/protein,affects transport of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease9479,MAPK8IP1,gene/protein,interacts (colocalizes) with,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease,AICD-JIP1B complex,complex/PPI,interacts (colocalizes) with,10524,KAT5,gene/protein,Alzheimer disease,AICD-JIP1B complex,complex/PPI,affects_quantity of,,AICD-JIP1B-TIP60  complex,complex/PPI,Alzheimer disease,AICD-FE65 complex,complex/PPI,affects_quantity of,,AICD-FE65-TIP60 complex,complex/PPI,Alzheimer disease320,APBA1,gene/protein,interacts (colocalizes) with,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,affects_expression of,351,APP,gene/protein,Alzheimer disease,APP (cytotoxic frag C31),gene/protein,is_part_of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease,APP (intracellular domain AICD),gene/protein,is_part_of,351,APP (membrane-attached frag C99),gene/protein,Alzheimer disease3416,IDE,gene/protein,decreases_activity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease3416,IDE,gene/protein,decreases_quantity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer diseaseGO:0007568,aging,process,decreases_quantity of,3416,IDE,gene/protein,Alzheimer diseaseGO:0007568,aging,process,increases_activity of,23621,BACE1,gene/protein,Alzheimer disease320,APBA1,gene/protein,decreases_activity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease321,APBA2,gene/protein,decreases_activity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease9546,APBA3,gene/protein,affects_activity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,3732,CD82,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,2932,GSK3B,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,351,APP,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,23621,BACE1,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,10524,KAT5,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,4311,MME,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,5727,PTCH1,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,7157,TP53,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,6876,TAGLN,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,3486,IGFBP3,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,6280,S100A9,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,358,AQP1,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,57084,SLC17A6,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,891,CCNB1,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,595,CCND1,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,decreases_expression of,1956,EGFR,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,decreases_expression of,4035,LRP1,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,decreases_expression of,1191,CLU,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,1649,DDIT3,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_expression of,59,ACTA2,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,affects_expression of,3486,IGFBP3,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,affects_expression of,6876,TAGLN,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,affects_expression of,59,ACTA2,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,affects_expression of,2335,FN1,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,affects_expression of,5865,RAB3B,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,affects_expression of,7168,TPM1,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,affects_expression of,8140,SLC7A5,gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,affects_expression of,9645,MICAL2,gene/protein,Alzheimer diseaseGO:0007568,aging,process,affects_quantity of,3416,IDE,gene/protein,Alzheimer diseaseGO:0007568,aging,process,decreases_quantity of,4311,MME,gene/protein,Alzheimer disease,exercise,environment,increases_activity of,GO:0007611,learning or memory,process,Alzheimer disease,exercise,environment,increases_activity of,4311,MME,gene/protein,Alzheimer disease,exercise,environment,decreases_activity of,GO:0007611,learning or memory,process,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,10344,CCL26,gene/protein,Alzheimer diseaseGO:0006954,inflammatory response,process,increases_quantity of,6347,CCL2,gene/protein,Alzheimer disease6347,CCL2,gene/protein,is localized in,BTO:0000237,cerebrospinal fluid,tissue/cell line,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,6347,CCL2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,358,AQP1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,361,AQP4,gene/protein,Alzheimer disease358,AQP1,gene/protein,interacts (colocalizes) with,BTO:0000099,astrocyte,tissue/cell line,Alzheimer disease361,AQP4,gene/protein,affects_activity of,BTO:0000099,astrocyte,tissue/cell line,Alzheimer diseasers63750847,APP rs63750847,SNP,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseasers63750847,APP rs63750847,SNP,decreases_activity of,,cognitive impairment,phenotype,Alzheimer diseasers63750847,APP rs63750847,SNP,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseasers63750847,APP rs63750847,SNP,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease351,APP (cytotoxic frag C31),gene/protein,increases_activity of,GO:0006915,apoptotic process,process,Alzheimer disease8883,NAE1,gene/protein,interacts (colocalizes) with,,C31,gene/protein,Alzheimer disease8883,NAE1,gene/protein,increases_activity of,GO:0006915,apoptotic process,process,Alzheimer disease8883,NAE1,gene/protein,affects_activity of,GO:0071897,DNA biosynthetic process,process,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,8883,NAE1,gene/protein,Alzheimer disease8883,NAE1,gene/protein,increases_activity of,4738,NEDD8,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects transport of,8883,NAE1,gene/protein,Alzheimer disease,HPA-axis,process,affects_activity of,,cognitive impairment,phenotype,Alzheimer diseaseMP:0000807,abnormal hippocampus morphology,phenotype,cooccurs with,,cognitive impairment,phenotype,Alzheimer disease8883,NAE1,gene/protein,affects_activity of,GO:0000075,cell cycle checkpoint,process,Alzheimer disease8883,NAE1,gene/protein,increases_activity of,GO:0051402,neuron apoptotic process,process,Alzheimer disease8883,NAE1,gene/protein,interacts (colocalizes) with,351,APP,gene/protein,Alzheimer disease8883,NAE1,gene/protein,interacts (colocalizes) with,9039,UBA3,gene/protein,Alzheimer disease9039,UBA3,gene/protein,affects_activity of,GO:0000075,cell cycle checkpoint,process,Alzheimer disease9040,UBE2M,gene/protein,affects_activity of,GO:0000075,cell cycle checkpoint,process,Alzheimer disease839,CASP6,gene/protein,affects_activity of,GO:0000075,cell cycle checkpoint,process,Alzheimer disease,Caspase-6 inhibitor VEID,drug/chemical compound,decreases_activity of,8883,NAE1,gene/protein,Alzheimer disease,Boc-D-FMK,drug/chemical compound,decreases_activity of,8883,NAE1,gene/protein,Alzheimer disease,Caspase-6 inhibitor VEID,drug/chemical compound,decreases_activity of,GO:0051402,neuron apoptotic process,process,Alzheimer disease,Boc-D-FMK,drug/chemical compound,decreases_activity of,GO:0051402,neuron apoptotic process,process,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,7276,TTR,gene/protein,Alzheimer disease7276,TTR,gene/protein,interacts (colocalizes) with,351,Amyloid beta peptide,gene/protein,Alzheimer disease7276,TTR,gene/protein,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,APP23 mouse,organism model,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease7276,TTR,gene/protein,decreases_quantity of,351,Amyloid beta peptide (fibrillar),gene/protein,Alzheimer disease,APP23 mouse,organism model,increases_expression of,7276,TTR,gene/protein,Alzheimer disease4738,NEDD8,gene/protein,affects_activity of,GO:0045116,protein neddylation,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_quantity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease,Sulindac sulfide,drug/chemical compound,decreases_quantity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer diseaseC11143,Dimethyl sulfoxide,drug/chemical compound,decreases_quantity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease,NSAID,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,NSAID,drug/chemical compound,decreases_quantity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease,NSAID,drug/chemical compound,decreases_quantity of,2066,ERBB4 (C-terminal fragment),gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,decreases_activity of,GO:0007613,memory,process,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,decreases_activity of,GO:0022008,neurogenesis,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,increases_activity of,GO:0022008,neurogenesis,process,Alzheimer diseaseC01517,Naproxen,drug/chemical compound,affects_activity of,GO:0022008,neurogenesis,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_activity of,,neuroinflammation,phenotype,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,increases_activity of,GO:0008283,cell proliferation,process,Alzheimer diseaseC10126,Anatabine,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseC10126,Anatabine,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer diseaseC10126,Anatabine,drug/chemical compound,decreases_quantity of,351,sAPP-beta,gene/protein,Alzheimer diseaseC10126,Anatabine,drug/chemical compound,affects_quantity of,351,sAPP-alpha,gene/protein,Alzheimer diseaseC10126,Anatabine,drug/chemical compound,decreases_activity of,4790,NFKB1,gene/protein,Alzheimer diseaseC10126,Anatabine,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease4790,NFKB1,gene/protein,affects_expression of,23621,BACE1,gene/protein,Alzheimer diseaseC10126,Anatabine,drug/chemical compound,decreases_expression of,23621,BACE1,gene/protein,Alzheimer disease4137,MAPT-phosThr231 (trans),protein modification,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease4137,MAPT-phosThr231 (cis),protein modification,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease5300,PIN1,gene/protein,increases_activity of,4137,MAPT-phosThr231 (cis),protein modification,Alzheimer disease5300,PIN1,gene/protein,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease5300,PIN1,gene/protein,decreases_quantity of,4137,MAPT-phosThr231 (cis),protein modification,Alzheimer disease5300,PIN1,gene/protein,increases_quantity of,4137,MAPT-phosThr231 (trans),protein modification,Alzheimer disease100379571,BACE1-AS,gene/protein,affects_expression of,23621,BACE1,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_expression of,100379571,BACE1-AS,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,100379571,BACE1-AS,gene/protein,Alzheimer diseaseD09918,Dimebolin,phenotype,increases_activity of,GO:0007613,memory,process,Alzheimer diseaseD07869,Donepezil,drug/chemical compound,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease,Huperzine A,drug/chemical compound,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,4843,NOS2,gene/protein,Alzheimer disease,Sin-1,drug/chemical compound,decreases_activity of,3416,IDE,gene/protein,Alzheimer disease,APP/PS1 mouse,organism model,decreases_activity of,3416,IDE,gene/protein,Alzheimer disease,Sin-1,drug/chemical compound,affects_activity of,4311,MME,gene/protein,Alzheimer disease,APP/PS1/NOS2(-/-) mouse,organism model,decreases_activity of,3416,IDE,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0001505,regulation of neurotransmitter levels,process,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,3358,HTR2C,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,BTO:0000914,natural killer cell,tissue/cell line,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,3350,HTR1A,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,3356,HTR2A,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,3357,HTR2B,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2023,ENO1,gene/protein,Alzheimer disease,mild cognitive impairment,phenotype,decreases_expression of,1821,DRP2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2670,GFAP,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,7170,TPM3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,5434,POLR2E,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,3320,HSP90AA1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2026,ENO2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,5434,POLR2E,gene/protein,Alzheimer disease,mild cognitive impairment,phenotype,decreases_expression of,3309,HSPA5,gene/protein,Alzheimer disease,mild cognitive impairment,phenotype,increases_expression of,5510,PPP1R7,gene/protein,Alzheimer disease,mild cognitive impairment,phenotype,increases_expression of,2670,GFAP,gene/protein,Alzheimer disease,mild cognitive impairment,phenotype,decreases_expression of,6620,SNCB,gene/protein,Alzheimer disease,Concanavalin-A,drug/chemical compound,interacts (colocalizes) with,1821,DRP2,gene/protein,Alzheimer disease,Concanavalin-A,drug/chemical compound,interacts (colocalizes) with,2746,GLUD1,gene/protein,Alzheimer disease,mild cognitive impairment,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease,Concanavalin-A,drug/chemical compound,interacts (colocalizes) with,3309,HSPA5,gene/protein,Alzheimer disease,Concanavalin-A,drug/chemical compound,interacts (colocalizes) with,5510,PPP1R7,gene/protein,Alzheimer disease,Concanavalin-A,drug/chemical compound,interacts (colocalizes) with,2670,GFAP,gene/protein,Alzheimer disease,Concanavalin-A,drug/chemical compound,interacts (colocalizes) with,6620,SNCB,gene/protein,Alzheimer disease,Concanavalin-A,drug/chemical compound,interacts (colocalizes) with,3320,HSP90AA1,gene/protein,Alzheimer disease,Concanavalin-A,drug/chemical compound,interacts (colocalizes) with,7170,TPM3,gene/protein,Alzheimer disease,Concanavalin-A,drug/chemical compound,interacts (colocalizes) with,5434,POLR2E,gene/protein,Alzheimer disease,Concanavalin-A,drug/chemical compound,interacts (colocalizes) with,2023,ENO1,gene/protein,Alzheimer disease,Concanavalin-A,drug/chemical compound,interacts (colocalizes) with,2026,ENO2,gene/protein,Alzheimer disease,Concanavalin-A,drug/chemical compound,interacts (colocalizes) with,,N-linked glycoprotein,drug/chemical compound,Alzheimer disease,Concanavalin-A,drug/chemical compound,interacts (colocalizes) with,,Non-glycoprotein (hydrophobic sites),drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,5539,PPY,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,3485,IGFBP2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,567,B2M,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,7412,VCAM1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,,Carcinoembryonic antigen,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,,Matrix metalloprotein 2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,,Macrophage inflammatory protein 1-alpha,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,958,CD40,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,6348,CCL3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,,Superoxide dismutase,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C05330,Homocysteine,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,348,APOE,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,1956,EGFR,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,,Hemoglobin,complex/PPI,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,C00076,Ca2+,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,C00038,Zn2+,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,3605,IL17A,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,213,ALB,gene/protein,Alzheimer diseaseMP:0001263,weight loss,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,BTO:0000614,hypothalamus,tissue/cell line,Alzheimer diseaseBTO:0000614,hypothalamus,tissue/cell line,affects_activity of,GO:2000505,regulation of energy homeostasis,process,Alzheimer diseaseMP:0006087,increased body mass index,phenotype,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,Insulin resistance,disease,affects_activity of,MP:0008428,abnormal spatial working memory,phenotype,Alzheimer disease,calorie restriction,environment,decreases_activity of,GO:0008340,determination of adult lifespan,process,Alzheimer disease,Diabetes mellitus,disease,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,high-fat/glucose diet,environment,increases_activity of,,Insulin resistance,disease,Alzheimer disease,Insulin resistance,disease,increases_activity of,,reduced hippocampal dendritic spine density,phenotype,Alzheimer disease,Insulin resistance,disease,increases_activity of,,reduced long-term potentiation,phenotype,Alzheimer disease,calorie restriction,environment,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseMP:0001559,hyperglycemia,phenotype,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseMP:0002078,abnormal glucose homeostasis,phenotype,increases_activity of,,cognitive impairment,phenotype,Alzheimer diseaseMP:0001559,hyperglycemia,phenotype,affects_activity of,,polyol pathway,process,Alzheimer diseaseMP:0001559,hyperglycemia,phenotype,affects_quantity of,,Advanced glycation end-product,drug/chemical compound,Alzheimer diseaseMP:0001559,hyperglycemia,phenotype,affects_activity of,,Protein kinase C,gene/protein,Alzheimer disease,increased glucose level,phenotype,increases_processing of,4137,MAPT,gene/protein,Alzheimer disease,increased glucose level,phenotype,increases_activity of,GO:0006915,apoptotic process,process,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,,Insulin receptor,complex/PPI,Alzheimer diseaseMP:0002079,increased circulating insulin level,phenotype,affects_quantity of,3416,IDE,gene/protein,Alzheimer disease125853,"Diabetes mellitus, type II",disease,cooccurs with,,increased MAPT-phos level,phenotype,Alzheimer disease222100,"Diabetes mellitus, type I",disease,cooccurs with,,increased MAPT-phos level,phenotype,Alzheimer disease5468,PPARG,gene/protein,affects_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease,PPARG agonist,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,PPARG agonist,drug/chemical compound,increases_activity of,GO:0007611,learning or memory,process,Alzheimer disease,PPARG agonist,drug/chemical compound,increases_activity of,,attention,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,increases_activity of,5468,PPARG,gene/protein,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_activity of,GO:0006954,inflammatory response,process,Alzheimer diseaseC01588,Ibuprofen,drug/chemical compound,decreases_activity of,,beta-amyloid pathology,phenotype,Alzheimer disease,PPARG agonist,drug/chemical compound,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,PPARG agonist,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease,PPARG agonist,drug/chemical compound,increases_activity of,GO:0032868,response to insulin,process,Alzheimer disease,PPARG agonist,drug/chemical compound,decreases_activity of,MP:0003367,increased glucocorticoid level,phenotype,Alzheimer disease5468,PPARG,gene/protein,increases_expression of,3416,IDE,gene/protein,Alzheimer disease5467,PPARD,gene/protein,affects_activity of,GO:0006629,lipid metabolic process,process,Alzheimer disease5467,PPARD,gene/protein,affects_activity of,GO:0006006,glucose metabolic process,process,Alzheimer disease5467,PPARD,gene/protein,is_expressed_in,BTO:0000142,brain,tissue/cell line,Alzheimer disease,GW742,drug/chemical compound,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseMP:0001262,decreased body weight,phenotype,cooccurs with,MP:0005668,decreased circulating leptin level,phenotype,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,,homeostasis between leptin and cortisol,process,Alzheimer diseaseMP:0005668,decreased circulating leptin level,phenotype,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease3953,LEPR,gene/protein,is_expressed_in,BTO:0000601,hippocampus,tissue/cell line,Alzheimer disease3952,LEP,gene/protein,decreases_activity of,23621,BACE1,gene/protein,Alzheimer disease3952,LEP,gene/protein,affects_activity of,348,APOE,gene/protein,Alzheimer disease3952,LEP,gene/protein,increases_activity of,GO:0007611,learning or memory,process,Alzheimer disease3952,LEP,gene/protein,decreases_phosphorylation of,4137,MAPT-phos,protein modification,Alzheimer disease3952,LEP,gene/protein,decreases_activity of,2932,GSK3B,gene/protein,Alzheimer disease3952,LEP,gene/protein,increases_activity of,GO:0060291,long-term synaptic potentiation,process,Alzheimer disease51738,Ghrelin,gene/protein,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease51738,Ghrelin,gene/protein,increases_activity of,GO:0060996,dendritic spine development,process,Alzheimer disease51738,Ghrelin,gene/protein,increases_activity of,GO:0060291,long-term synaptic potentiation,process,Alzheimer disease51738,Ghrelin,gene/protein,affects_activity of,GO:0007611,learning or memory,process,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,MP:0011611,abnormal circulating ghrelin level,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,MP:0004892,increased adiponectin level,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,MP:0008596,increased circulating interleukin-6 level,phenotype,Alzheimer disease9370,ADIPOQ,gene/protein,decreases_activity of,GO:0072604,interleukin-6 secretion,process,Alzheimer disease2641,GCG,gene/protein,affects_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC15894,Exendin-4,drug/chemical compound,affects_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease2641,GLP1,gene/protein,decreases_activity of,,oxidative insult,phenotype,Alzheimer diseaseC15894,Exendin-4,drug/chemical compound,decreases_activity of,,oxidative insult,phenotype,Alzheimer disease2641,GLP1,gene/protein,decreases_quantity of,351,APP,gene/protein,Alzheimer diseaseBTO:0000099,astrocyte,tissue/cell line,affects_activity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer diseaseBTO:0000099,astrocyte,tissue/cell line,affects_activity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseGO:0043157,response to cation stress,process,affects_activity of,GO:0006950,response to stress,process,Alzheimer disease,GLP1R agonist,drug/chemical compound,decreases_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,GLP1R agonist,drug/chemical compound,increases_activity of,GO:0043526,neuroprotection,process,Alzheimer disease,GLP1R agonist,drug/chemical compound,decreases_activity of,GO:0051402,neuron apoptotic process,process,Alzheimer disease,GLP1R agonist,drug/chemical compound,decreases_activity of,,cholinergic neuron atrophy,phenotype,Alzheimer disease1803,DPP4,gene/protein,increases_processing of,2641,GLP1,gene/protein,Alzheimer disease1803,DPP4,gene/protein,decreases_activity of,2641,GLP1,gene/protein,Alzheimer disease2641,GLP1,gene/protein,is_part_of,2641,GCG,gene/protein,Alzheimer diseaseD08516,Sitagliptin,drug/chemical compound,decreases_activity of,1803,DPP4,gene/protein,Alzheimer diseaseD08516,Sitagliptin,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD08516,Sitagliptin,drug/chemical compound,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,627,BDNF,gene/protein,Alzheimer disease627,BDNF,gene/protein,is_part_of,,Neutrophin,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,627,BDNF,gene/protein,Alzheimer disease6653,SORL1,gene/protein,affects transport of,351,APP,gene/protein,Alzheimer disease6653,SORL1,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer disease6653,SORL1,gene/protein,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease627,BDNF,gene/protein,increases_expression of,6653,SORL1,gene/protein,Alzheimer disease,APP/PS1 mouse,organism model,increases_activity of,GO:0001774,microglial cell activation,process,Alzheimer diseaseGO:0001774,microglial cell activation,process,increases_expression of,2018,IL12A-IL12B complex,complex/PPI,Alzheimer diseaseGO:0001774,microglial cell activation,process,increases_expression of,3593,IL12B,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,3593,IL12B,gene/protein,Alzheimer disease,APP/PS1 mouse,organism model,increases_expression of,,Proinflammatory cytokine,gene/protein,Alzheimer disease,APP/PS1 mouse,organism model,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseGO:0035722,interleukin-12-mediated signaling pathway,process,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseGO:0035722,interleukin-12-mediated signaling pathway,process,affects_activity of,,cognitive impairment,phenotype,Alzheimer diseaseGO:0038155,interleukin-23-mediated signaling pathway,process,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseGO:0038155,interleukin-23-mediated signaling pathway,process,affects_activity of,,cognitive impairment,phenotype,Alzheimer disease3565,IL4,gene/protein,affects_quantity of,,Cytokine,gene/protein,Alzheimer disease3565,IL4,gene/protein,affects_quantity of,,Chemokine,gene/protein,Alzheimer disease3586,IL10,gene/protein,affects_quantity of,,Cytokine,gene/protein,Alzheimer disease3586,IL10,gene/protein,affects_quantity of,,Chemokine,gene/protein,Alzheimer disease3596,IL13,gene/protein,affects_quantity of,,Cytokine,gene/protein,Alzheimer disease3596,IL13,gene/protein,affects_quantity of,,Chemokine,gene/protein,Alzheimer disease3586,IL10,gene/protein,decreases_quantity of,3552,IL1A,gene/protein,Alzheimer disease3586,IL10,gene/protein,decreases_quantity of,3553,IL1B,gene/protein,Alzheimer disease3586,IL10,gene/protein,decreases_quantity of,3569,IL6,gene/protein,Alzheimer disease3586,IL10,gene/protein,decreases_quantity of,7124,TNF,gene/protein,Alzheimer disease3586,IL10,gene/protein,decreases_quantity of,6347,CCL2,gene/protein,Alzheimer disease3565,IL4,gene/protein,increases_activity of,GO:0035926,chemokine (C-C motif) ligand 2 secretion,process,Alzheimer disease3596,IL13,gene/protein,increases_activity of,GO:0035926,chemokine (C-C motif) ligand 2 secretion,process,Alzheimer disease3565,IL4,gene/protein,decreases_activity of,GO:0072604,interleukin-6 secretion,process,Alzheimer disease3596,IL13,gene/protein,decreases_activity of,GO:0072604,interleukin-6 secretion,process,Alzheimer disease3565,IL4,gene/protein,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease3586,IL10,gene/protein,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease3596,IL13,gene/protein,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,increases_quantity of,3552,IL1A,gene/protein,Alzheimer disease3565,IL4,gene/protein,decreases_quantity of,3569,IL6,gene/protein,Alzheimer disease3596,IL13,gene/protein,decreases_quantity of,3569,IL6,gene/protein,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,increases_quantity of,3553,IL1B,gene/protein,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,increases_quantity of,7124,TNF,gene/protein,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,increases_quantity of,3569,IL6,gene/protein,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,increases_quantity of,6347,CCL2,gene/protein,Alzheimer disease3553,IL1B,gene/protein,is_part_of,,Proinflammatory cytokine,gene/protein,Alzheimer disease7124,TNF,gene/protein,is_part_of,,Proinflammatory cytokine,gene/protein,Alzheimer disease3569,IL6,gene/protein,is_part_of,,Proinflammatory cytokine,gene/protein,Alzheimer disease3586,IL10,gene/protein,is_part_of,,Antiinflammatory cytokine,gene/protein,Alzheimer disease3596,IL13,gene/protein,is_part_of,,Antiinflammatory cytokine,gene/protein,Alzheimer disease3565,IL4,gene/protein,is_part_of,,Antiinflammatory cytokine,gene/protein,Alzheimer disease3565,IL4,gene/protein,increases_quantity of,6347,CCL2,gene/protein,Alzheimer disease3596,IL13,gene/protein,increases_quantity of,6347,CCL2,gene/protein,Alzheimer disease3565,IL4,gene/protein,increases_activity of,GO:0042116,macrophage activation,process,Alzheimer disease3586,IL10,gene/protein,increases_activity of,GO:0042116,macrophage activation,process,Alzheimer disease3596,IL13,gene/protein,increases_activity of,GO:0042116,macrophage activation,process,Alzheimer disease3565,IL4,gene/protein,increases_activity of,BTO:0000801,M2 macrophage,tissue/cell line,Alzheimer disease3586,IL10,gene/protein,increases_activity of,BTO:0000801,M2 macrophage,tissue/cell line,Alzheimer disease3596,IL13,gene/protein,increases_activity of,BTO:0000801,M2 macrophage,tissue/cell line,Alzheimer diseaseBTO:0000801,M1 macrophage,tissue/cell line,increases_quantity of,7124,TNF,gene/protein,Alzheimer diseaseBTO:0000801,M1 macrophage,tissue/cell line,increases_quantity of,,IL-12 p70,gene/protein,Alzheimer diseaseBTO:0000801,M2 macrophage,tissue/cell line,increases_quantity of,3586,IL10,gene/protein,Alzheimer diseaseBTO:0000801,M2 macrophage,tissue/cell line,increases_quantity of,3557,IL1RN,gene/protein,Alzheimer diseaseBTO:0000801,M2 macrophage,tissue/cell line,increases_quantity of,7850,IL1R2,gene/protein,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,interacts (colocalizes) with,351,Amyloid beta peptide (fibrillar),gene/protein,Alzheimer disease351,Amyloid beta peptide (fibrillar),gene/protein,interacts (colocalizes) with,948,CD36,gene/protein,Alzheimer disease351,Amyloid beta peptide (fibrillar),gene/protein,increases_activity of,GO:0007165,signal transduction,process,Alzheimer diseaseGO:0002224,toll-like receptor signaling pathway,process,affects_activity of,BTO:0000078,microglia,tissue/cell line,Alzheimer disease929,CD14,gene/protein,affects_activity of,BTO:0000078,microglia,tissue/cell line,Alzheimer disease351,Amyloid beta peptide (fibrillar),gene/protein,affects_activity of,BTO:0000078,microglia,tissue/cell line,Alzheimer disease7099,TLR4,gene/protein,affects_activity of,GO:0002224,toll-like receptor signaling pathway,process,Alzheimer disease7097,TLR2,gene/protein,affects_activity of,GO:0002224,toll-like receptor signaling pathway,process,Alzheimer diseaseGO:0002224,toll-like receptor signaling pathway,process,affects_activity of,GO:0001774,microglial cell activation,process,Alzheimer disease929,CD14,gene/protein,interacts (colocalizes) with,7099,TLR4,gene/protein,Alzheimer disease929,CD14,gene/protein,interacts (colocalizes) with,7097,TLR2,gene/protein,Alzheimer disease929,CD14,gene/protein,interacts (colocalizes) with,351,Amyloid beta peptide (fibrillar),gene/protein,Alzheimer disease351,Amyloid beta peptide (fibrillar),gene/protein,affects_activity of,GO:0001774,microglial cell activation,process,Alzheimer disease7099,TLR4,gene/protein,affects_activity of,,Src-Vav-Rac signaling cascade,process,Alzheimer disease7097,TLR2,gene/protein,affects_activity of,,Src-Vav-Rac signaling cascade,process,Alzheimer disease7099,TLR4,gene/protein,increases_activity of,,p38 MAPK,gene/protein,Alzheimer disease7097,TLR2,gene/protein,increases_activity of,,p38 MAPK,gene/protein,Alzheimer disease929,CD14,gene/protein,increases_activity of,,p38 MAPK,gene/protein,Alzheimer disease351,Amyloid beta peptide (fibrillar),gene/protein,increases_activity of,,p38 MAPK,gene/protein,Alzheimer disease929,CD14,gene/protein,is localized in,GO:0009986,cell surface,cellular component,Alzheimer disease7099,TLR4,gene/protein,is localized in,GO:0009986,cell surface,cellular component,Alzheimer disease7097,TLR2,gene/protein,is localized in,GO:0009986,cell surface,cellular component,Alzheimer disease929,CD14,gene/protein,affects_activity of,GO:0006909,phagocytosis,process,Alzheimer disease7099,TLR4,gene/protein,affects_activity of,GO:0006909,phagocytosis,process,Alzheimer disease7097,TLR2,gene/protein,affects_activity of,GO:0006909,phagocytosis,process,Alzheimer disease929,CD14,gene/protein,affects_activity of,GO:0001774,microglial cell activation,process,Alzheimer disease929,CD14,gene/protein,affects_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease7099,TLR4,gene/protein,affects_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease7097,TLR2,gene/protein,affects_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease,p38 MAPK,gene/protein,affects_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease,p38 MAPK,gene/protein,affects_activity of,GO:0006909,phagocytosis,process,Alzheimer disease177,AGER,gene/protein,interacts (colocalizes) with,351,Amyloid beta peptide,gene/protein,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,interacts (colocalizes) with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased AGER level,phenotype,Alzheimer disease,AGER-Abeta interaction,complex/PPI,increases_activity of,GO:0033554,cellular response to stress,process,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_expression of,7124,TNF,gene/protein,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_expression of,,Matrix metallopeptidase,gene/protein,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_expression of,4843,NOS2,gene/protein,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,decreases_activity of,GO:0007611,learning or memory,process,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_activity of,GO:0070997,neuron death,process,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased proinflammatory cytokine level,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,MP:0003009,abnormal cytokine secretion,phenotype,Alzheimer diseaseBTO:0001025,peripheral blood mononuclear cell,tissue/cell line,increases_quantity of,,Proinflammatory cytokine,gene/protein,Alzheimer diseaseBTO:0001025,peripheral blood mononuclear cell,tissue/cell line,increases_quantity of,,Chemokine,gene/protein,Alzheimer disease3553,IL1B,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease3553,IL1B,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease3553,IL1B,gene/protein,affects_activity of,,neuroinflammation,phenotype,Alzheimer disease3553,IL1B,gene/protein,affects_activity of,GO:0045321,leukocyte activation,process,Alzheimer diseaseGO:0006954,inflammatory response,process,affects_activity of,GO:0048143,astrocyte activation,process,Alzheimer diseaseGO:0006954,inflammatory response,process,affects_activity of,GO:0001774,microglial cell activation,process,Alzheimer disease177,AGER,gene/protein,is_part_of,,AGER-Abeta interaction,complex/PPI,Alzheimer disease3553,IL1B,gene/protein,increases_expression of,4843,NOS2,gene/protein,Alzheimer disease3553,IL1B,gene/protein,affects transport of,,nitric oxide metabolite,drug/chemical compound,Alzheimer diseaseC03722,Quinolinic acid,drug/chemical compound,affects_activity of,GO:0048143,astrocyte activation,process,Alzheimer diseaseC03722,Quinolinic acid,drug/chemical compound,affects_activity of,GO:0070997,neuron death,process,Alzheimer diseaseC03722,Quinolinic acid,drug/chemical compound,increases_expression of,3553,IL1B,gene/protein,Alzheimer diseaseC03722,Quinolinic acid,drug/chemical compound,affects_activity of,GO:0006954,inflammatory response,process,Alzheimer disease6285,S100B,gene/protein,is_part_of,,Cytokine,gene/protein,Alzheimer disease3553,IL1B,gene/protein,affects_quantity of,6285,S100B,gene/protein,Alzheimer diseaseGO:0048143,astrocyte activation,process,increases_quantity of,6285,S100B,gene/protein,Alzheimer diseasers1800587,IL1 rs1800587,SNP,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease3557,IL1RN,gene/protein,affects_quantity of,3553,IL1B,gene/protein,Alzheimer disease3557,IL1RN,gene/protein,affects_quantity of,3552,IL1A,gene/protein,Alzheimer disease3553,IL1B,gene/protein,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease3569,IL6,gene/protein,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer diseaseBTO:0002900,monocyte-derived dendritic cell,tissue/cell line,increases_quantity of,3569,IL6,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,decreased vitamin B12 level,phenotype,Alzheimer disease,decreased vitamin B12 level,phenotype,increases_quantity of,3569,IL6,gene/protein,Alzheimer disease3569,IL6 (promoter),gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease,high cholesterol diet,environment,increases_quantity of,3569,IL6,gene/protein,Alzheimer disease,high cholesterol diet,environment,increases_activity of,MP:0002183,gliosis,phenotype,Alzheimer disease,high cholesterol diet,environment,increases_activity of,GO:0048143,astrocyte activation,process,Alzheimer disease,high cholesterol diet,environment,increases_activity of,,neuroinflammation,phenotype,Alzheimer disease,high cholesterol diet,environment,increases_expression of,1728,NQO1,gene/protein,Alzheimer diseaseD08492,Rosuvastatin,drug/chemical compound,decreases_quantity of,BTO:0000078,microglia,tissue/cell line,Alzheimer diseaseD08492,Rosuvastatin,drug/chemical compound,decreases_quantity of,3569,IL6,gene/protein,Alzheimer disease3606,IL18,gene/protein,is_part_of,,Proinflammatory cytokine,gene/protein,Alzheimer disease834,CASP1,gene/protein,increases_processing of,3606,IL18,gene/protein,Alzheimer disease834,CASP1,gene/protein,increases_quantity of,3606,IL18 (active secreted form),gene/protein,Alzheimer disease8809,IL18R1,gene/protein,interacts (colocalizes) with,8807,IL18RAP,gene/protein,Alzheimer disease3606,IL18,gene/protein,interacts (colocalizes) with,8807,IL18RAP,gene/protein,Alzheimer disease3606,IL18,gene/protein,interacts (colocalizes) with,8809,IL18R1,gene/protein,Alzheimer disease3606,IL18,gene/protein,interacts (colocalizes) with,351,Amyloid beta peptide,gene/protein,Alzheimer disease3606,IL18,gene/protein,interacts (colocalizes) with,4137,MAPT,gene/protein,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,increases_quantity of,3606,IL18,gene/protein,Alzheimer diseaseBTO:0000099,astrocyte,tissue/cell line,increases_quantity of,3606,IL18,gene/protein,Alzheimer diseaseBTO:0002088,ependymoma cell,tissue/cell line,increases_quantity of,3606,IL18,gene/protein,Alzheimer diseaseBTO:0003686,medial habenular nucleus,tissue/cell line,increases_quantity of,3606,IL18,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased IL18 level,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased CASP1 level,phenotype,Alzheimer disease,gender,phenotype,affects_quantity of,3606,IL18,gene/protein,Alzheimer disease3606,IL18,gene/protein,affects_activity of,,cognitive impairment,phenotype,Alzheimer disease3458,IFNG,gene/protein,affects_quantity of,351,APP,gene/protein,Alzheimer disease3458,IFNG,gene/protein,decreases_activity of,GO:0042982,amyloid precursor protein metabolic process,process,Alzheimer disease3458,IFNG,gene/protein,affects_activity of,,oligodendrogenesis,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased TNF level,phenotype,Alzheimer disease7124,TNF (soluble),gene/protein,affects_activity of,,neuroinflammation,phenotype,Alzheimer disease7124,TNF (soluble),gene/protein,is_part_of,,Proinflammatory cytokine,gene/protein,Alzheimer disease6868,ADAM17,gene/protein,affects_quantity of,7124,TNF,gene/protein,Alzheimer disease7124,TNF (soluble),gene/protein,increases_activity of,7132,TNFRSF1A,gene/protein,Alzheimer disease7124,TNF (transmembrane),gene/protein,increases_activity of,7132,TNFRSF1A,gene/protein,Alzheimer disease7133,TNFRSF1B,gene/protein,is_expressed_in,BTO:0000078,microglia,tissue/cell line,Alzheimer disease7133,TNFRSF1B,gene/protein,is_expressed_in,BTO:0001176,endothelial cell,tissue/cell line,Alzheimer disease7124,TNF (transmembrane),gene/protein,increases_activity of,7133,TNFRSF1B,gene/protein,Alzheimer disease7132,TNFRSF1A,gene/protein,is_expressed_in,BTO:0000938,neuron,tissue/cell line,Alzheimer disease7133,TNFRSF1B,gene/protein,is_expressed_in,BTO:0000938,neuron,tissue/cell line,Alzheimer disease7132,TNFRSF1A,gene/protein,affects_activity of,GO:0070997,neuron death,process,Alzheimer disease7132,TNFRSF1A,gene/protein,affects_quantity of,23621,BACE1,gene/protein,Alzheimer disease7132,TNFRSF1A,gene/protein,affects_activity of,23621,BACE1 (promoter),gene/protein,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased TRAIL level,phenotype,Alzheimer disease8743,TNFSF10,gene/protein,increases_activity of,GO:0006915,apoptotic process,process,Alzheimer disease8743,TNFSF10,gene/protein,interacts (colocalizes) with,8795,TNFRSF10B,gene/protein,Alzheimer disease8795,TNFRSF10B,gene/protein,is_expressed_in,BTO:0000938,neuron,tissue/cell line,Alzheimer disease8795,TNFRSF10B,gene/protein,affects_activity of,GO:0031266,TRAIL death-inducing signaling complex,cellular component,Alzheimer disease146433,IL34,gene/protein,increases_quantity of,BTO:0000078,microglia,tissue/cell line,Alzheimer disease146433,IL34,gene/protein,decreases_quantity of,351,"Amyloid beta peptide (oligomer, soluble)",gene/protein,Alzheimer disease146433,IL34,gene/protein,increases_expression of,3416,IDE,gene/protein,Alzheimer disease146433,IL34,gene/protein,increases_expression of,3162,HMOX1,gene/protein,Alzheimer disease146433,IL34,gene/protein,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased TGFB2 level,phenotype,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_expression of,7042,TGFB2,gene/protein,Alzheimer disease7042,TGFB2,gene/protein,interacts (colocalizes) with,351,APP,gene/protein,Alzheimer disease7042,TGFB2,gene/protein,affects_quantity of,GO:0005764,lysosome,cellular component,Alzheimer disease7042,TGFB2,gene/protein,increases_activity of,MP:0005058,abnormal lysosome morphology,phenotype,Alzheimer disease7042,TGFB2,gene/protein,increases_activity of,GO:0070997,neuron death,process,Alzheimer disease7042,TGFB2,gene/protein,interacts (colocalizes) with,351,Amyloid beta peptide,gene/protein,Alzheimer disease6900,CNTN2,gene/protein,interacts (colocalizes) with,351,APP,gene/protein,Alzheimer disease6900,CNTN2,gene/protein,decreases_activity of,7042,TGFB2,gene/protein,Alzheimer disease7040,TGFB1,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,decreased TGFBR2 level,phenotype,Alzheimer diseaseBTO:0000938,neuron,tissue/cell line,increases_expression of,7048,TGFBR2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased TGFB1 level,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased SMAD7 level,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased CTNNB1 level,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,MP:0008836,abnormal transforming growth factor beta level,phenotype,Alzheimer disease7040,TGFB1,gene/protein,increases_activity of,MP:0000259,abnormal vascular development,phenotype,Alzheimer disease3565,IL4,gene/protein,increases_expression of,948,CD36,gene/protein,Alzheimer disease3596,IL13,gene/protein,increases_expression of,948,CD36,gene/protein,Alzheimer disease4311,MME,gene/protein,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease1889,ECE1,gene/protein,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease3565,IL4,gene/protein,increases_activity of,GO:0017038,protein import,process,Alzheimer disease3565,IL4,gene/protein,increases_expression of,4311,MME,gene/protein,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,increases_expression of,958,CD40,gene/protein,Alzheimer disease3565,IL4,gene/protein,increases_expression of,131450,CD200R1,gene/protein,Alzheimer disease3596,IL13,gene/protein,increases_expression of,131450,CD200R1,gene/protein,Alzheimer disease3565,IL4,gene/protein,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease3565,IL4,gene/protein,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased NADPH oxidase complex level,phenotype,Alzheimer disease351,Amyloid beta peptide (oligomer),gene/protein,increases_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease,NADPH oxidase complex,complex/PPI,affects_activity of,GO:0070997,neuron death,phenotype,Alzheimer disease3586,IL10,gene/protein,decreases_quantity of,,Cytokine,gene/protein,Alzheimer disease3586,IL10,gene/protein,increases_phosphorylation of,6774,STAT3,gene/protein,Alzheimer disease3586,IL10-mut,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,increases_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease,Reactive oxygen species,drug/chemical compound,increases_activity of,,neuroinflammation,phenotype,Alzheimer disease,Reactive oxygen species,drug/chemical compound,increases_quantity of,,Proinflammatory cytokine,gene/protein,Alzheimer disease,Reactive oxygen species,drug/chemical compound,increases_quantity of,7124,TNF,gene/protein,Alzheimer disease,Reactive oxygen species,drug/chemical compound,increases_quantity of,C00584,Prostaglandin E2,drug/chemical compound,Alzheimer disease,Reactive oxygen species,drug/chemical compound,increases_quantity of,3553,IL1B,gene/protein,Alzheimer disease3586,IL10,gene/protein,decreases_quantity of,,Chemokine,gene/protein,Alzheimer disease3586,IL10,gene/protein,increases_phosphorylation of,6772,STAT1,gene/protein,Alzheimer diseaseC07610,Silibinin,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (fibrillar),gene/protein,Alzheimer diseaseC07610,Silibinin,drug/chemical compound,decreases_activity of,GO:0070997,neuron death,process,Alzheimer diseaseC07610,Silibinin,drug/chemical compound,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseC07610,Silibinin,drug/chemical compound,decreases_activity of,MP:0004924,abnormal behavior,phenotype,Alzheimer diseaseC07610,Silibinin,drug/chemical compound,decreases_activity of,MP:0001363,increased anxiety-related response,phenotype,Alzheimer diseaseC07610,Silibinin,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (oligomer),gene/protein,Alzheimer diseaseC07610,Silibinin,drug/chemical compound,is_part_of,C01579,Flavonoid,drug/chemical compound,Alzheimer diseaseC07610,Silibinin,drug/chemical compound,decreases_activity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseC07610,Silibinin,drug/chemical compound,decreases_quantity of,C00027,H2O2,drug/chemical compound,Alzheimer diseaseMI0000558,let-7b,ncRNA/miRNA,increases_activity of,51284,TLR7,gene/protein,Alzheimer diseaseMI0000558,let-7b,ncRNA/miRNA,increases_activity of,BTO:0000078,microglia,tissue/cell line,Alzheimer diseaseMI0000558,let-7b,ncRNA/miRNA,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer diseaseMI0000558,let-7b,ncRNA/miRNA,increases_activity of,BTO:0000801,macrophage,tissue/cell line,Alzheimer diseaseMI0000558,let-7b,ncRNA/miRNA,increases_quantity of,7124,TNF,gene/protein,Alzheimer disease51284,TLR7,gene/protein,is localized in,BTO:0000227,central nervous system,tissue/cell line,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased let-7b level,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,,increased advanced glycation end-product level,phenotype,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,is localized in,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,is localized in,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer diseaseGO:0006979,response to oxidative stress,process,increases_activity of,,Advanced glycation end-product,drug/chemical compound,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_activity of,GO:0006979,response to oxidative stress,process,Alzheimer diseaseC00023,Iron,drug/chemical compound,increases_quantity of,,Advanced glycation end-product,drug/chemical compound,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_activity of,MP:0000604,amyloidosis,phenotype,Alzheimer diseaseC00070,Cu+,drug/chemical compound,increases_quantity of,,Advanced glycation end-product,drug/chemical compound,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_activity of,MP:0001614,abnormal blood vessel morphology,phenotype,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,is localized in,BTO:0003102,pyramidal neuron,tissue/cell line,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,interacts (colocalizes) with,BTO:0000099,astrocyte,tissue/cell line,Alzheimer diseaseGO:0006950,response to stress,process,affects_quantity of,4843,NOS2,gene/protein,Alzheimer diseaseGO:0006950,response to stress,process,affects_quantity of,4842,NOS1,gene/protein,Alzheimer diseaseGO:0006950,response to stress,process,affects_quantity of,6647,SOD1,gene/protein,Alzheimer diseaseGO:0006950,response to stress,process,affects_quantity of,5621,PRNP,gene/protein,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,cooccurs with,4137,MAPT-hyperphos,protein modification,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,interacts (colocalizes) with,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer disease4137,MAPT,gene/protein,affects_quantity of,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer diseaseMP:0004254,cerebral amyloid angiopathy,phenotype,cooccurs with,,increased advanced glycation end-product level,phenotype,Alzheimer disease,increased Carboxymethyllysine level,phenotype,cooccurs with,,increased MAPT level,phenotype,Alzheimer disease,Carboxymethyllysine,drug/chemical compound,is_part_of,,Advanced glycation end-product,drug/chemical compound,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_quantity of,351,Amyloid beta peptide (oligomer),gene/protein,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide (monomer),gene/protein,Alzheimer diseaseC14818,Fe2+,drug/chemical compound,increases_quantity of,351,Amyloid beta peptide (oligomer),gene/protein,Alzheimer diseaseC14819,Fe3+,drug/chemical compound,increases_quantity of,351,Amyloid beta peptide (oligomer),gene/protein,Alzheimer diseaseC00070,Cu+,drug/chemical compound,increases_quantity of,351,Amyloid beta peptide (oligomer),gene/protein,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_quantity of,,Reactive oxygen species,drug/chemical compound,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_activity of,GO:0006915,apoptotic process,process,Alzheimer diseaseC00777,Retinoic acid,drug/chemical compound,increases_activity of,,Advanced glycation end-product,drug/chemical compound,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_quantity of,C00051,Glutathione,drug/chemical compound,Alzheimer diseaseD00221,Acetylcysteine,drug/chemical compound,decreases_quantity of,C00051,Glutathione,drug/chemical compound,Alzheimer diseaseC00725,Lipoate,drug/chemical compound,decreases_quantity of,C00051,Glutathione,drug/chemical compound,Alzheimer diseaseC00951,Estradiol,drug/chemical compound,decreases_quantity of,C00051,Glutathione,drug/chemical compound,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_quantity of,C01432,Lactate,drug/chemical compound,Alzheimer diseaseGO:0071159,NF-kappaB complex,process,affects_activity of,,Advanced glycation end-product,drug/chemical compound,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_expression of,,Proinflammatory cytokine,gene/protein,Alzheimer disease177,AGER,gene/protein,affects_expression of,,Proinflammatory cytokine,gene/protein,Alzheimer diseaseBTO:0000801,macrophage,tissue/cell line,affects_quantity of,6347,CCL2,gene/protein,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,affects_quantity of,6347,CCL2,gene/protein,Alzheimer diseaseBTO:0000801,macrophage,tissue/cell line,affects_quantity of,7124,TNF,gene/protein,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,affects_quantity of,7124,TNF,gene/protein,Alzheimer diseaseC00338,Lipopolysaccharide,drug/chemical compound,affects_quantity of,2018,IL12A-IL12B complex,complex/PPI,Alzheimer diseaseC00338,Lipopolysaccharide,drug/chemical compound,affects_expression of,3458,IFNG,gene/protein,Alzheimer diseaseC00338,Lipopolysaccharide,drug/chemical compound,affects_expression of,3586,IL10,gene/protein,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,affects_quantity of,2018,IL12A-IL12B complex,complex/PPI,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,affects_expression of,3458,IFNG,gene/protein,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,affects_expression of,3586,IL10,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_quantity of,3553,pro-IL1B,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_quantity of,3569,IL6,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_quantity of,7124,TNF,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_quantity of,6347,CCL2,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_quantity of,3576,CXCL8,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_quantity of,6348,CCL3,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_quantity of,,M-CSF,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,8942,KYNU,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,3620,IDO1,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,increases_activity of,6279,S100A8,gene/protein,Alzheimer disease7124,TNF,gene/protein,increases_expression of,23621,BACE1,gene/protein,Alzheimer disease7124,TNF,gene/protein,increases_processing of,351,APP,gene/protein,Alzheimer disease7124,TNF,gene/protein,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_activity of,177,AGER,gene/protein,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,increases_activity of,7124,TNF,gene/protein,Alzheimer disease,M-CSF,gene/protein,increases_expression of,177,AGER,gene/protein,Alzheimer disease7124,TNF,gene/protein,increases_expression of,177,AGER,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C00546,Methylglyoxal,drug/chemical compound,Alzheimer diseaseGO:0046914,transition metal ion binding,process,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,affects_activity of,BTO:0000078,microglia,tissue/cell line,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,increases_expression of,,Class A scavenger receptor,complex/PPI,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,increases_expression of,948,CD36,gene/protein,Alzheimer disease948,CD36,gene/protein,affects_activity of,GO:0006909,phagocytosis,process,Alzheimer disease,Class A scavenger receptor,complex/PPI,affects_activity of,GO:0006909,phagocytosis,process,Alzheimer disease948,CD36,gene/protein,affects_activity of,GO:0097242,beta-amyloid clearance,process,Alzheimer disease,Class A scavenger receptor,complex/PPI,affects_activity of,GO:0097242,beta-amyloid clearance,process,Alzheimer diseaseBTO:0000801,macrophage,tissue/cell line,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer diseaseGO:0007568,aging,process,decreases_activity of,BTO:0000078,microglia,tissue/cell line,Alzheimer diseaseGO:0007568,aging,process,decreases_expression of,,Class A scavenger receptor,complex/PPI,Alzheimer diseaseGO:0007568,aging,process,decreases_expression of,177,AGER,gene/protein,Alzheimer diseaseGO:0007568,aging,process,decreases_expression of,948,CD36,gene/protein,Alzheimer diseaseGO:0007568,aging,process,decreases_expression of,3416,IDE,gene/protein,Alzheimer diseaseGO:0007568,aging,process,decreases_expression of,4311,MME,gene/protein,Alzheimer diseaseGO:0007568,aging,process,decreases_expression of,4318,MMP9,gene/protein,Alzheimer diseaseGO:0007568,aging,process,increases_expression of,,IL1,gene/protein,Alzheimer diseaseGO:0007568,aging,process,increases_expression of,7124,TNF,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,GO:0030073,insulin secretion,process,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased fasting glucose level,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,177,AGER,gene/protein,Alzheimer disease177,AGER,gene/protein,affects_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease177,AGER,gene/protein,is localized in,BTO:0000099,astrocyte,tissue/cell line,Alzheimer disease,Advanced glycation end-product,drug/chemical compound,is localized in,BTO:0000099,astrocyte,tissue/cell line,Alzheimer diseaseBTO:0000078,microglia,tissue/cell line,increases_expression of,177,AGER,gene/protein,Alzheimer diseaseBTO:0000938,neuron,tissue/cell line,increases_expression of,177,AGER,gene/protein,Alzheimer disease177,AGER (soluble splice variant),mRNA/protein variant,affects_activity of,GO:0006979,response to oxidative stress,process,Alzheimer disease177,AGER (soluble splice variant),mRNA/protein variant,affects_activity of,GO:0002544,chronic inflammatory response,process,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,decreased AGER (soluble splice variant) level,phenotype,Alzheimer disease,mild cognitive impairment,phenotype,cooccurs with,,decreased AGER (soluble splice variant) level,phenotype,Alzheimer disease177,AGER,gene/protein,interacts (colocalizes) with,,S100,gene/protein,Alzheimer disease177,AGER,gene/protein,interacts (colocalizes) with,3146,HMGB1,gene/protein,Alzheimer disease,Aminoguanidine,drug/chemical compound,decreases_activity of,,Advanced glycation end-product,drug/chemical compound,Alzheimer disease,Tenilsetam,drug/chemical compound,decreases_activity of,,Advanced glycation end-product,drug/chemical compound,Alzheimer disease,Tenilsetam,drug/chemical compound,decreases_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,Aminoguanidine,drug/chemical compound,decreases_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC00386,Carnosine,drug/chemical compound,decreases_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease177,AGER,gene/protein,affects transport of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC02477,alpha-Tocopherol,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,Estrogen,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC00725,Lipoate,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease203228,C9orf72 (GGGGCC-repeat expansion),gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,C9orf72 pathology,phenotype,Alzheimer disease54209,TREM2-mut,gene/protein mutant,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseasers75932628,TREM2 rs75932628,SNP,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased homocysteine level,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,MP:0006076,abnormal circulating homocysteine level,phenotype,Alzheimer disease,increased homocysteine level,phenotype,cooccurs with,,cognitive impairment,phenotype,Alzheimer diseaseC05776,Vitamin B12,drug/chemical compound,decreases_quantity of,C05330,Homocysteine,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,decreased folate level,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased homocystein level,phenotype,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,3458,IFNG,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,3586,IL10,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,,IL12A-IL12B complex,complex/PPI,Alzheimer disease,Epstein-Barr virus infection,process,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease,Epstein-Barr virus infection,process,affects_activity of,,B cell transformation,phenotype,Alzheimer disease29979,UBQLN1 (TV4),mRNA/protein variant,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease29979,UBQLN1 (TV3),mRNA/protein variant,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease29979,UBQLN1 (TV2),mRNA/protein variant,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer disease29979,UBQLN1 (TV1),mRNA/protein variant,is localized in,BTO:0000142,brain,tissue/cell line,Alzheimer diseasers12344615,UBQLN1 rs12344615,SNP,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseasers12344615,UBQLN1 rs12344615,SNP,affects_quantity of,29979,UBQLN1-var (TV2/TV1),mRNA/protein variant,Alzheimer disease29979,UBQLN1,gene/protein,affects transport of,351,APP,gene/protein,Alzheimer disease29979,UBQLN1 (TV3),mRNA/protein variant,affects_quantity of,5663,PSEN1,gene/protein,Alzheimer disease29979,UBQLN1 (TV3),mRNA/protein variant,affects transport of,5663,PSEN1,gene/protein,Alzheimer disease29979,UBQLN1 (TV1),mRNA/protein variant,affects transport of,5663,PSEN1,gene/protein,Alzheimer disease29979,UBQLN1 (TV1),mRNA/protein variant,interacts (colocalizes) with,5663,PSEN1,gene/protein,Alzheimer disease29979,UBQLN1,gene/protein,interacts (colocalizes) with,,MAP1LC3,gene/protein,Alzheimer disease29979,UBQLN1 (UBL domain),gene/protein,affects transport of,,PolyQ protein,gene/protein,Alzheimer disease,Abeta (2535) injected mouse,organism model,increases_activity of,,cognitive impairment,phenotype,Alzheimer diseaseD03753,Perindopril,drug/chemical compound,decreases_activity of,,cognitive impairment,phenotype,Alzheimer diseaseD07892,Enalapril,drug/chemical compound,decreases_activity of,,cognitive impairment,phenotype,Alzheimer diseaseD08068,Imidapril,drug/chemical compound,decreases_activity of,,cognitive impairment,phenotype,Alzheimer disease,ApoE4 transgenic mouse,organism model,increases_activity of,GO:0007611,learning or memory,process,Alzheimer disease,APP23 mouse,organism model,increases_activity of,,cognitive impairment,phenotype,Alzheimer disease29979,UBQLN1,gene/protein,affects_activity of,GO:0061077,chaperone-mediated protein folding,process,Alzheimer disease29979,UBQLN1,gene/protein,affects_processing of,351,APP,gene/protein,Alzheimer disease29979,UBQLN1,gene/protein,affects_processing of,GO:0042982,amyloid precursor protein metabolic process,process,Alzheimer disease177,AGER,gene/protein,increases_transport of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,AGER-Abeta interaction,complex/PPI,decreases_activity of,GO:0035633,maintenance of blood-brain barrier,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,affects_activity of,GO:0043114,regulation of vascular permeability,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,affects_expression of,7082,TJP1,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,affects_activity of,GO:0006816,calcium ion transport,process,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,affects transport of,,MMP,gene/protein,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,decreases_activity of,BTO:0004395,microvessel,tissue/cell line,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,increases_expression of,177,AGER,gene/protein,Alzheimer diseaseMP:0003329,amyloid beta deposits,phenotype,increases_quantity of,,MMP,gene/protein,Alzheimer disease351,"Amyloid beta peptide (soluble, 56K)",complex/PPI,affects_activity of,BTO:0000142,brain,tissue/cell line,Alzheimer disease351,"Amyloid beta peptide (soluble, 56K)",complex/PPI,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer diseaseGO:0006688,glycosphingolipid biosynthetic process,process,affects_quantity of,351,APP,gene/protein,Alzheimer diseaseGO:0006688,glycosphingolipid biosynthetic process,process,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,Glycosphingolipid,drug/chemical compound,affects_quantity of,351,sAPP,gene/protein,Alzheimer diseaseGO:0006688,glycosphingolipid biosynthetic process,process,affects_quantity of,,Glycosphingolipid,drug/chemical compound,Alzheimer diseaseD00234,Astemizole,drug/chemical compound,interacts (colocalizes) with,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer diseaseD00355,Lansoprazole,drug/chemical compound,interacts (colocalizes) with,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer diseaseD00234,Astemizole,drug/chemical compound,interacts (colocalizes) with,MP:0004250,tau protein deposits,phenotype,Alzheimer diseaseD00355,Lansoprazole,drug/chemical compound,interacts (colocalizes) with,MP:0004250,tau protein deposits,phenotype,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,increased kynurenine metabolism,phenotype,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,C00328,L-Kynurenine,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,C01717,Kynurenic acid,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,C02794,3-Hydroxykynurenine,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,883,CCBL1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,51166,AADAT,gene/protein,Alzheimer diseaseC01717,Kynurenic acid,drug/chemical compound,decreases_activity of,,NMDA receptor complex,complex/PPI,Alzheimer disease51166,AADAT,gene/protein,increases_quantity of,C01717,Kynurenic acid,drug/chemical compound,Alzheimer diseaseC00328,L-Kynurenine,drug/chemical compound,increases_activity of,,kynurenine pathway,process,Alzheimer diseaseGO:0097053,L-kynurenine catabolic process,process,increases_quantity of,C01717,Kynurenic acid,drug/chemical compound,Alzheimer diseaseGO:0097053,L-kynurenine catabolic process,process,increases_quantity of,C02794,3-Hydroxykynurenine,drug/chemical compound,Alzheimer diseaseGO:0019441,tryptophan catabolic process to kynurenine,process,increases_quantity of,C00328,L-Kynurenine,drug/chemical compound,Alzheimer diseaseD00458,Quetiapine fumarate,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseGO:0007568,aging,process,increases_quantity of,C05330,Homocysteine,drug/chemical compound,Alzheimer diseaseGO:0007568,aging,process,decreases_quantity of,C02170,Methylmalonate,drug/chemical compound,Alzheimer disease3458,IFNG,gene/protein,increases_activity of,GO:0001774,microglial cell activation,process,Alzheimer diseaseBTO:0001678,Th1-cell,tissue/cell line,affects_quantity of,3458,IFNG,gene/protein,Alzheimer disease3458,IFNG,gene/protein,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,APP/PS1 mouse,organism model,increases_expression of,351,APP,gene/protein,Alzheimer disease,APP/PS1 mouse,organism model,increases_expression of,5663,PSEN1,gene/protein,Alzheimer diseaseBTO:0000782,T-lymphocyte,tissue/cell line,increases_activity of,GO:0072615,interleukin-17 secretion,process,Alzheimer diseaseBTO:0000782,T-lymphocyte,tissue/cell line,increases_activity of,GO:0072643,interferon-gamma secretion,process,Alzheimer disease,APP/PS1 mouse,organism model,increases_quantity of,BTO:0000782,T-lymphocyte,tissue/cell line,Alzheimer diseaseMP:0002229,neurodegeneration,phenotype,affects_quantity of,C13550,24-Hydroxycholesterol,drug/chemical compound,Alzheimer disease,mild cognitive impairment,phenotype,affects_quantity of,C13550,24-Hydroxycholesterol,drug/chemical compound,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,C13550,24-Hydroxycholesterol,drug/chemical compound,Alzheimer diseaseC15473,Lithium,drug/chemical compound,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease4137,MAPT,gene/protein,affects_activity of,2534,FYN,gene/protein,Alzheimer disease2534,FYN,gene/protein,affects_activity of,,NMDA receptor complex,complex/PPI,Alzheimer diseaseC00220,Methylene blue,drug/chemical compound,decreases_quantity of,MP:0004250,tau protein deposits,phenotype,Alzheimer diseaseC00220,Methylene blue,drug/chemical compound,is_part_of,D02601,Phenothiazine,drug/chemical compound,Alzheimer diseaseC00220,Methylene blue,drug/chemical compound,decreases_quantity of,4137,MAPT,gene/protein,Alzheimer diseaseC00220,Methylene blue,drug/chemical compound,decreases_quantity of,4137,MAPT-phos,protein modification,Alzheimer diseaseC14078,Congo red,drug/chemical compound,increases_quantity of,MP:0004250,tau protein deposits,phenotype,Alzheimer diseaseC14078,Congo red,drug/chemical compound,is_part_of,,Anionic dye,drug/chemical compound,Alzheimer disease,Thiazine red,drug/chemical compound,is_part_of,,Anionic dye,drug/chemical compound,Alzheimer disease,Thioflavin S,drug/chemical compound,is_part_of,,Anionic dye,drug/chemical compound,Alzheimer disease,Thiazine red,drug/chemical compound,increases_quantity of,MP:0004250,tau protein deposits,phenotype,Alzheimer disease,Thioflavin S,drug/chemical compound,increases_quantity of,MP:0004250,tau protein deposits,phenotype,Alzheimer diseaseC00220,Methylene blue,drug/chemical compound,decreases_activity of,C14078,Congo red,drug/chemical compound,Alzheimer diseaseC00220,Methylene blue,drug/chemical compound,decreases_activity of,,Thiazine red,drug/chemical compound,Alzheimer diseaseC00220,Methylene blue,drug/chemical compound,decreases_activity of,,Thioflavin S,drug/chemical compound,Alzheimer disease4137,MAPT,gene/protein,interacts (colocalizes) with,,Anionic dye,drug/chemical compound,Alzheimer disease,Aminothienopyridazine,drug/chemical compound,decreases_quantity of,MP:0004250,tau protein deposits,phenotype,Alzheimer diseaseC00220,Methylene blue,drug/chemical compound,increases_activity of,GO:0016236,macroautophagy,process,Alzheimer diseaseGO:0016236,macroautophagy,process,affects_activity of,GO:0043526,neuroprotection,process,Alzheimer diseaseC00220,Methylene blue,drug/chemical compound,affects_activity of,,AMPK,complex/PPI,Alzheimer diseaseC07625,Chloroquine,drug/chemical compound,decreases_activity of,GO:0016236,macroautophagy,process,Alzheimer diseaseC00220,Methylene blue,drug/chemical compound,increases_expression of,5562,PRKAA1,gene/protein,Alzheimer diseaseC00220,Methylene blue,drug/chemical compound,increases_activity of,GO:0006754,ATP biosynthetic process,process,Alzheimer diseaseC00220,Methylene blue,drug/chemical compound,increases_expression of,5563,PRKAA2,gene/protein,Alzheimer diseaseC00220,Methylene blue,drug/chemical compound,increases_expression of,5564,PRKAB1,gene/protein,Alzheimer diseaseC00220,Methylene blue,drug/chemical compound,increases_expression of,5565,PRKAB2,gene/protein,Alzheimer disease,AMPK,complex/PPI,increases_quantity of,81631,MAP1LC3B,gene/protein,Alzheimer disease,increased 24-hydroxycholesterol level,phenotype,cooccurs with,,cognitive impairment,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,4803,NGF,gene/protein,Alzheimer disease,decreased TRKA level,phenotype,is localized in,,basal forebrain cortical neuron,cellular component,Alzheimer disease,decreased NGF level,phenotype,increases_activity of,MP:0002229,neurodegeneration,phenotype,Alzheimer disease,decreased NGF level,phenotype,affects_activity of,GO:0008291,acetylcholine metabolic process,process,Alzheimer disease,decreased NGF level,phenotype,decreases_expression of,1103,CHAT,gene/protein,Alzheimer disease,decreased NGF level,phenotype,decreases_expression of,43,ACHE,gene/protein,Alzheimer disease,decreased CHAT level,phenotype,cooccurs with,,mild cognitive impairment,phenotype,Alzheimer disease,decreased ACHE level,phenotype,cooccurs with,,mild cognitive impairment,phenotype,Alzheimer disease,amnesia,phenotype,cooccurs with,,mild cognitive impairment,phenotype,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,4914,NTRK1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,4803,ProNGF,gene/protein,Alzheimer disease4803,ProNGF,gene/protein,increases_activity of,GO:0006915,apoptotic process,process,Alzheimer disease627,BDNF,gene/protein,interacts (colocalizes) with,627,BDNF,gene/protein,Alzheimer disease627,BDNF,gene/protein,is localized in,GO:0044297,cell body,cellular component,Alzheimer disease627,BDNF,gene/protein,is localized in,GO:0030425,dendrite,cellular component,Alzheimer diseaseGO:0030425,dendrite,cellular component,affects transport of,627,BDNF,gene/protein,Alzheimer disease627,BDNF,gene/protein,interacts (colocalizes) with,4915,NTRK2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,decreased BDNF level,phenotype,Alzheimer disease,exercise,environment,increases_quantity of,627,BDNF,gene/protein,Alzheimer disease,cognitive stimulation,environment,increases_quantity of,627,BDNF,gene/protein,Alzheimer diseaseGO:0007568,aging,process,decreases_quantity of,627,BDNF,gene/protein,Alzheimer disease,increased Amyloid beta peptide (oligomer) level,phenotype,cooccurs with,,decreased BDNF level,phenotype,Alzheimer disease6750,SST,gene/protein,affects_expression of,4311,MME,gene/protein,Alzheimer disease,decreased MME level,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease,decreased MME level,phenotype,cooccurs with,,mild cognitive impairment,phenotype,Alzheimer disease9718,ECE2,gene/protein,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease1889,ECE1,gene/protein,is localized in,BTO:0000601,hippocampus,tissue/cell line,Alzheimer disease9718,ECE2,gene/protein,is localized in,BTO:0000601,hippocampus,tissue/cell line,Alzheimer disease1889,ECE1,gene/protein,is localized in,BTO:0000233,cerebral cortex,tissue/cell line,Alzheimer disease9718,ECE2,gene/protein,is localized in,BTO:0000233,cerebral cortex,tissue/cell line,Alzheimer disease,decreased EC2 level,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease,increased ECE2 level,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease,increased BACE1 level,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease,Hericium erinaceus (bearded tooth) supplementation,environment,decreases_activity of,351,Amyloid beta peptide (25-35),gene/protein,Alzheimer disease,Hericium erinaceus (bearded tooth) supplementation,environment,decreases_activity of,,spatial short-term impairment,process,Alzheimer disease,Hericium erinaceus (bearded tooth) supplementation,environment,decreases_activity of,,visual recognition memory impairment,process,Alzheimer disease,Hericium erinaceus (bearded tooth) supplementation,environment,increases_expression of,4803,NGF,gene/protein,Alzheimer disease,SP600125,drug/chemical compound,decreases_expression of,4803,NGF,gene/protein,Alzheimer disease,Hericium erinaceus (bearded tooth) supplementation,environment,increases_phosphorylation of,5599,MAPK8,gene/protein,Alzheimer disease,Hericium erinaceus (bearded tooth) supplementation,environment,increases_activity of,GO:0031175,neuron projection development,process,Alzheimer disease,SP600125,drug/chemical compound,decreases_activity of,,Hericium erinaceus (bearded tooth) supplementation,environment,Alzheimer disease,SP600125,drug/chemical compound,decreases_activity of,5599,MAPK8,gene/protein,Alzheimer disease,Hericium erinaceus (bearded tooth) supplementation,environment,increases_expression of,2353,FOS,gene/protein,Alzheimer disease,Hericium erinaceus (bearded tooth) supplementation,environment,increases_phosphorylation of,3725,JUN,gene/protein,Alzheimer disease,increased galanin level,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease,decreased alpha-MSH level,phenotype,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease5443,Alpha-MSH,gene/protein,is_part_of,5443,POMC,gene/protein,Alzheimer diseaseC09731,Epigallocatechin 3-gallate,drug/chemical compound,is_part_of,,Green tea polyphenol,drug/chemical compound,Alzheimer disease,ADAM10 (active),protein modification,increases_quantity of,351,APP (alpha-CTF),gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_quantity of,5443,ACTH,gene/protein,Alzheimer disease,mild cognitive impairment,phenotype,affects_activity of,GO:0034651,cortisol biosynthetic process,process,Alzheimer disease,mild cognitive impairment,phenotype,increases_quantity of,C00735,Cortisol,drug/chemical compound,Alzheimer disease,mild cognitive impairment,phenotype,affects_quantity of,5443,ACTH,gene/protein,Alzheimer diseaseC15473,Lithium,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD00326,Fluoxetine,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC15473,Lithium,drug/chemical compound,decreases_expression of,7124,TNF,gene/protein,Alzheimer diseaseD00326,Fluoxetine,drug/chemical compound,increases_expression of,114815,SORCS1,gene/protein,Alzheimer diseaseD00326,Fluoxetine,drug/chemical compound,increases_expression of,1191,CLU,gene/protein,Alzheimer diseaseD00326,Fluoxetine,drug/chemical compound,increases_expression of,4739,NEDD9,gene/protein,Alzheimer diseaseD00326,Fluoxetine,drug/chemical compound,increases_expression of,2896,GRN,gene/protein,Alzheimer diseaseD00326,Fluoxetine,drug/chemical compound,increases_expression of,1889,ECE1,gene/protein,Alzheimer disease,Atypical antipsychotic drug,drug/chemical compound,decreases_expression of,7018,TF,gene/protein,Alzheimer disease,Atypical antipsychotic drug,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD00426,Risperidone,drug/chemical compound,decreases_expression of,3553,IL1B,gene/protein,Alzheimer diseaseC07322,Olanzapine,drug/chemical compound,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC07322,Olanzapine,drug/chemical compound,increases_expression of,7019,TFAM,gene/protein,Alzheimer diseaseC07322,Olanzapine,drug/chemical compound,decreases_expression of,5621,PRNP,gene/protein,Alzheimer diseaseC15473,Lithium,drug/chemical compound,decreases_expression of,3553,IL1B,gene/protein,Alzheimer disease,Neuroleptic drug,drug/chemical compound,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease,Neuroleptic drug,drug/chemical compound,increases_expression of,7018,TF,gene/protein,Alzheimer diseaseGO:0097332,response to antipsychotic drug,process,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseD00136,Haloperidol,drug/chemical compound,increases_expression of,3553,IL1B,gene/protein,Alzheimer diseaseD00136,Haloperidol,drug/chemical compound,increases_expression of,54103,GSAP,gene/protein,Alzheimer diseaseD00136,Haloperidol,drug/chemical compound,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC07322,Olanzapine,drug/chemical compound,decreases_expression of,7067,THRA,gene/protein,Alzheimer diseaseC07322,Olanzapine,drug/chemical compound,increases_expression of,3552,IL1A,gene/protein,Alzheimer diseaseC07322,Olanzapine,drug/chemical compound,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC06906,Chlorpromazine,drug/chemical compound,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC06906,Chlorpromazine,drug/chemical compound,increases_expression of,3553,IL1B,gene/protein,Alzheimer diseaseC07049,Imipramine,drug/chemical compound,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC07049,Imipramine,drug/chemical compound,increases_expression of,3553,IL1B,gene/protein,Alzheimer diseaseC07107,Maprotiline,drug/chemical compound,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC07107,Maprotiline,drug/chemical compound,increases_expression of,3553,IL1B,gene/protein,Alzheimer diseaseC07571,Fluvoxamine,drug/chemical compound,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC06948,Diazepam,drug/chemical compound,increases_expression of,3553,IL1B,gene/protein,Alzheimer diseaseC06948,Diazepam,drug/chemical compound,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease1499,CTNNB1,gene/protein,increases_activity of,GO:0060070,canonical Wnt signaling pathway,process,Alzheimer disease,Pyrrolidine dithiocarbamate,drug/chemical compound,decreases_expression of,3656,IRAK2,gene/protein,Alzheimer disease,Pyrrolidine dithiocarbamate,drug/chemical compound,decreases_expression of,MI0000477,mir-146a,ncRNA/miRNA,Alzheimer disease,Pyrrolidine dithiocarbamate,drug/chemical compound,increases_expression of,3654,IRAK1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,132299,OCIAD2,gene/protein,Alzheimer disease132299,OCIAD2,gene/protein,increases_quantity of,351,APP,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,351,APP,gene/protein,Alzheimer disease3831,KLC1,gene/protein,affects_activity of,GO:0008088,axon cargo transport,process,Alzheimer disease1808,DPYSL2-mut,gene/protein mutant,increases_activity of,MP:0003651,abnormal axon outgrowth,phenotype,Alzheimer disease8743,TNFSF10,gene/protein,is_expressed_in,BTO:0000142,brain,tissue/cell line,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,79191,IRX3,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,367,AR,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,4843,NOS2,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,7421,VDR,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,4804,NGFR,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,904,CCNT1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,3416,IDE,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,117246,FTSJ3,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,3763,KCNJ6,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,4842,NOS1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,51196,PLCE1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,5562,PRKAA1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,6531,SLC6A3,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,4626,MYH8,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,2224,FDPS,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,3162,HMOX1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,1270,CNTF,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,6655,SOS2,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,2182,ACSL4,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,153,ADRB1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,19,ABCA1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,55937,APOM,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,2740,GLP1R,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,9023,CH25H,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,1889,ECE1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,11016,ATF7,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,increases_expression of,2162,F13A1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,9,NAT1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,345,APOC3,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,7479,WNT8B,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,4311,MME,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,347,APOD,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,4035,LRP1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,197,AHSG,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,9846,GAB2,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,4312,MMP1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,6947,TCN1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,23522,KAT6B,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,7133,TNFRSF1B,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,653145,ANXA8,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,948,CD36,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,1520,CTSS,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,2099,ESR1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,6425,SFRP5,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,5295,PIK3R1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,5451,POU2F1,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,7124,TNF,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,7067,THRA,gene/protein,Alzheimer disease,Amyloid beta peptide (42)-Al3+ complex,complex/PPI,decreases_expression of,2207,FCER1G,gene/protein,Alzheimer disease,Reactive oxygen species,drug/chemical compound,increases_activity of,GO:0006954,inflammatory response,process,Alzheimer disease2902,GRIN1,gene/protein,is_part_of,,NMDA receptor complex,complex/PPI,Alzheimer disease682,BSG,gene/protein,is_part_of,466,Gamma-secretase complex,complex/PPI,Alzheimer disease,Amyloid beta peptide (42),gene/protein,interacts (colocalizes) with,1139,CHRNA7,gene/protein,Alzheimer disease1139,CHRNA7,gene/protein,interacts (colocalizes) with,,Amyloid beta peptide (42),gene/protein,Alzheimer disease1139,CHRNA7,gene/protein,is_part_of,,Amyloid beta peptide (42)-CHRNA7 complex,complex/PPI,Alzheimer disease,Amyloid beta peptide (42),gene/protein,is_part_of,,Amyloid beta peptide (42)-CHRNA7 complex,complex/PPI,Alzheimer disease,Amyloid beta peptide (42)-CHRNA7 complex,complex/PPI,affects_expression of,84867,PTPN5,mRNA/protein variant,Alzheimer disease84867,PTPN5,mRNA/protein variant,decreases_activity of,5595,MAPK3,gene/protein,Alzheimer disease5595,MAPK3,gene/protein,affects_activity of,GO:0007611,learning or memory,process,Alzheimer disease104300,Alzheimer disease,disease,cooccurs with,,decreased AKT1-phos level,phenotype,Alzheimer disease125853,"Diabetes mellitus, type II",disease,increases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease23621,BACE1,gene/protein,increases_quantity of,351,APP (membrane-attached frag C99),gene/protein,Alzheimer disease5663,PSEN1,gene/protein,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease5664,PSEN2,gene/protein,affects_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer disease5663,PSEN1,gene/protein,affects_quantity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease5664,PSEN2,gene/protein,affects_quantity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease,Alpha-secretase,gene/protein,increases_quantity of,351,APP (C-terminal frag C83),gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,decreases_quantity of,351,APP (C-terminal frag C83),gene/protein,Alzheimer disease466,Gamma-secretase complex,complex/PPI,decreases_quantity of,351,APP (membrane-attached frag C99),gene/protein,Alzheimer disease351,APP (membrane-attached frag C99),gene/protein,increases_quantity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease351,APP (C-terminal frag C83),gene/protein,increases_quantity of,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,cooccurs with,104300,Alzheimer disease,disease,Alzheimer disease836,CASP3,gene/protein,increases_processing of,351,APP,gene/protein,Alzheimer disease836,CASP3,gene/protein,increases_quantity of,351,APP (cytotoxic frag C31),gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_activity of,23621,BACE1,gene/protein,Alzheimer disease2885,GRB2,gene/protein,interacts (colocalizes) with,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease25,ABL1,gene/protein,interacts (colocalizes) with,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease8650,NUMB,gene/protein,interacts (colocalizes) with,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease1600,DAB1,gene/protein,interacts (colocalizes) with,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease6464,SHC1,gene/protein,interacts (colocalizes) with,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease25759,SHC2,gene/protein,interacts (colocalizes) with,351,APP (intracellular domain AICD),gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,interacts (colocalizes) with,,NOTCH (intracellular domain NICD),gene/protein,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,affects_activity of,GO:0055074,calcium ion homeostasis,process,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,increases_activity of,GO:0008219,cell death,process,Alzheimer disease351,APP (intracellular domain AICD),gene/protein,interacts (colocalizes) with,7157,TP53 (promoter),gene/protein,Alzheimer disease351,APP (membrane-attached frag C99),gene/protein,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease351,APP,gene/protein,decreases_quantity of,1499,CTNNB1,gene/protein,Alzheimer disease351,APP,gene/protein,increases_phosphorylation of,1499,CTNNB1,gene/protein,Alzheimer disease351,Amyloid beta peptide (42),gene/protein,interacts (colocalizes) with,7855,FZD5,gene/protein,Alzheimer disease351,Amyloid beta peptide (40),gene/protein,interacts (colocalizes) with,7855,FZD5,gene/protein,Alzheimer disease351,Amyloid beta peptide (40),gene/protein,interacts (colocalizes) with,8322,FZD4,gene/protein,Alzheimer disease351,Amyloid beta peptide (40),gene/protein,decreases_quantity of,1499,CTNNB1,gene/protein,Alzheimer disease7376,NR1H2,gene/protein,affects_activity of,GO:0008203,cholesterol metabolic process,process,Alzheimer disease7376,NR1H2,gene/protein,affects_activity of,GO:0002263,cell activation involved in immune response,process,Alzheimer disease,Uncharged thioflavin-T derivative,drug/chemical compound,interacts (colocalizes) with,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease,Uncharged thioflavin-T derivative,drug/chemical compound,interacts (colocalizes) with,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer disease2932,GSK3B,gene/protein,affects_activity of,1020,CDK5,gene/protein,Alzheimer disease,increased APP level,phenotype,cooccurs with,,decreased cytochrome oxidase activity,phenotype,Alzheimer disease,increased APP level,phenotype,cooccurs with,,increased H2O2 generation,phenotype,Alzheimer disease,increased APP level,phenotype,cooccurs with,,impaired mitochondrial reducing capacity,phenotype,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,1508,CTSB,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,7416,VDAC1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,1073,CFL2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,10015,PDCD6IP,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,9744,ACAP1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,9104,RGN,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,506,ATP5B,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_quantity of,132,ADK,gene/protein,Alzheimer disease,potassium channel Kv3,complex/PPI,increases_activity of,GO:0019228,neuronal action potential,process,Alzheimer disease3749,KCNC4,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease3746,KCNC1,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,3749,KCNC4,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_quantity of,3749,KCNC4,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,increases_phosphorylation of,1809,DPYSL3,gene/protein,Alzheimer disease351,Amyloid beta peptide (endogenous),gene/protein,increases_quantity of,4137,MAPT-hyperphos,protein modification,Alzheimer disease26133,TRPC4AP,gene/protein,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseasers1925690,ZNF292 rs1925690,SNP,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseasers1925690,ZNF292 rs1925690,SNP,increases_activity of,MP:0006300,abnormal entorhinal cortex morphology,phenotype,Alzheimer diseasers11129640,ARPP21 rs11129640,SNP,increases_activity of,104300,Alzheimer disease,disease,Alzheimer diseasers11129640,ARPP21 rs11129640,SNP,increases_activity of,MP:0006300,abnormal entorhinal cortex morphology,phenotype,Alzheimer disease8301,PICALM,gene/protein,decreases_activity of,104300,Alzheimer disease,disease,Alzheimer disease23036,ZNF292,gene/protein,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease10777,ARPP21,gene/protein,increases_activity of,104300,Alzheimer disease,disease,Alzheimer disease8564,KMO,gene/protein,increases_activity of,GO:0097053,L-kynurenine catabolic process,process,Alzheimer disease23475,QPRT,gene/protein,decreases_quantity of,C03722,Quinolinic acid,drug/chemical compound,Alzheimer diseaseC00328,L-Kynurenine,drug/chemical compound,increases_quantity of,C01717,Kynurenic acid,drug/chemical compound,Alzheimer diseaseC00328,L-Kynurenine,drug/chemical compound,increases_quantity of,C02794,3-Hydroxykynurenine,drug/chemical compound,Alzheimer disease8564,KMO,gene/protein,decreases_quantity of,C00328,L-Kynurenine,drug/chemical compound,Alzheimer disease8942,KYNU,gene/protein,decreases_quantity of,C02794,3-Hydroxykynurenine,drug/chemical compound,Alzheimer disease8942,KYNU,gene/protein,increases_quantity of,C00632,3-Hydroxyanthranilate,drug/chemical compound,Alzheimer disease8564,KMO,gene/protein,increases_quantity of,C02794,3-Hydroxykynurenine,drug/chemical compound,Alzheimer disease23498,HAAO,gene/protein,increases_quantity of,C03722,Quinolinic acid,drug/chemical compound,Alzheimer disease23498,HAAO,gene/protein,decreases_quantity of,C00632,3-Hydroxyanthranilate,drug/chemical compound,Alzheimer disease23475,QPRT,gene/protein,increases_quantity of,,Nicotinic acid mononucleotide,drug/chemical compound,Alzheimer disease3620,IDO1,gene/protein,decreases_quantity of,C00806,Tryptophan,drug/chemical compound,Alzheimer disease3620,IDO1,gene/protein,increases_quantity of,C02700,L-Formylkynurenine,drug/chemical compound,Alzheimer disease125061,AFMID,gene/protein,increases_quantity of,C00328,L-Kynurenine,drug/chemical compound,Alzheimer disease125061,AFMID,gene/protein,decreases_quantity of,C02700,L-Formylkynurenine,drug/chemical compound,Alzheimer disease883,CCBL1,gene/protein,increases_quantity of,C01717,Kynurenic acid,drug/chemical compound,Alzheimer disease883,CCBL1,gene/protein,decreases_quantity of,C00328,L-Kynurenine,drug/chemical compound,Alzheimer disease51166,AADAT,gene/protein,decreases_quantity of,C00328,L-Kynurenine,drug/chemical compound,Alzheimer disease1410,CRYAB,gene/protein,increases_activity of,,protein homeostasis,process,Alzheimer disease1410,CRYAB,gene/protein,interacts (colocalizes) with,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease1410,CRYAB,gene/protein,decreases_activity of,,uncontrolled protein aggregation,process,Alzheimer disease1410,CRYAB,gene/protein,interacts (colocalizes) with,4069,LYZ,gene/protein,Alzheimer disease1410,CRYAB,gene/protein,affects_activity of,GO:0061077,chaperone-mediated protein folding,process,Alzheimer disease1410,CRYAB,gene/protein,increases_activity of,GO:0006461,protein complex assembly,process,Alzheimer disease1410,CRYAB,gene/protein,decreases_activity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease1410,CRYAB,gene/protein,decreases_quantity of,MP:0003329,amyloid beta deposits,phenotype,Alzheimer disease51738,Ghrelin,gene/protein,increases_activity of,GO:0000502,proteasome complex,cellular component,Alzheimer disease51738,Ghrelin,gene/protein,increases_activity of,,cell viability,process,Alzheimer disease51738,Ghrelin,gene/protein,is localized in,,parietal cell of gastrointestinal tract,tissue/cell line,Alzheimer disease351,APP,gene/protein,increases_expression of,2693,GHSR,gene/protein,Alzheimer disease51738,Ghrelin,gene/protein,decreases_activity of,GO:0000502,proteasome complex,process,Alzheimer disease51738,Ghrelin,gene/protein,increases_activity of,GO:0006915,apoptotic process,process,Alzheimer disease51738,Ghrelin,gene/protein,increases_activity of,GO:0006914,autophagy,process,Alzheimer disease51738,Ghrelin,gene/protein,increases_expression of,596,BCL2,gene/protein,Alzheimer disease51738,Ghrelin,gene/protein,increases_expression of,8678,BECN1,gene/protein,Alzheimer disease51738,Ghrelin,gene/protein,increases_expression of,,MAP1LC3,gene/protein,Alzheimer disease51738,Ghrelin,gene/protein,increases_expression of,8878,SQSTM1,gene/protein,Alzheimer disease51738,Ghrelin,gene/protein,decreases_activity of,1508,CTSB,gene/protein,Alzheimer disease51738,Ghrelin,gene/protein,increases_expression of,5111,PCNA,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_activity of,,AMPK,complex/PPI,Alzheimer diseaseMP:0000807,abnormal hippocampus morphology,phenotype,affects_activity of,BTO:0000601,hippocampus,tissue/cell line,Alzheimer disease10891,PPARGC1A,gene/protein,affects_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,2026,ENO2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,4233,MET,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,321,APBA2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,6285,S100B,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,968,CD68,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,199,AIF1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,3958,LGALS3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2015,EMR1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,4155,MBP,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,6663,SOX10,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,4340,MOG,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,4099,MAG,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,1113,CHGA,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,203068,TUBB,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,6855,SYP,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,4744,NEFH,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,4741,NEFM,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,4747,NEFL,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,6616,SNAP25,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,6857,SYT1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,146713,RBFOX3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,5999,RGS4,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,9956,HS3ST2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,4885,NPTX2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,63974,NEUROD6,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,5874,RAB27B,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,348980,HCN1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,9456,HOMER1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,2697,GJA1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,165,AEBP1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,117248,GALNT15,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,321,APBA2,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,491,ATP2B2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,491,ATP2B2,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,1141,CHRNB2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,1141,CHRNB2,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,10815,CPLX1,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,1950,EGF,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,1950,EGF,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,1960,EGR3,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,1996,ELAVL4,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,2554,GABRA1,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,2557,GABRA4,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,2558,GABRA5,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,2566,GABRG2,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,2743,GLRB,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,2743,GLRB,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,9456,HOMER1,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,3251,HPRT1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,3251,HPRT1,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,9215,LARGE,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,4747,NEFL,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,5122,PCSK1,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,26051,PPP1R16B,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,26051,PPP1R16B,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,5579,PRKCB,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,5999,RGS4,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,6000,RGS7,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,6014,RIT2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,6014,RIT2,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,57030,SLC17A7,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,57030,SLC17A7,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,23657,SLC7A11,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,23657,SLC7A11,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,6616,SNAP25,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,11075,STMN2,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,6860,SYT4,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,9066,SYT7,gene/protein,Alzheimer disease181500,Schizophrenia,disease,affects_activity of,10628,TXNIP,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,5774,PTPN3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,5176,SERPINF1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,7422,VEGFA,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,1960,EGR3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,9118,INA,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,747,DAGLA,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,64405,CDH22,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,10040,TOM1L1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,54472,TOLLIP,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,56993,TOMM22,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,2554,GABRA1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,2675,GFRA2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,10815,CPLX1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,51305,KCNK9,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,6000,RGS7,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,398,ARHGDIG,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,2566,GABRG2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,11075,STMN2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,3897,L1CAM,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,9066,SYT7,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,6861,SYT5,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,2557,GABRA4,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,3763,KCNJ6,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,112755,STX1B,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,2558,GABRA5,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,5798,PTPRN,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,6860,SYT4,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,1848,DUSP6,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,6853,SYN1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,84867,PTPN5,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,5799,PTPRN2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,10628,TXNIP,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,7412,VCAM1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,284,ANGPT1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,3595,IL12RB2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,5579,PRKCB,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,644150,WIPF3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,51299,NRN1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,8507,ENC1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,6304,SATB1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,221692,PHACTR1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,1996,ELAVL4,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,2170,FABP3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,65985,AACS,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,9215,LARGE,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,6712,SPTBN2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,7532,YWHAG,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,5126,PCSK2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,5122,PCSK1,gene/protein,Alzheimer disease601665,Obesity,disease,affects_activity of,165,AEBP1,gene/protein,Alzheimer disease601665,Obesity,disease,affects_activity of,11238,CA5B,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,increases_expression of,11238,CA5B,gene/protein,Alzheimer disease601665,Obesity,disease,affects_activity of,887,CCKBR,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,887,CCKBR,gene/protein,Alzheimer disease601665,Obesity,disease,affects_activity of,1141,CHRNB2,gene/protein,Alzheimer disease601665,Obesity,disease,affects_activity of,126129,CPT1C,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,126129,CPT1C,gene/protein,Alzheimer disease601665,Obesity,disease,affects_activity of,2554,GABRA1,gene/protein,Alzheimer disease601665,Obesity,disease,affects_activity of,2557,GABRA4,gene/protein,Alzheimer disease601665,Obesity,disease,affects_activity of,2558,GABRA5,gene/protein,Alzheimer disease601665,Obesity,disease,affects_activity of,2566,GABRG2,gene/protein,Alzheimer disease601665,Obesity,disease,affects_activity of,5122,PCSK1,gene/protein,Alzheimer disease601665,Obesity,disease,affects_activity of,6860,SYT4,gene/protein,Alzheimer disease601665,Obesity,disease,affects_activity of,7422,VEGFA,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,63982,ANO3,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,534,ATP6V1G2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,26033,ATRNL1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,407738,FAM19A1,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,9758,FRMPD4,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,9568,GABBR2,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,5601,MAPK9,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,5550,PREP,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,6534,SLC6A7,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,affects_expression of,64409,WBSCR17,gene/protein,Alzheimer disease104300,Alzheimer disease,disease,decreases_expression of,57630,SH3RF1,gene/protein,Alzheimer disease,AMPK,complex/PPI,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease6794,STK11,gene/protein,increases_phosphorylation of,,AMPK,complex/PPI,Alzheimer disease,AMPK,complex/PPI,decreases_activity of,GO:0031929,TOR signaling,process,Alzheimer disease10645,CAMKK2,gene/protein,increases_phosphorylation of,,AMPK,complex/PPI,Alzheimer disease6794,STK11,gene/protein,increases_activity of,,AMPK,complex/PPI,Alzheimer disease10645,CAMKK2,gene/protein,increases_activity of,,AMPK,complex/PPI,Alzheimer disease,AMPK,complex/PPI,increases_activity of,GO:0006914,autophagy,process,Alzheimer disease,PRKAA,gene/protein,is_part_of,,AMPK,complex/PPI,Alzheimer disease,PRKAB,gene/protein,is_part_of,,AMPK,complex/PPI,Alzheimer disease,PRKAG,gene/protein,is_part_of,,AMPK,complex/PPI,Alzheimer disease,PRKAA,gene/protein,is_expressed_in,BTO:0000938,neuron,tissue/cell line,Alzheimer disease,PRKAB,gene/protein,is_expressed_in,BTO:0000938,neuron,tissue/cell line,Alzheimer disease,PRKAG,gene/protein,is_expressed_in,BTO:0000938,neuron,tissue/cell line,Alzheimer disease,AMPK,complex/PPI,affects_activity of,GO:0097009,energy homeostasis,process,Alzheimer diseaseD04966,Metformin,drug/chemical compound,increases_activity of,,AMPK,complex/PPI,Alzheimer disease23621,BACE1,gene/protein,increases_processing of,351,APP,gene/protein,Alzheimer diseaseC04677,AICAR,drug/chemical compound,increases_activity of,,AMPK,complex/PPI,Alzheimer disease,AMPK,complex/PPI,decreases_phosphorylation of,4137,MAPT,gene/protein,Alzheimer disease,Compound C,drug/chemical compound,decreases_activity of,,AMPK,complex/PPI,Alzheimer disease,Compound C,drug/chemical compound,increases_phosphorylation of,4137,MAPT,gene/protein,Alzheimer disease,AMPK,complex/PPI,increases_phosphorylation of,4137,MAPT,gene/protein,Alzheimer disease,AMPK,complex/PPI,affects_activity of,GO:0008017,microtubule binding,process,Alzheimer disease104300,Alzheimer disease,disease,affects_activity of,GO:0006914,autophagy,process,Alzheimer diseaseGO:0031929,TOR signaling,process,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseGO:0031929,TOR signaling,process,decreases_quantity of,4137,MAPT,gene/protein,Alzheimer diseaseGO:0031929,TOR signaling,process,affects_activity of,104300,Alzheimer disease,disease,Alzheimer diseaseC07909,Rapamycin,drug/chemical compound,increases_activity of,GO:0007611,learning or memory,process,Alzheimer diseaseC07909,Rapamycin,drug/chemical compound,decreases_activity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC07909,Rapamycin,drug/chemical compound,decreases_activity of,4137,MAPT,gene/protein,Alzheimer disease,AMPK,complex/PPI,increases_phosphorylation of,8408,ULK1,gene/protein,Alzheimer disease,AMPK,complex/PPI,increases_activity of,8408,ULK1,gene/protein,Alzheimer disease8408,ULK1,gene/protein,increases_activity of,GO:0006914,autophagy,process,Alzheimer disease2475,MTOR,gene/protein,decreases_activity of,GO:0006914,autophagy,process,Alzheimer diseaseC00076,Ca2+,drug/chemical compound,increases_activity of,GO:0006914,autophagy,process,Alzheimer diseaseC00076,Ca2+,drug/chemical compound,increases_activity of,10645,CAMKK2,gene/protein,Alzheimer diseaseC03582,Resveratrol,drug/chemical compound,increases_activity of,,AMPK,complex/PPI,Alzheimer diseaseC03582,Resveratrol,drug/chemical compound,increases_quantity of,C00076,Ca2+,drug/chemical compound,Alzheimer diseaseC03582,Resveratrol,drug/chemical compound,increases_phosphorylation of,,AMPK,drug/chemical compound,Alzheimer diseaseC03582,Resveratrol,drug/chemical compound,decreases_activity of,2475,MTOR,gene/protein,Alzheimer diseaseC03582,Resveratrol,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseC03582,Resveratrol,drug/chemical compound,increases_activity of,GO:0006914,autophagy,process,Alzheimer diseaseC03582,Resveratrol,drug/chemical compound,increases_activity of,10645,CAMKK2,gene/protein,Alzheimer disease,RSVA314,drug/chemical compound,increases_activity of,10645,CAMKK2,gene/protein,Alzheimer disease,RSVA314,drug/chemical compound,increases_activity of,,AMPK,complex/PPI,Alzheimer disease,RSVA314,drug/chemical compound,decreases_activity of,2475,MTOR,gene/protein,Alzheimer disease,RSVA314,drug/chemical compound,increases_activity of,GO:0006914,autophagy,process,Alzheimer disease,RSVA314,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,RSVA405,drug/chemical compound,increases_activity of,10645,CAMKK2,gene/protein,Alzheimer disease,RSVA405,drug/chemical compound,increases_activity of,,AMPK,complex/PPI,Alzheimer disease,RSVA405,drug/chemical compound,decreases_activity of,2475,MTOR,gene/protein,Alzheimer disease,RSVA405,drug/chemical compound,increases_activity of,GO:0006914,autophagy,process,Alzheimer disease,RSVA405,drug/chemical compound,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer diseaseGO:0006914,autophagy,process,decreases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease,AMPK,complex/PPI,decreases_activity of,2475,MTOR,gene/protein,Alzheimer disease2475,MTOR,gene/protein,increases_activity of,GO:0031929,TOR signaling,process,Alzheimer disease,AMPK,complex/PPI,increases_activity of,,Tauopathy,disease,Alzheimer diseaseC01598,Melatonin,drug/chemical compound,increases_activity of,C03582,Resveratrol,drug/chemical compound,Alzheimer disease4137,MAPT-var (4R),mRNA/protein variant,increases_activity of,GO:0008017,microtubule binding,process,Alzheimer disease4137,MAPT-var (3R),mRNA/protein variant,increases_activity of,5880,RAC2,gene/protein,Alzheimer disease4137,MAPT-var (3R),mRNA/protein variant,affects_activity of,GO:0035567,non-canonical Wnt signaling pathway,process,Alzheimer disease6421,SFPQ,gene/protein,increases_quantity of,4137,MAPT-var (3R),mRNA/protein variant,Alzheimer disease6421,SFPQ,gene/protein,interacts (colocalizes) with,4137,MAPT,gene/protein,Alzheimer diseaseC15473,Lithium,drug/chemical compound,decreases_phosphorylation of,4137,MAPT,gene/protein,Alzheimer diseaseC15473,Lithium,drug/chemical compound,decreases_activity of,,cognitive impairment,phenotype,Alzheimer diseaseC15473,Lithium,drug/chemical compound,decreases_phosphorylation of,2931,GSK3A,gene/protein,Alzheimer diseaseC15473,Lithium,drug/chemical compound,decreases_phosphorylation of,2932,GSK3B,gene/protein,Alzheimer disease2932,GSK3B,gene/protein,decreases_quantity of,351,Amyloid beta peptide (40),gene/protein,Alzheimer disease2932,GSK3B,gene/protein,decreases_quantity of,351,Amyloid beta peptide (42),gene/protein,Alzheimer diseaseC00076,Ca2+,drug/chemical compound,increases_activity of,823,CAPN1,gene/protein,Alzheimer diseaseGO:0055074,calcium ion homeostasis,process,affects_activity of,823,CAPN1,gene/protein,Alzheimer disease823,CAPN1,gene/protein,increases_expression of,23621,BACE1,gene/protein,Alzheimer disease,12/15-Lipoxygenase,gene/protein,increases_activity of,,cognitive impairment,phenotype,Alzheimer disease23621,BACE1,gene/protein,increases_quantity of,351,Amyloid beta peptide,gene/protein,Alzheimer disease823,CAPN1,gene/protein,increases_quantity of,4137,MAPT-hyperphos,protein modification,Alzheimer disease4137,MAPT-hyperphos,protein modification,increases_quantity of,MP:0003214,neurofibrillary tangles,phenotype,Alzheimer disease8851,CDK5R1,gene/protein,increases_quantity of,8851,p25,gene/protein,Alzheimer disease823,CAPN1,gene/protein,increases_quantity of,8851,p25,gene/protein,Alzheimer diseaseC01595,Linoleic acid,drug/chemical compound,decreases_activity of,823,CAPN1,gene/protein,Alzheimer diseaseGO:0007568,aging,process,increases_activity of,,increased advanced glycation end-product level,phenotype,Alzheimer diseaseGO:0001774,microglial cell activation,process,increases_activity of,,NADPH oxidase complex,complex/PPI,Alzheimer disease